Full Transcript
Read or copy the complete episode transcript.
My question as a longevity researcher is My question as a longevity researcher is why do you age? What drives aging? Dr. why do you age? What drives aging? Dr. why do you age? What drives aging? Dr. Steve Horvath, professor of human Steve Horvath, professor of human Steve Horvath, professor of human genetics. He's got a lot of background genetics. He's got a lot of background genetics. He's got a lot of background that has led to a landmark finding in that has led to a landmark finding in that has led to a landmark finding in biio medicine, the Horvath clock. biio medicine, the Horvath clock. biio medicine, the Horvath clock. >> I've heard people out there talk about >> I've heard people out there talk about >> I've heard people out there talk about reversing their biological age by 5 reversing their biological age by 5 reversing their biological age by 5 years in 7 months. Is that something years in 7 months. Is that something years in 7 months. Is that something that you think could be a real biologic that you think could be a real biologic that you think could be a real biologic effect? effect? effect? >> It's all about prevention. If you start >> It's all about prevention. If you start >> It's all about prevention. If you start with a person who was obese, had with a person who was obese, had with a person who was obese, had inflammation, diabetes, and they really inflammation, diabetes, and they really inflammation, diabetes, and they really changed everything, it would perhaps be changed everything, it would perhaps be changed everything, it would perhaps be possible. possible. possible. >> Let's talk about the multivitamin. So, >> Let's talk about the multivitamin. So, >> Let's talk about the multivitamin. So, this was the Cosmos trial, and at the this was the Cosmos trial, and at the this was the Cosmos trial, and at the end of the trial, the the people that end of the trial, the the people that end of the trial, the the people that were given the multivitamin had slowed were given the multivitamin had slowed were given the multivitamin had slowed their brain aging by 2.1 years. But their brain aging by 2.1 years. But their brain aging by 2.1 years. But another area that's very exciting has to another area that's very exciting has to another area that's very exciting has to do with our mental health and our our do with our mental health and our our do with our mental health and our our social relationships. This was the social relationships. This was the social relationships. This was the biggest surprise to me and why would biggest surprise to me and why would biggest surprise to me and why would that translate to changes on the DNA that translate to changes on the DNA that translate to changes on the DNA molecule in blood and the great surprise molecule in blood and the great surprise molecule in blood and the great surprise to me was to me was to me was before we get started today. I just before we get started today. I just before we get started today. I just wanted to frame this episode. My guest wanted to frame this episode. My guest wanted to frame this episode. My guest Dr. Steve Horvath is really a legend and Dr. Steve Horvath is really a legend and Dr. Steve Horvath is really a legend and one of the most important scientists in one of the most important scientists in one of the most important scientists in the modern biology of aging. He's the modern biology of aging. He's the modern biology of aging. He's someone whose work has fundamentally someone whose work has fundamentally someone whose work has fundamentally changed how scientists can actually changed how scientists can actually changed how scientists can actually measure aging itself. For that reason, measure aging itself. For that reason, measure aging itself. For that reason, Steve and I go a little deep into Steve and I go a little deep into Steve and I go a little deep into explaining some of these epigenetic explaining some of these epigenetic explaining some of these epigenetic clocks because we have to lay the clocks because we have to lay the clocks because we have to lay the foundation. But I promise you, after the foundation. But I promise you, after the foundation. But I promise you, after the first 20 minutes or so, which may be a first 20 minutes or so, which may be a first 20 minutes or so, which may be a little technical for a few of you, we're little technical for a few of you, we're little technical for a few of you, we're going to get into all those practical going to get into all those practical going to get into all those practical questions that everyone wants answered, questions that everyone wants answered, questions that everyone wants answered, like, can vitamin supplements slow like, can vitamin supplements slow like, can vitamin supplements slow aging? What type of exercise is best to aging? What type of exercise is best to aging? What type of exercise is best to slow aging? Is there a good diet that slow aging? Is there a good diet that slow aging? Is there a good diet that can slow aging? And is it actually can slow aging? And is it actually can slow aging? And is it actually possible to reverse aging itself? So, possible to reverse aging itself? So, possible to reverse aging itself? So, all that's coming up, so please stick all that's coming up, so please stick all that's coming up, so please stick around. And lastly, I want to mention around. And lastly, I want to mention around. And lastly, I want to mention that only about 10% of you watching this that only about 10% of you watching this that only about 10% of you watching this podcast are actually subscribed to the podcast are actually subscribed to the podcast are actually subscribed to the YouTube channel. So, if you could please YouTube channel. So, if you could please YouTube channel. So, if you could please just press pause for a second and just press pause for a second and just press pause for a second and subscribe to my podcast, enable subscribe to my podcast, enable subscribe to my podcast, enable notifications, it's really one of the notifications, it's really one of the notifications, it's really one of the easiest ways that you can support what easiest ways that you can support what easiest ways that you can support what we're doing here. You can support the we're doing here. You can support the we're doing here. You can support the show, and you can help us amplify our show, and you can help us amplify our show, and you can help us amplify our message. We really greatly appreciate message. We really greatly appreciate message. We really greatly appreciate it. Thank you so much, and enjoy this it. Thank you so much, and enjoy this it. Thank you so much, and enjoy this episode with Dr. Steve Horvath. Welcome episode with Dr. Steve Horvath. Welcome episode with Dr. Steve Horvath. Welcome back to the podcast. I am sitting here back to the podcast. I am sitting here back to the podcast. I am sitting here with Dr. Steve Horvath. Steve, good to with Dr. Steve Horvath. Steve, good to with Dr. Steve Horvath. Steve, good to see you again. This is the second time see you again. This is the second time see you again. This is the second time you've been on this podcast. You have you've been on this podcast. You have you've been on this podcast. You have been incredibly influential in the been incredibly influential in the been incredibly influential in the longevity field. You are the developer longevity field. You are the developer longevity field. You are the developer of the original Horvath epigenetic aging of the original Horvath epigenetic aging of the original Horvath epigenetic aging clock, which is really revolutionized clock, which is really revolutionized clock, which is really revolutionized the way the aging field has been able to the way the aging field has been able to the way the aging field has been able to measure biological aging. So, thanks for measure biological aging. So, thanks for measure biological aging. So, thanks for coming back on the show. coming back on the show. coming back on the show. >> Yeah, thank you. I'm very excited to be >> Yeah, thank you. I'm very excited to be >> Yeah, thank you. I'm very excited to be here. Um, the science has evolved quite here. Um, the science has evolved quite here. Um, the science has evolved quite a bit from the last time we spoke. So, a bit from the last time we spoke. So, a bit from the last time we spoke. So, it's a wonderful opportunity for me to it's a wonderful opportunity for me to it's a wonderful opportunity for me to talk to you and your audience. talk to you and your audience. talk to you and your audience. >> I'm so excited. I mean, the last time we >> I'm so excited. I mean, the last time we >> I'm so excited. I mean, the last time we spoke was in 2019, so I would hope that spoke was in 2019, so I would hope that spoke was in 2019, so I would hope that there's been a lot of new exciting data there's been a lot of new exciting data there's been a lot of new exciting data to discuss. But um you know may maybe to discuss. But um you know may maybe to discuss. But um you know may maybe this the way we could start this is for this the way we could start this is for this the way we could start this is for people who might be new to the field people who might be new to the field people who might be new to the field this idea of biological aging and this idea of biological aging and this idea of biological aging and explaining what biological aging means. explaining what biological aging means. explaining what biological aging means. It's a good question. Everyone talks It's a good question. Everyone talks It's a good question. Everyone talks about biologic age but it has so many about biologic age but it has so many about biologic age but it has so many different definitions. So for many different definitions. So for many different definitions. So for many people biologic age refers to fertility people biologic age refers to fertility people biologic age refers to fertility issues as an example. Um, broadly it issues as an example. Um, broadly it issues as an example. Um, broadly it relates to this phenomenon that people relates to this phenomenon that people relates to this phenomenon that people of the same age have um different of the same age have um different of the same age have um different mortality risks, morbidity risks or mortality risks, morbidity risks or mortality risks, morbidity risks or people who um you know from your high people who um you know from your high people who um you know from your high school they look older or younger than school they look older or younger than school they look older or younger than you. All of that is in that concept of you. All of that is in that concept of you. All of that is in that concept of biologic age. Um however um longevity biologic age. Um however um longevity biologic age. Um however um longevity researchers or um geroscientists who researchers or um geroscientists who researchers or um geroscientists who study aging um really um conceptualize study aging um really um conceptualize study aging um really um conceptualize biological age using measurement biological age using measurement biological age using measurement technologies. How do you get a number uh technologies. How do you get a number uh technologies. How do you get a number uh for measuring biologic age and the field for measuring biologic age and the field for measuring biologic age and the field has really exploded over the last uh 13 has really exploded over the last uh 13 has really exploded over the last uh 13 14 years. Um people have developed 14 years. Um people have developed 14 years. Um people have developed biologic age measures based on biologic age measures based on biologic age measures based on variables, step counts, gate speed, variables, step counts, gate speed, variables, step counts, gate speed, which is very exciting. Many imaging which is very exciting. Many imaging which is very exciting. Many imaging data um you can measure your brain age data um you can measure your brain age data um you can measure your brain age um based on imaging for example. Um my um based on imaging for example. Um my um based on imaging for example. Um my field is um in in the realm of molecular field is um in in the realm of molecular field is um in in the realm of molecular markers of uh aging. Um so I work on um markers of uh aging. Um so I work on um markers of uh aging. Um so I work on um epigenetic marks um and we can talk epigenetic marks um and we can talk epigenetic marks um and we can talk about it later but I just want to uh um about it later but I just want to uh um about it later but I just want to uh um give an overview of the field. Um there give an overview of the field. Um there give an overview of the field. Um there are so many so-called genomic are so many so-called genomic are so many so-called genomic technologies um for measuring anything technologies um for measuring anything technologies um for measuring anything from gene expression proteome metabolom from gene expression proteome metabolom from gene expression proteome metabolom glycom glycom glycom really any ohm and for any readout really any ohm and for any readout really any ohm and for any readout people have developed clocks aging people have developed clocks aging people have developed clocks aging measures you know um I started with DNA measures you know um I started with DNA measures you know um I started with DNA methylation um back in 2011 we published methylation um back in 2011 we published methylation um back in 2011 we published our very first epigenetic clocks. Uh and our very first epigenetic clocks. Uh and our very first epigenetic clocks. Uh and um why methylation? Because the signal um why methylation? Because the signal um why methylation? Because the signal for aging and even mortality is very for aging and even mortality is very for aging and even mortality is very strong in methylation. Um but when you strong in methylation. Um but when you strong in methylation. Um but when you want to measure biologic age you really want to measure biologic age you really want to measure biologic age you really need to look at many uh levels of need to look at many uh levels of need to look at many uh levels of readouts molecular then um biochemical readouts molecular then um biochemical readouts molecular then um biochemical readouts blood biochemistry readouts blood biochemistry readouts blood biochemistry various measures of organ function various measures of organ function various measures of organ function fibrosis as an example and then of fibrosis as an example and then of fibrosis as an example and then of course above all functioning measures um course above all functioning measures um course above all functioning measures um um V2 max gate speed and um daily level um V2 max gate speed and um daily level um V2 max gate speed and um daily level living activities and living activities and living activities and >> fraily frailty. All of that. >> fraily frailty. All of that. >> fraily frailty. All of that. >> It's so important, you know, for people >> It's so important, you know, for people >> It's so important, you know, for people to understand that like you you know, as to understand that like you you know, as to understand that like you you know, as we have this chronological age, everyone we have this chronological age, everyone we have this chronological age, everyone knows their age, right? This is how long knows their age, right? This is how long knows their age, right? This is how long you've been alive since the time you you've been alive since the time you you've been alive since the time you were the day you were born. And and the were the day you were born. And and the were the day you were born. And and the interesting thing you you talked about interesting thing you you talked about interesting thing you you talked about biological aging, you know, you have biological aging, you know, you have biological aging, you know, you have this this these processes that are this this these processes that are this this these processes that are happening that affect your your daily happening that affect your your daily happening that affect your your daily function. They affect your disease risk. function. They affect your disease risk. function. They affect your disease risk. And not everyone has the same disease And not everyone has the same disease And not everyone has the same disease risk at the same age. And so there could risk at the same age. And so there could risk at the same age. And so there could be this disconnect where some people be this disconnect where some people be this disconnect where some people perhaps, you know, genetic and also perhaps, you know, genetic and also perhaps, you know, genetic and also lifestyle factors contribute to them not lifestyle factors contribute to them not lifestyle factors contribute to them not aging quite as good. And so they may get aging quite as good. And so they may get aging quite as good. And so they may get cardiovascular disease earlier or cancer cardiovascular disease earlier or cancer cardiovascular disease earlier or cancer earlier, right? And the opposite is earlier, right? And the opposite is earlier, right? And the opposite is true. And that's what people are really true. And that's what people are really true. And that's what people are really interested in. Let's say I'm 50 years interested in. Let's say I'm 50 years interested in. Let's say I'm 50 years old, but I want, you know, the organs in old, but I want, you know, the organs in old, but I want, you know, the organs in my body and the cells in my body to seem my body and the cells in my body to seem my body and the cells in my body to seem like they're 30 years old, right? like they're 30 years old, right? like they're 30 years old, right? >> Yes. >> Yes. >> Yes. >> To be younger. And so that's why it's >> To be younger. And so that's why it's >> To be younger. And so that's why it's exciting to have these tools that do exciting to have these tools that do exciting to have these tools that do measure function like you mentioned I measure function like you mentioned I measure function like you mentioned I think you know cardiorespiratory fitness think you know cardiorespiratory fitness think you know cardiorespiratory fitness and V2 max you know frailty I there's a and V2 max you know frailty I there's a and V2 max you know frailty I there's a lot of different ways that people are lot of different ways that people are lot of different ways that people are measuring function but then on the measuring function but then on the measuring function but then on the molecular level that's very exciting molecular level that's very exciting molecular level that's very exciting because it's quantifying this process of because it's quantifying this process of because it's quantifying this process of aging so I aging so I aging so I >> yes I mean there is one key word that >> yes I mean there is one key word that >> yes I mean there is one key word that has to be mentioned in that context it's has to be mentioned in that context it's has to be mentioned in that context it's all about prevention you know so what all about prevention you know so what all about prevention you know so what motivated my work was to understand motivated my work was to understand motivated my work was to understand aging in people who do everything right. aging in people who do everything right. aging in people who do everything right. For example, in you, why do you age? Um For example, in you, why do you age? Um For example, in you, why do you age? Um given that you and me, we we really take given that you and me, we we really take given that you and me, we we really take care of ourselves on we um try to care of ourselves on we um try to care of ourselves on we um try to optimize lifestyle, prevention, all of optimize lifestyle, prevention, all of optimize lifestyle, prevention, all of that. But something still changes deep that. But something still changes deep that. But something still changes deep inside of us in our cells. And what is inside of us in our cells. And what is inside of us in our cells. And what is it? What drives aging? And um um these it? What drives aging? And um um these it? What drives aging? And um um these methylation clocks that um I've methylation clocks that um I've methylation clocks that um I've developed, they they really track damage developed, they they really track damage developed, they they really track damage accumulation on one way or another, you accumulation on one way or another, you accumulation on one way or another, you know, because that is something that know, because that is something that know, because that is something that just happens, you know, and um that just happens, you know, and um that just happens, you know, and um that drives then um organ dysfunction many drives then um organ dysfunction many drives then um organ dysfunction many years and decades later, you know, but years and decades later, you know, but years and decades later, you know, but it's almost unavoidable to age. Um and it's almost unavoidable to age. Um and it's almost unavoidable to age. Um and um what I wanted to accomplish with um what I wanted to accomplish with um what I wanted to accomplish with these methylation clocks is to have a these methylation clocks is to have a these methylation clocks is to have a precise tool to allow researchers to precise tool to allow researchers to precise tool to allow researchers to actually identify novel interventions. actually identify novel interventions. actually identify novel interventions. How do we truly reverse the age the ages How do we truly reverse the age the ages How do we truly reverse the age the ages of individual cells of organs and the of individual cells of organs and the of individual cells of organs and the whole organism? You know, whole organism? You know, whole organism? You know, >> you mentioned something that caught my >> you mentioned something that caught my >> you mentioned something that caught my attention. And you said these attention. And you said these attention. And you said these methylation methylation methylation clocks or patterns are able to track the clocks or patterns are able to track the clocks or patterns are able to track the damage that occurs and and that's to me damage that occurs and and that's to me damage that occurs and and that's to me always been a question. Is it tracking always been a question. Is it tracking always been a question. Is it tracking the damage that occurs and or if you're the damage that occurs and or if you're the damage that occurs and or if you're changing these patterns, does that changing these patterns, does that changing these patterns, does that change the damage? So because you're change the damage? So because you're change the damage? So because you're globally affecting, you know, the way globally affecting, you know, the way globally affecting, you know, the way genes are activated or not activated, genes are activated or not activated, genes are activated or not activated, gene expression as we call it, then you gene expression as we call it, then you gene expression as we call it, then you would imagine is it like a two-way would imagine is it like a two-way would imagine is it like a two-way street possibly where you're able to street possibly where you're able to street possibly where you're able to increase, you know, genes that we have increase, you know, genes that we have increase, you know, genes that we have that help take care of damage, repair, that help take care of damage, repair, that help take care of damage, repair, you know, all these, you know, stress you know, all these, you know, stress you know, all these, you know, stress response genes better as well. But I response genes better as well. But I response genes better as well. But I guess we'll get into that. That's so I guess we'll get into that. That's so I guess we'll get into that. That's so I think I think one of the the points of think I think one of the the points of think I think one of the the points of confusion I've heard repeatedly, you confusion I've heard repeatedly, you confusion I've heard repeatedly, you know, from from my audience and just know, from from my audience and just know, from from my audience and just from, you know, in general like out from, you know, in general like out from, you know, in general like out there is that people think these there is that people think these there is that people think these biological aging clocks are just sort of biological aging clocks are just sort of biological aging clocks are just sort of like one thing. You hear biological age, like one thing. You hear biological age, like one thing. You hear biological age, it's like this one thing. You reverse it's like this one thing. You reverse it's like this one thing. You reverse biological age, it's just this one thing biological age, it's just this one thing biological age, it's just this one thing that's happening. But we actually have that's happening. But we actually have that's happening. But we actually have very, you know, different clocks that very, you know, different clocks that very, you know, different clocks that seem to be perhaps tracking or have seem to be perhaps tracking or have seem to be perhaps tracking or have different, you know, strengths and different, you know, strengths and different, you know, strengths and weaknesses and what they are tracking weaknesses and what they are tracking weaknesses and what they are tracking and what they are sensitive to in the and what they are sensitive to in the and what they are sensitive to in the context of the aging process. So maybe context of the aging process. So maybe context of the aging process. So maybe we can kind of just can you walk us we can kind of just can you walk us we can kind of just can you walk us through some of these clocks and you through some of these clocks and you through some of these clocks and you know what their core strength is like know what their core strength is like know what their core strength is like what they are tracking and perhaps even what they are tracking and perhaps even what they are tracking and perhaps even what a common misconception is in terms what a common misconception is in terms what a common misconception is in terms of what it's tracking. of what it's tracking. of what it's tracking. >> Yes. So um maybe we start with the big >> Yes. So um maybe we start with the big >> Yes. So um maybe we start with the big picture. Aging is of course associated picture. Aging is of course associated picture. Aging is of course associated with the accumulation of damage on all with the accumulation of damage on all with the accumulation of damage on all levels. Um the proteomic level, levels. Um the proteomic level, levels. Um the proteomic level, metabolomic um um intercellular metabolomic um um intercellular metabolomic um um intercellular communication but also damage communication but also damage communication but also damage accumulation accumulation accumulation surrounding the DNA molecule. these surrounding the DNA molecule. these surrounding the DNA molecule. these chemical changes to the DNA um there is chemical changes to the DNA um there is chemical changes to the DNA um there is an accumulation of damage and that an accumulation of damage and that an accumulation of damage and that impairs then the cell function. For impairs then the cell function. For impairs then the cell function. For example, certain cell identity genes example, certain cell identity genes example, certain cell identity genes need to be active in a liver cell and need to be active in a liver cell and need to be active in a liver cell and different genes need to be acting in a different genes need to be acting in a different genes need to be acting in a brain cell and and so on. And so the brain cell and and so on. And so the brain cell and and so on. And so the damage impairs the function of cells and damage impairs the function of cells and damage impairs the function of cells and then tissues and then organs. And um then tissues and then organs. And um then tissues and then organs. And um interestingly um methylation interestingly um methylation interestingly um methylation um changes can be observed at really um changes can be observed at really um changes can be observed at really millions of locations on the DNA millions of locations on the DNA millions of locations on the DNA molecule. And um many of these changes molecule. And um many of these changes molecule. And um many of these changes have actually no consequence. And by the have actually no consequence. And by the have actually no consequence. And by the way, when I talk about changes on the way, when I talk about changes on the way, when I talk about changes on the DNA, I talk about gain of methylation at DNA, I talk about gain of methylation at DNA, I talk about gain of methylation at the wrong places, but also loss of the wrong places, but also loss of the wrong places, but also loss of methylation at the wrong places. So what methylation at the wrong places. So what methylation at the wrong places. So what is happening with aging is that methyl is happening with aging is that methyl is happening with aging is that methyl the methylation landscape really the methylation landscape really the methylation landscape really flattens out and uh conversely in a flattens out and uh conversely in a flattens out and uh conversely in a young cell you you want to have really young cell you you want to have really young cell you you want to have really uh peaks of methylation at regions that uh peaks of methylation at regions that uh peaks of methylation at regions that need to be shut down and conversely low need to be shut down and conversely low need to be shut down and conversely low methylation at regions that need to be methylation at regions that need to be methylation at regions that need to be accessible you know on the DNA. So accessible you know on the DNA. So accessible you know on the DNA. So anyways um these methylation clocks um anyways um these methylation clocks um anyways um these methylation clocks um look typically at hundreds of locations look typically at hundreds of locations look typically at hundreds of locations on the DNA that are carefully chosen. on the DNA that are carefully chosen. on the DNA that are carefully chosen. However, However, However, one can really look at tens of millions one can really look at tens of millions one can really look at tens of millions of locations and um people have of locations and um people have of locations and um people have developed different clocks based on developed different clocks based on developed different clocks based on tracking changes at different locations. tracking changes at different locations. tracking changes at different locations. And one of the great misconceptions is And one of the great misconceptions is And one of the great misconceptions is to expect that all clocks disagree uh to expect that all clocks disagree uh to expect that all clocks disagree uh agree with each other that all clocks agree with each other that all clocks agree with each other that all clocks give you this one readout. Um that give you this one readout. Um that give you this one readout. Um that wouldn't be reasonable, right? Because wouldn't be reasonable, right? Because wouldn't be reasonable, right? Because you have millions of locations. So um you have millions of locations. So um you have millions of locations. So um methylation clocks really capture again methylation clocks really capture again methylation clocks really capture again different properties of aging. Some different properties of aging. Some different properties of aging. Some clocks are very good at tracking clocks are very good at tracking clocks are very good at tracking inflammation. Um other clocks are very inflammation. Um other clocks are very inflammation. Um other clocks are very good at metab metabolic syndrome. Then good at metab metabolic syndrome. Then good at metab metabolic syndrome. Then the so-called these are now second the so-called these are now second the so-called these are now second generation clocks you know they really generation clocks you know they really generation clocks you know they really uh relate to inflammation and various uh relate to inflammation and various uh relate to inflammation and various stressors smoking. Um but then the stressors smoking. Um but then the stressors smoking. Um but then the earlier generation of clocks so-called earlier generation of clocks so-called earlier generation of clocks so-called uh first generation clocks had a totally uh first generation clocks had a totally uh first generation clocks had a totally different goal. they just want to different goal. they just want to different goal. they just want to measure calendar age, you know, and um measure calendar age, you know, and um measure calendar age, you know, and um yeah, so the misconception is that yeah, so the misconception is that yeah, so the misconception is that people get disappointed that two people get disappointed that two people get disappointed that two different clocks lead to slightly different clocks lead to slightly different clocks lead to slightly different readouts. But um the metaphor different readouts. But um the metaphor different readouts. But um the metaphor I want to use is think of the world of I want to use is think of the world of I want to use is think of the world of proteomics. If I told you protein one proteomics. If I told you protein one proteomics. If I told you protein one measures the same as protein 2, you measures the same as protein 2, you measures the same as protein 2, you would just not believe it. And the same would just not believe it. And the same would just not believe it. And the same happens in the case of methylation. if happens in the case of methylation. if happens in the case of methylation. if you target certain parts of the DNA, you target certain parts of the DNA, you target certain parts of the DNA, they give you a different readout from they give you a different readout from they give you a different readout from other parts. other parts. other parts. >> Okay. Yeah, that's that's really good to >> Okay. Yeah, that's that's really good to >> Okay. Yeah, that's that's really good to to kind of clear up. And um you know, I to kind of clear up. And um you know, I to kind of clear up. And um you know, I I guess if you understand that concept, I guess if you understand that concept, I guess if you understand that concept, you wouldn't want all these clocks to be you wouldn't want all these clocks to be you wouldn't want all these clocks to be giving you the same readout because then giving you the same readout because then giving you the same readout because then that would be kind of a problem, I that would be kind of a problem, I that would be kind of a problem, I think. Um think. Um think. Um >> it would be overly simplistic, right? >> it would be overly simplistic, right? >> it would be overly simplistic, right? And most clocks were tailor made for And most clocks were tailor made for And most clocks were tailor made for blood uh for the sake of convenience. blood uh for the sake of convenience. blood uh for the sake of convenience. But arguably you would want to develop But arguably you would want to develop But arguably you would want to develop special clocks for the brain, for the special clocks for the brain, for the special clocks for the brain, for the liver, for the kidney, you know, and the liver, for the kidney, you know, and the liver, for the kidney, you know, and the field is moving in that direction. So field is moving in that direction. So field is moving in that direction. So people develop actually single cell people develop actually single cell people develop actually single cell clocks and organ specific clocks. clocks and organ specific clocks. clocks and organ specific clocks. >> Oh, that's cool. >> Oh, that's cool. >> Oh, that's cool. >> Yeah. >> Yeah. >> Yeah. >> Um so let's talk about some of the main >> Um so let's talk about some of the main >> Um so let's talk about some of the main ones that are used. And so we have the ones that are used. And so we have the ones that are used. And so we have the one that was, you know, the original one that was, you know, the original one that was, you know, the original Horvath epigenetic aging clock, first Horvath epigenetic aging clock, first Horvath epigenetic aging clock, first generation for chronological age, and generation for chronological age, and generation for chronological age, and then you we we kind of get into these then you we we kind of get into these then you we we kind of get into these other clocks which were first generation other clocks which were first generation other clocks which were first generation and then they have second generation and then they have second generation and then they have second generation versions as well. But so the DNA pheno versions as well. But so the DNA pheno versions as well. But so the DNA pheno age um does that clock lean more towards age um does that clock lean more towards age um does that clock lean more towards inflammatory and metabolic function than inflammatory and metabolic function than inflammatory and metabolic function than pure chronological age? pure chronological age? pure chronological age? >> Yeah, for sure. you know, so the >> Yeah, for sure. you know, so the >> Yeah, for sure. you know, so the so-called pheno age clock was a giant so-called pheno age clock was a giant so-called pheno age clock was a giant step forward when it came to mortality step forward when it came to mortality step forward when it came to mortality risk prediction. Um, this clock was very risk prediction. Um, this clock was very risk prediction. Um, this clock was very much constructed to track um really much constructed to track um really much constructed to track um really biochemical markers and also um um biochemical markers and also um um biochemical markers and also um um changes in blood cell composition. Um changes in blood cell composition. Um changes in blood cell composition. Um these markers measure organ dysfunction these markers measure organ dysfunction these markers measure organ dysfunction one way or another. And the idea was to one way or another. And the idea was to one way or another. And the idea was to actually develop a methylation surrogate actually develop a methylation surrogate actually develop a methylation surrogate of these clinical parameters. And we of these clinical parameters. And we of these clinical parameters. And we should discuss the pros and cons of that should discuss the pros and cons of that should discuss the pros and cons of that idea, you know. Um but yes, so this idea, you know. Um but yes, so this idea, you know. Um but yes, so this clock um was then clock um was then clock um was then impressive mortality risk predictor for impressive mortality risk predictor for impressive mortality risk predictor for humans, you know. Um however, it it was humans, you know. Um however, it it was humans, you know. Um however, it it was then superseded by the grim age clock then superseded by the grim age clock then superseded by the grim age clock which was named after the grim reaper. which was named after the grim reaper. which was named after the grim reaper. It um was published also many years ago, It um was published also many years ago, It um was published also many years ago, 2019, but it continues to be very 2019, but it continues to be very 2019, but it continues to be very impressive for mortality risk. And um impressive for mortality risk. And um impressive for mortality risk. And um from a mathematical perspective, these from a mathematical perspective, these from a mathematical perspective, these clocks were constructed in very clocks were constructed in very clocks were constructed in very different ways, but overall they very different ways, but overall they very different ways, but overall they very often agree. you know when when you have often agree. you know when when you have often agree. you know when when you have an intervention that appears to slow uh an intervention that appears to slow uh an intervention that appears to slow uh grim age progression it also uh slows grim age progression it also uh slows grim age progression it also uh slows pheno age progression you know so often pheno age progression you know so often pheno age progression you know so often there is actually agreement to some there is actually agreement to some there is actually agreement to some extent which is impressive given that extent which is impressive given that extent which is impressive given that these clocks were constructed in very these clocks were constructed in very these clocks were constructed in very different ways different ways different ways >> can you talk a little bit about the >> can you talk a little bit about the >> can you talk a little bit about the different ways they were I mean different ways they were I mean different ways they were I mean constructed so with the with the grim constructed so with the with the grim constructed so with the with the grim age you know I think it was my age you know I think it was my age you know I think it was my understanding that there's smoking is understanding that there's smoking is understanding that there's smoking is somehow embedded in that in that uh somehow embedded in that in that uh somehow embedded in that in that uh calculation or you know whatever we want calculation or you know whatever we want calculation or you know whatever we want to call it um to call it um to call it um >> stress related proteins inflammation but >> stress related proteins inflammation but >> stress related proteins inflammation but the feno age also has some inflammation the feno age also has some inflammation the feno age also has some inflammation as well in there as well in there as well in there >> yes yeah maybe I'll start with a much >> yes yeah maybe I'll start with a much >> yes yeah maybe I'll start with a much simpler um uh example simpler um uh example simpler um uh example C reactive protein um as a marker of C reactive protein um as a marker of C reactive protein um as a marker of chronic inflammation it's a very chronic inflammation it's a very chronic inflammation it's a very important biochemical readout out and um important biochemical readout out and um important biochemical readout out and um the doctor will measure it when you have the doctor will measure it when you have the doctor will measure it when you have certain conditions but interestingly you certain conditions but interestingly you certain conditions but interestingly you can actually estimate C reactive protein can actually estimate C reactive protein can actually estimate C reactive protein levels based on methylation and I should levels based on methylation and I should levels based on methylation and I should say the estimate is not very tight for say the estimate is not very tight for say the estimate is not very tight for the experts I will say correlation the experts I will say correlation the experts I will say correlation maybe.3 or lower you know so it's not a maybe.3 or lower you know so it's not a maybe.3 or lower you know so it's not a tight correlation but I want to mention tight correlation but I want to mention tight correlation but I want to mention it as an example for this idea of using it as an example for this idea of using it as an example for this idea of using methylation to estimate um a famous methylation to estimate um a famous methylation to estimate um a famous marker. But now imagine you actually get marker. But now imagine you actually get marker. But now imagine you actually get these two readouts from the lab. Let's these two readouts from the lab. Let's these two readouts from the lab. Let's say you go to a longevity clinic. They say you go to a longevity clinic. They say you go to a longevity clinic. They can easily measure both. But which one can easily measure both. But which one can easily measure both. But which one is more informative for you? Now a is more informative for you? Now a is more informative for you? Now a medical doctor will always focus on the medical doctor will always focus on the medical doctor will always focus on the plasma based readout. They are trained plasma based readout. They are trained plasma based readout. They are trained to look at thresholds and then they to look at thresholds and then they to look at thresholds and then they diagnose um maybe an acute infection. Um diagnose um maybe an acute infection. Um diagnose um maybe an acute infection. Um but but the surprising finding is that but but the surprising finding is that but but the surprising finding is that the methylation estimate is actually a the methylation estimate is actually a the methylation estimate is actually a better predictor of your mortality risk. better predictor of your mortality risk. better predictor of your mortality risk. Far better predictor of your mortality Far better predictor of your mortality Far better predictor of your mortality risk than the plasma measure. And um risk than the plasma measure. And um risk than the plasma measure. And um that's one famous example that has been that's one famous example that has been that's one famous example that has been validated. I give you now another validated. I give you now another validated. I give you now another example smoking. So you can ask someone example smoking. So you can ask someone example smoking. So you can ask someone how many cigarettes do you smoke per how many cigarettes do you smoke per how many cigarettes do you smoke per week? for how many years have you smoked week? for how many years have you smoked week? for how many years have you smoked and this is known as the smoking pack and this is known as the smoking pack and this is known as the smoking pack year estimate of smoking exposure. year estimate of smoking exposure. year estimate of smoking exposure. Interestingly, you can use methylation Interestingly, you can use methylation Interestingly, you can use methylation to estimate smoking exposure as well and to estimate smoking exposure as well and to estimate smoking exposure as well and you can ask the same question. Well, you can ask the same question. Well, you can ask the same question. Well, which measure is more predictive of how which measure is more predictive of how which measure is more predictive of how long you end up living? Is it the long you end up living? Is it the long you end up living? Is it the self-reported measure or the blood self-reported measure or the blood self-reported measure or the blood measure? And again, we know the answer measure? And again, we know the answer measure? And again, we know the answer from many studies by now. Again, the from many studies by now. Again, the from many studies by now. Again, the methylation estimator is actually methylation estimator is actually methylation estimator is actually superior to self-reported. superior to self-reported. superior to self-reported. So, I mention it because that then gives So, I mention it because that then gives So, I mention it because that then gives rise to an idea. rise to an idea. rise to an idea. Well, why don't I build a clock that Well, why don't I build a clock that Well, why don't I build a clock that uses these methylation estimators of C uses these methylation estimators of C uses these methylation estimators of C reactive protein of many other famous reactive protein of many other famous reactive protein of many other famous proteins or and also the methylation proteins or and also the methylation proteins or and also the methylation estimator of smoking history. Why don't estimator of smoking history. Why don't estimator of smoking history. Why don't I use these methylation biomarkers in a I use these methylation biomarkers in a I use these methylation biomarkers in a linear combination? I combine it in an linear combination? I combine it in an linear combination? I combine it in an optimal way to build a mortality risk optimal way to build a mortality risk optimal way to build a mortality risk predictor. And this idea is underlying predictor. And this idea is underlying predictor. And this idea is underlying the grim age clock, the grim reaper the grim age clock, the grim reaper the grim age clock, the grim reaper clock. And um it just worked beautifully clock. And um it just worked beautifully clock. And um it just worked beautifully in many validation studies. We now know in many validation studies. We now know in many validation studies. We now know this idea worked. But that's really the this idea worked. But that's really the this idea worked. But that's really the idea of the uh grim age clock idea of the uh grim age clock idea of the uh grim age clock >> and this was from this was developed >> and this was from this was developed >> and this was from this was developed with in your lab the grim age clock. with in your lab the grim age clock. with in your lab the grim age clock. >> Yes by au in my lab you know pheno age >> Yes by au in my lab you know pheno age >> Yes by au in my lab you know pheno age was developed by Morgan Lavine when she was developed by Morgan Lavine when she was developed by Morgan Lavine when she was a post in my lab was a post in my lab was a post in my lab >> when Morgan was on our podcast a few >> when Morgan was on our podcast a few >> when Morgan was on our podcast a few years back as well. years back as well. years back as well. >> Yes. >> Yes. >> Yes. >> So why should methylation patterns be >> So why should methylation patterns be >> So why should methylation patterns be able to predict your mortality? I mean able to predict your mortality? I mean able to predict your mortality? I mean that's and and and I mean how accurate that's and and and I mean how accurate that's and and and I mean how accurate is that? I mean like what's what are we is that? I mean like what's what are we is that? I mean like what's what are we talking about you know? talking about you know? talking about you know? >> Yeah. Um yeah the first question um why >> Yeah. Um yeah the first question um why >> Yeah. Um yeah the first question um why does methylation relate to mortality? does methylation relate to mortality? does methylation relate to mortality? It is a good question because when I It is a good question because when I It is a good question because when I published the very first clocks I published the very first clocks I published the very first clocks I remember I was extremely nervous about remember I was extremely nervous about remember I was extremely nervous about what I had published. I thought maybe what I had published. I thought maybe what I had published. I thought maybe these clocks have no use. maybe they these clocks have no use. maybe they these clocks have no use. maybe they just measure your calendar age, you just measure your calendar age, you just measure your calendar age, you know, and um and now I'm I I was so know, and um and now I'm I I was so know, and um and now I'm I I was so relieved that um basically 6 weeks after relieved that um basically 6 weeks after relieved that um basically 6 weeks after I had published it, somebody came to me I had published it, somebody came to me I had published it, somebody came to me at UCLA and said, you know, we just at UCLA and said, you know, we just at UCLA and said, you know, we just applied your clock and it predicts applied your clock and it predicts applied your clock and it predicts mortality. Yeah, I was. But um anyways mortality. Yeah, I was. But um anyways mortality. Yeah, I was. But um anyways um but then um by now we know that these um but then um by now we know that these um but then um by now we know that these methylation clocks very much predict methylation clocks very much predict methylation clocks very much predict mortality risk to the point that um um mortality risk to the point that um um mortality risk to the point that um um certain startups pursue the idea of certain startups pursue the idea of certain startups pursue the idea of using methylation clocks for pricing um using methylation clocks for pricing um using methylation clocks for pricing um life insurance policies or financial life insurance policies or financial life insurance policies or financial products, you know. Um and of course u products, you know. Um and of course u products, you know. Um and of course u methylation clocks are used in serious methylation clocks are used in serious methylation clocks are used in serious randomized control trials you know so um randomized control trials you know so um randomized control trials you know so um the evidence is very strong and without the evidence is very strong and without the evidence is very strong and without any debate um but why is that you know any debate um but why is that you know any debate um but why is that you know and um I it could be that these clocks and um I it could be that these clocks and um I it could be that these clocks really track long-term exposures of a really track long-term exposures of a really track long-term exposures of a stressor. So for example, smoking again, stressor. So for example, smoking again, stressor. So for example, smoking again, you know, so um maybe maybe if you just you know, so um maybe maybe if you just you know, so um maybe maybe if you just smoke a bit, it uh it doesn't really smoke a bit, it uh it doesn't really smoke a bit, it uh it doesn't really show up in other biomarkers, but if you show up in other biomarkers, but if you show up in other biomarkers, but if you have an ex really this prolonged have an ex really this prolonged have an ex really this prolonged stressor, it really alters the stressor, it really alters the stressor, it really alters the epiggenome. Um why? Because the epiggenome. Um why? Because the epiggenome. Um why? Because the epiggenome epiggenome epiggenome creates a memory. really think of the creates a memory. really think of the creates a memory. really think of the epiggenome as uh a memory of stressors epiggenome as uh a memory of stressors epiggenome as uh a memory of stressors and it primes the cell to respond. And and it primes the cell to respond. And and it primes the cell to respond. And you can imagine if um the cell senses you can imagine if um the cell senses you can imagine if um the cell senses this onslaught of various stresses, it this onslaught of various stresses, it this onslaught of various stresses, it tries to remodel its regulatory system tries to remodel its regulatory system tries to remodel its regulatory system so that it prepares for future stress. so that it prepares for future stress. so that it prepares for future stress. That's maybe one way to um conceptualize That's maybe one way to um conceptualize That's maybe one way to um conceptualize it. it. it. >> Yeah. And I mean we even I think the >> Yeah. And I mean we even I think the >> Yeah. And I mean we even I think the this concept of you know the stressor this concept of you know the stressor this concept of you know the stressor affecting the epiggenome you know we affecting the epiggenome you know we affecting the epiggenome you know we even know it can affect the epiggenome even know it can affect the epiggenome even know it can affect the epiggenome in gonads right in sperm and eggs and in gonads right in sperm and eggs and in gonads right in sperm and eggs and that's why certain we have those the that's why certain we have those the that's why certain we have those the studies out of Sweden where they went studies out of Sweden where they went studies out of Sweden where they went through these periods of starvation like through these periods of starvation like through these periods of starvation like famine and then there was feasting famine and then there was feasting famine and then there was feasting depending on you know the what food was depending on you know the what food was depending on you know the what food was available at the time and and I know available at the time and and I know available at the time and and I know that some researchers had looked at how that some researchers had looked at how that some researchers had looked at how the epiggenome had changed and that also the epiggenome had changed and that also the epiggenome had changed and that also seemed to affect life expectancy of the seemed to affect life expectancy of the seemed to affect life expectancy of the offspring as well. So, um, and then offspring as well. So, um, and then offspring as well. So, um, and then >> yes, I think this is a study from the >> yes, I think this is a study from the >> yes, I think this is a study from the Netherlands, the so-called Dutch hunger Netherlands, the so-called Dutch hunger Netherlands, the so-called Dutch hunger perhaps. I'm not sure whether that's perhaps. I'm not sure whether that's perhaps. I'm not sure whether that's what you meant. Yeah, that's right. what you meant. Yeah, that's right. what you meant. Yeah, that's right. >> Yeah, very exciting work. You know that >> Yeah, very exciting work. You know that >> Yeah, very exciting work. You know that u maybe a couple of years of starvation u maybe a couple of years of starvation u maybe a couple of years of starvation could already change the gonad methylme could already change the gonad methylme could already change the gonad methylme and that could then um lead to changes and that could then um lead to changes and that could then um lead to changes in the offspring. So, I think it's very in the offspring. So, I think it's very in the offspring. So, I think it's very exciting, but I need to tell you I exciting, but I need to tell you I exciting, but I need to tell you I haven't worked in that space. haven't worked in that space. haven't worked in that space. >> Yeah. Well, I I as far as as far it's >> Yeah. Well, I I as far as as far it's >> Yeah. Well, I I as far as as far it's been years since I've looked at those been years since I've looked at those been years since I've looked at those studies, but I think there were like studies, but I think there were like studies, but I think there were like prepubescent boys too where it's like if prepubescent boys too where it's like if prepubescent boys too where it's like if they have gone through these periods of they have gone through these periods of they have gone through these periods of like hunger where they were calorically like hunger where they were calorically like hunger where they were calorically restricted, it obviously changed their, restricted, it obviously changed their, restricted, it obviously changed their, you know, their gonads epigenome and and you know, their gonads epigenome and and you know, their gonads epigenome and and their sperm in a way that was, you know, their sperm in a way that was, you know, their sperm in a way that was, you know, more permanent. And so, um, they had more permanent. And so, um, they had more permanent. And so, um, they had offspring that were like more resilient offspring that were like more resilient offspring that were like more resilient against type two diabetes and, you know, against type two diabetes and, you know, against type two diabetes and, you know, other age- related diseases as well. So other age- related diseases as well. So other age- related diseases as well. So I think I think they also lived longer I think I think they also lived longer I think I think they also lived longer like their grandkids or something like like their grandkids or something like like their grandkids or something like it affected their life expectancy as it affected their life expectancy as it affected their life expectancy as well. But smoking is another one that well. But smoking is another one that well. But smoking is another one that would also go it gets I mean that's would also go it gets I mean that's would also go it gets I mean that's something that goes you know deeper something that goes you know deeper something that goes you know deeper right and affects the gonads if I'm right and affects the gonads if I'm right and affects the gonads if I'm correct. I mean correct. I mean correct. I mean >> um yeah I need to tell you regarding >> um yeah I need to tell you regarding >> um yeah I need to tell you regarding these findings I'm usually interested these findings I'm usually interested these findings I'm usually interested and excited about them but I want to and excited about them but I want to and excited about them but I want to emphasize to your audience they are emphasize to your audience they are emphasize to your audience they are controversial fundamentally. controversial fundamentally. controversial fundamentally. >> Okay. uh very smart people disagree with >> Okay. uh very smart people disagree with >> Okay. uh very smart people disagree with these findings. Personally, I'm I'm these findings. Personally, I'm I'm these findings. Personally, I'm I'm completely neutral. I um but I just want completely neutral. I um but I just want completely neutral. I um but I just want you to know that you to know that you to know that >> they disagree that the epino changes. >> they disagree that the epino changes. >> they disagree that the epino changes. >> Yeah. So that um no um just to be very >> Yeah. So that um no um just to be very >> Yeah. So that um no um just to be very precise that an exposure from your precise that an exposure from your precise that an exposure from your parents for example has an effect on parents for example has an effect on parents for example has an effect on you. you. you. >> Um again this brilliant people publish >> Um again this brilliant people publish >> Um again this brilliant people publish on it. And these studies go through on it. And these studies go through on it. And these studies go through rigorous peer review. But I just want rigorous peer review. But I just want rigorous peer review. But I just want you to be aware that there are uh strong you to be aware that there are uh strong you to be aware that there are uh strong counterarguments, you know. So it counterarguments, you know. So it counterarguments, you know. So it remains to be seen. I want to say remains to be seen. I want to say remains to be seen. I want to say because um they um I want to think that because um they um I want to think that because um they um I want to think that if your parents or grandparents if your parents or grandparents if your parents or grandparents um went through severe stressors, I want um went through severe stressors, I want um went through severe stressors, I want to think that you still are born with a to think that you still are born with a to think that you still are born with a clean slate, you know, so that you're in clean slate, you know, so that you're in clean slate, you know, so that you're in certain ways not predisposed certain ways not predisposed certain ways not predisposed or doomed in one way or another, you or doomed in one way or another, you or doomed in one way or another, you know. So, um know. So, um know. So, um >> well, sure that would be a nice thing to >> well, sure that would be a nice thing to >> well, sure that would be a nice thing to think. Yes. think. Yes. think. Yes. >> But I mean on the bright side of things >> But I mean on the bright side of things >> But I mean on the bright side of things even if there there is and I've seen you even if there there is and I've seen you even if there there is and I've seen you know the I've seen evidence that know the I've seen evidence that know the I've seen evidence that convince me that there's an epigenetic convince me that there's an epigenetic convince me that there's an epigenetic change that does happen. Yes. change that does happen. Yes. change that does happen. Yes. >> And in you know sperm DNA for example >> And in you know sperm DNA for example >> And in you know sperm DNA for example like if you have an obese male and then like if you have an obese male and then like if you have an obese male and then they lose weight like you can look at they lose weight like you can look at they lose weight like you can look at their sperm DNA and it changes from their sperm DNA and it changes from their sperm DNA and it changes from being obese to lean and epigenetic being obese to lean and epigenetic being obese to lean and epigenetic changes gene expression changes are changes gene expression changes are changes gene expression changes are happening. So um but even if even if happening. So um but even if even if happening. So um but even if even if it's on the bad side, you know, the good it's on the bad side, you know, the good it's on the bad side, you know, the good news is that once you're born, you can news is that once you're born, you can news is that once you're born, you can do things in your life to change things do things in your life to change things do things in your life to change things in a positive way too, right? So it's in a positive way too, right? So it's in a positive way too, right? So it's not like, not like, not like, >> you know, even even if you don't have >> you know, even even if you don't have >> you know, even even if you don't have the cleanest slate. Um the cleanest slate. Um the cleanest slate. Um >> yes. Yeah. What I want to tell you >> yes. Yeah. What I want to tell you >> yes. Yeah. What I want to tell you briefly about sperm that is um yes, briefly about sperm that is um yes, briefly about sperm that is um yes, there are methylation changes and also there are methylation changes and also there are methylation changes and also changes with aging. So the sperm methyl changes with aging. So the sperm methyl changes with aging. So the sperm methyl of a 50 year old is different from that of a 50 year old is different from that of a 50 year old is different from that of a 20 year old. However, the changes of a 20 year old. However, the changes of a 20 year old. However, the changes that occur um um are at completely that occur um um are at completely that occur um um are at completely different location from the changes that different location from the changes that different location from the changes that we use in any of our other clocks. You we use in any of our other clocks. You we use in any of our other clocks. You know another way to say it is if I take know another way to say it is if I take know another way to say it is if I take grim age or pheno age or any of my grim age or pheno age or any of my grim age or pheno age or any of my clocks and apply it to sperm it clocks and apply it to sperm it clocks and apply it to sperm it completely fails it. Um so for example completely fails it. Um so for example completely fails it. Um so for example what is known as the Horvath pant tissue what is known as the Horvath pant tissue what is known as the Horvath pant tissue clock you apply to sperm you get one clock you apply to sperm you get one clock you apply to sperm you get one number 37 or so but everybody has the number 37 or so but everybody has the number 37 or so but everybody has the same number in essence you know same number in essence you know same number in essence you know uninformative it's just very different uninformative it's just very different uninformative it's just very different locations locations locations the same statement also holds by the way the same statement also holds by the way the same statement also holds by the way um for the placenta so people have um um for the placenta so people have um um for the placenta so people have um developed clocks um applied to placenta developed clocks um applied to placenta developed clocks um applied to placenta to estimate the age of the newborn to estimate the age of the newborn to estimate the age of the newborn meaning gestation age or also various uh meaning gestation age or also various uh meaning gestation age or also various uh stressors uh from the mother. But again, stressors uh from the mother. But again, stressors uh from the mother. But again, these changes are very different from these changes are very different from these changes are very different from what we observe in blood or um adult what we observe in blood or um adult what we observe in blood or um adult tissues. tissues. tissues. >> Have there been clocks um for sperm that >> Have there been clocks um for sperm that >> Have there been clocks um for sperm that have been developed that are more have been developed that are more have been developed that are more precise? precise? precise? >> Yes. Okay. >> Yes. Okay. >> Yes. Okay. >> Yeah. >> Yeah. >> Yeah. >> Um I have a question about grim age, but >> Um I have a question about grim age, but >> Um I have a question about grim age, but it it sort of leads us into the next it it sort of leads us into the next it it sort of leads us into the next clock that I want to have you discuss, clock that I want to have you discuss, clock that I want to have you discuss, which is the the duadin pace. Did I say which is the the duadin pace. Did I say which is the the duadin pace. Did I say it right? Do I I think it's called it right? Do I I think it's called it right? Do I I think it's called Dunidan paste. Dunidan paste. Dunidan paste. >> Dun needed and paste. That's right. Dun >> Dun needed and paste. That's right. Dun >> Dun needed and paste. That's right. Dun need and paste. need and paste. need and paste. >> So the question I have is you know with >> So the question I have is you know with >> So the question I have is you know with the DNA grimage we're talking about this the DNA grimage we're talking about this the DNA grimage we're talking about this methylation pattern being able to methylation pattern being able to methylation pattern being able to predict mortality and very you know predict mortality and very you know predict mortality and very you know pretty pretty accurately mortality risk pretty pretty accurately mortality risk pretty pretty accurately mortality risk and it's it's it's able to measure you and it's it's it's able to measure you and it's it's it's able to measure you know this accumulation of damage that's know this accumulation of damage that's know this accumulation of damage that's changed the epiggenome in a way that's changed the epiggenome in a way that's changed the epiggenome in a way that's obviously you know quantifiable. obviously you know quantifiable. obviously you know quantifiable. What if you're 45 years old? You get What if you're 45 years old? You get What if you're 45 years old? You get your DNA grim age test done. It gives your DNA grim age test done. It gives your DNA grim age test done. It gives you your mortality because you've had you your mortality because you've had you your mortality because you've had all this, you know, lifetime exposures all this, you know, lifetime exposures all this, you know, lifetime exposures up until the age of 45 of, you know, up until the age of 45 of, you know, up until the age of 45 of, you know, let's say air pollution, maybe you let's say air pollution, maybe you let's say air pollution, maybe you smoked a little bit, whatever, alcohol, smoked a little bit, whatever, alcohol, smoked a little bit, whatever, alcohol, poor diet, stress, chronic stress, all poor diet, stress, chronic stress, all poor diet, stress, chronic stress, all those sorts of things. But, you know, those sorts of things. But, you know, those sorts of things. But, you know, you change your lifestyle and it gets you change your lifestyle and it gets you change your lifestyle and it gets better. better. better. Does that does that grim age change? Does that does that grim age change? Does that does that grim age change? >> If you had asked me that question two >> If you had asked me that question two >> If you had asked me that question two years ago, I would have humped and hard, years ago, I would have humped and hard, years ago, I would have humped and hard, you know, and I was always very cautious you know, and I was always very cautious you know, and I was always very cautious about that in certain ways. How about that in certain ways. How about that in certain ways. How reversible are these changes, you know, reversible are these changes, you know, reversible are these changes, you know, but the the science has really advanced but the the science has really advanced but the the science has really advanced and now I'm confident in saying that you and now I'm confident in saying that you and now I'm confident in saying that you can reverse grimage to some extent. The can reverse grimage to some extent. The can reverse grimage to some extent. The key word is to some extent because these key word is to some extent because these key word is to some extent because these changes appear to be very minor. We can changes appear to be very minor. We can changes appear to be very minor. We can talk about it later, but there have been talk about it later, but there have been talk about it later, but there have been very rigorous uh randomized control very rigorous uh randomized control very rigorous uh randomized control trials with supplements and medications. trials with supplements and medications. trials with supplements and medications. So, there's a hopeful message you can So, there's a hopeful message you can So, there's a hopeful message you can reverse it. reverse it. reverse it. >> So, that's what we're going to get into >> So, that's what we're going to get into >> So, that's what we're going to get into folks. That's going to be the exciting folks. That's going to be the exciting folks. That's going to be the exciting stuff. stuff. stuff. >> Mhm. >> Mhm. >> Mhm. >> So, this this this other clock that's >> So, this this this other clock that's >> So, this this this other clock that's able to measure able to measure able to measure >> Yeah. >> Yeah. >> Yeah. >> the pace of aging. Can you talk a little >> the pace of aging. Can you talk a little >> the pace of aging. Can you talk a little bit about the bit about the bit about the >> Yeah. Um >> Yeah. Um >> Yeah. Um >> do can you say >> do can you say >> do can you say >> Yeah. Yeah. So there is another widely >> Yeah. Yeah. So there is another widely >> Yeah. Yeah. So there is another widely used clock which is known as a Junedan used clock which is known as a Junedan used clock which is known as a Junedan pace clock. It was developed by Dr. pace clock. It was developed by Dr. pace clock. It was developed by Dr. Moffett and Dan Bellski and um it was Moffett and Dan Bellski and um it was Moffett and Dan Bellski and um it was constructed in a very different logic constructed in a very different logic constructed in a very different logic from other clocks and um the metaphor is from other clocks and um the metaphor is from other clocks and um the metaphor is it's supposed to be an odometer. It it's it's supposed to be an odometer. It it's it's supposed to be an odometer. It it's supposed to measure the speed of aging supposed to measure the speed of aging supposed to measure the speed of aging or what what they call the pace of or what what they call the pace of or what what they call the pace of aging. whereas um previous clocks really aging. whereas um previous clocks really aging. whereas um previous clocks really measured in certain ways the measured in certain ways the measured in certain ways the accumulation of damage. So the idea is accumulation of damage. So the idea is accumulation of damage. So the idea is very compelling. Um maybe I just review very compelling. Um maybe I just review very compelling. Um maybe I just review um how it was constructed. So um the um how it was constructed. So um the um how it was constructed. So um the team really looked at rate of change in team really looked at rate of change in team really looked at rate of change in established physiologic markers and established physiologic markers and established physiologic markers and biochemical markers including also biochemical markers including also biochemical markers including also importantly and we should discuss that importantly and we should discuss that importantly and we should discuss that change in body mass index. So um um but change in body mass index. So um um but change in body mass index. So um um but also measures of um waist to hip ratio. also measures of um waist to hip ratio. also measures of um waist to hip ratio. So um also measures of uh glucose um So um also measures of uh glucose um So um also measures of uh glucose um impairment, markers of inflammation, impairment, markers of inflammation, impairment, markers of inflammation, many readouts and the study leveraged a many readouts and the study leveraged a many readouts and the study leveraged a unique uh epidemiologic cohort study in unique uh epidemiologic cohort study in unique uh epidemiologic cohort study in New Zealand in the city of Duniden and New Zealand in the city of Duniden and New Zealand in the city of Duniden and um so it's a study where they tracked um so it's a study where they tracked um so it's a study where they tracked middle-aged people and younger people middle-aged people and younger people middle-aged people and younger people for many years and and assessed these for many years and and assessed these for many years and and assessed these readouts repeatedly. readouts repeatedly. readouts repeatedly. it um for the experts it's a it um for the experts it's a it um for the experts it's a longitudinal studies and by having these longitudinal studies and by having these longitudinal studies and by having these longitudinal data multiple measurements longitudinal data multiple measurements longitudinal data multiple measurements per person they could really um estimate per person they could really um estimate per person they could really um estimate the pace each person's individual the pace each person's individual the pace each person's individual trajectory so far so good so you have trajectory so far so good so you have trajectory so far so good so you have these um pace measures but then they these um pace measures but then they these um pace measures but then they went to the next step which is similar went to the next step which is similar went to the next step which is similar to Grimage they said why don't we use to Grimage they said why don't we use to Grimage they said why don't we use methylation to estimate ate the pace of methylation to estimate ate the pace of methylation to estimate ate the pace of aging based on these physiological aging based on these physiological aging based on these physiological measures and I think that's a very good measures and I think that's a very good measures and I think that's a very good idea. Um why? Because people care about idea. Um why? Because people care about idea. Um why? Because people care about what's my current pace of aging. You what's my current pace of aging. You what's my current pace of aging. You know it it actually it's a good know it it actually it's a good know it it actually it's a good question. I'm I'm not quite sure what question. I'm I'm not quite sure what question. I'm I'm not quite sure what people care about. Some people want to people care about. Some people want to people care about. Some people want to know let me know where I stand right now know let me know where I stand right now know let me know where I stand right now >> or how an intervention is affecting how >> or how an intervention is affecting how >> or how an intervention is affecting how they're aging perhaps. they're aging perhaps. they're aging perhaps. >> Exly. Yes. Thank you. Yeah, that's a >> Exly. Yes. Thank you. Yeah, that's a >> Exly. Yes. Thank you. Yeah, that's a good point. you know, so if you have an good point. you know, so if you have an good point. you know, so if you have an intervention intervention intervention um you want to see does it really change um you want to see does it really change um you want to see does it really change the pace? Does it affect the odometer, the pace? Does it affect the odometer, the pace? Does it affect the odometer, you know, um and um so um therefore you know, um and um so um therefore you know, um and um so um therefore people use Dunid and pace along with all people use Dunid and pace along with all people use Dunid and pace along with all the other clocks that I mentioned in the other clocks that I mentioned in the other clocks that I mentioned in when they study interventions. It's by when they study interventions. It's by when they study interventions. It's by now part of the standard repertoire of now part of the standard repertoire of now part of the standard repertoire of clocks. when people uh publish a paper clocks. when people uh publish a paper clocks. when people uh publish a paper on longevity interventions, they on longevity interventions, they on longevity interventions, they hopefully report about five clocks, I hopefully report about five clocks, I hopefully report about five clocks, I want to say, just um in order to give want to say, just um in order to give want to say, just um in order to give the reader a chance to judge the the reader a chance to judge the the reader a chance to judge the evidence because the very best evidence because the very best evidence because the very best intervention will touch on many clocks. intervention will touch on many clocks. intervention will touch on many clocks. You know, that would be a robust uh You know, that would be a robust uh You know, that would be a robust uh rejuvenation of the methylone. rejuvenation of the methylone. rejuvenation of the methylone. >> In my experience from reading the >> In my experience from reading the >> In my experience from reading the literature, that's pretty much what I've literature, that's pretty much what I've literature, that's pretty much what I've seen. I see the main clocks that are seen. I see the main clocks that are seen. I see the main clocks that are being used are the pheno age grimage being used are the pheno age grimage being used are the pheno age grimage perhaps Grimage 2. perhaps Grimage 2. perhaps Grimage 2. >> Yes. >> Yes. >> Yes. >> Um and I see the Duadinian pace that >> Um and I see the Duadinian pace that >> Um and I see the Duadinian pace that those are those are at least three of those are those are at least three of those are those are at least three of the ones that are they seem to be and the ones that are they seem to be and the ones that are they seem to be and then there there's a few others that then there there's a few others that then there there's a few others that sometimes are in the mix. But um those sometimes are in the mix. But um those sometimes are in the mix. But um those those three stand out to me when I'm those three stand out to me when I'm those three stand out to me when I'm reading the literature maybe because I reading the literature maybe because I reading the literature maybe because I know them the best, but but um those are know them the best, but but um those are know them the best, but but um those are the ones that stand out with this the ones that stand out with this the ones that stand out with this disagreement. And we kind of you kind of disagreement. And we kind of you kind of disagreement. And we kind of you kind of touched on this already. you know, if touched on this already. you know, if touched on this already. you know, if you're if you're looking at an you're if you're looking at an you're if you're looking at an intervention, and we're gonna get into intervention, and we're gonna get into intervention, and we're gonna get into those in a minute, and you see, you those in a minute, and you see, you those in a minute, and you see, you know, your DNA grim age doesn't change. know, your DNA grim age doesn't change. know, your DNA grim age doesn't change. So, your mortality your when your So, your mortality your when your So, your mortality your when your mortality risk is the same or, you know, mortality risk is the same or, you know, mortality risk is the same or, you know, determining when you're going to die is determining when you're going to die is determining when you're going to die is the same. And yet, your rate of your the same. And yet, your rate of your the same. And yet, your rate of your rate of aging perhaps slows a little rate of aging perhaps slows a little rate of aging perhaps slows a little bit. Maybe it's not much, maybe it's 2%. bit. Maybe it's not much, maybe it's 2%. bit. Maybe it's not much, maybe it's 2%. Some people will look at that and go, Some people will look at that and go, Some people will look at that and go, "Oh, these are all like if you're "Oh, these are all like if you're "Oh, these are all like if you're changing your pace of aging, why are you changing your pace of aging, why are you changing your pace of aging, why are you not cha changing the grim age?" And then not cha changing the grim age?" And then not cha changing the grim age?" And then the question in my mind is, "Well, how the question in my mind is, "Well, how the question in my mind is, "Well, how long was the trial?" You know, so if long was the trial?" You know, so if long was the trial?" You know, so if you're changing the pace at which you you're changing the pace at which you you're changing the pace at which you age by 2% and the trial was 6 months, age by 2% and the trial was 6 months, age by 2% and the trial was 6 months, is that going to be reflected in the is that going to be reflected in the is that going to be reflected in the grim age or, you know, what's the grim age or, you know, what's the grim age or, you know, what's the standard deviation here that we're even standard deviation here that we're even standard deviation here that we're even talking about with grim age, right? talking about with grim age, right? talking about with grim age, right? >> Yes. I think you make a very important >> Yes. I think you make a very important >> Yes. I think you make a very important point. If you have an intervention that point. If you have an intervention that point. If you have an intervention that has a very strong effect, I would expect has a very strong effect, I would expect has a very strong effect, I would expect that most of these clocks will show it. that most of these clocks will show it. that most of these clocks will show it. Um why? Because these clocks are Um why? Because these clocks are Um why? Because these clocks are correlated with each other. And um just correlated with each other. And um just correlated with each other. And um just to throw out a number correlation five to throw out a number correlation five to throw out a number correlation five after you regress out age, sex, and after you regress out age, sex, and after you regress out age, sex, and various variables, but they still a various variables, but they still a various variables, but they still a fairly good agreement. This is the fairly good agreement. This is the fairly good agreement. This is the typical glass half full half empty is a typical glass half full half empty is a typical glass half full half empty is a correlation of 0.5 high on low you know correlation of 0.5 high on low you know correlation of 0.5 high on low you know to me it's reasonably high if you have a to me it's reasonably high if you have a to me it's reasonably high if you have a very strong rejuvenating intervention very strong rejuvenating intervention very strong rejuvenating intervention now when it comes to I I need to tell now when it comes to I I need to tell now when it comes to I I need to tell you I'm obsessed about the question you I'm obsessed about the question you I'm obsessed about the question which clock is best and so I which clock is best and so I which clock is best and so I >> best for what >> best for what >> best for what >> for judging longevity interventions and >> for judging longevity interventions and >> for judging longevity interventions and >> okay >> okay >> okay >> um yeah because when comes to mortality >> um yeah because when comes to mortality >> um yeah because when comes to mortality risk prediction, we know the answer risk prediction, we know the answer risk prediction, we know the answer right now. After several large studies, right now. After several large studies, right now. After several large studies, there was a study in Scotland, there was a study in Scotland, there was a study in Scotland, Generation Scotland, 18,000 uh people Generation Scotland, 18,000 uh people Generation Scotland, 18,000 uh people were evaluated and Grimage was best. And were evaluated and Grimage was best. And were evaluated and Grimage was best. And then there was a study from Harvard, I then there was a study from Harvard, I then there was a study from Harvard, I want to say 30,000 people were want to say 30,000 people were want to say 30,000 people were evaluated, Grimage was best. So, so we evaluated, Grimage was best. So, so we evaluated, Grimage was best. So, so we know which clock is best for mortality know which clock is best for mortality know which clock is best for mortality respirator. respirator. respirator. >> Can I pause you right there? And and >> Can I pause you right there? And and >> Can I pause you right there? And and that I just want to make this point that I just want to make this point that I just want to make this point because usually when we have these because usually when we have these because usually when we have these studies at least observational studies studies at least observational studies studies at least observational studies looking at looking at looking at >> diet because you'll never have a >> diet because you'll never have a >> diet because you'll never have a randomized control trial that's going to randomized control trial that's going to randomized control trial that's going to last you know 30 years. Yes or 40 years. last you know 30 years. Yes or 40 years. last you know 30 years. Yes or 40 years. So if you have if you have if you're So if you have if you have if you're So if you have if you have if you're looking at observational data and how looking at observational data and how looking at observational data and how different lifestyle like affect or diet different lifestyle like affect or diet different lifestyle like affect or diet and lifestyle affect mortality you're and lifestyle affect mortality you're and lifestyle affect mortality you're typically looking at okay how much typically looking at okay how much typically looking at okay how much seafood did they eat? How many people seafood did they eat? How many people seafood did they eat? How many people died from cardiovascular disease? How died from cardiovascular disease? How died from cardiovascular disease? How many people died from cancer right? So many people died from cancer right? So many people died from cancer right? So you get this all cause mortality right you get this all cause mortality right you get this all cause mortality right number and what you're saying is that number and what you're saying is that number and what you're saying is that you can actually now instead of having you can actually now instead of having you can actually now instead of having to just have observational data looking to just have observational data looking to just have observational data looking at that all-c cause mortality you can at that all-c cause mortality you can at that all-c cause mortality you can now have an intervention now have an intervention now have an intervention we're going to give people you know you we're going to give people you know you we're going to give people you know you know fish or whatever we're going to do know fish or whatever we're going to do know fish or whatever we're going to do this intervention for a period of time this intervention for a period of time this intervention for a period of time and you can have the grim age which is and you can have the grim age which is and you can have the grim age which is kind of like this surrogate all-c cause kind of like this surrogate all-c cause kind of like this surrogate all-c cause mortality but but it's very actually a mortality but but it's very actually a mortality but but it's very actually a very good estim estimate of it. Is that very good estim estimate of it. Is that very good estim estimate of it. Is that am I thinking of it a little bit am I thinking of it a little bit am I thinking of it a little bit correctly or correctly or correctly or >> Yeah, you think of it correctly and >> Yeah, you think of it correctly and >> Yeah, you think of it correctly and that's certainly the ambition but I want that's certainly the ambition but I want that's certainly the ambition but I want to be very precise uh using the language to be very precise uh using the language to be very precise uh using the language of the FDA because I think we should do of the FDA because I think we should do of the FDA because I think we should do that. So the dream of the longevity that. So the dream of the longevity that. So the dream of the longevity field is to develop what is known as a field is to develop what is known as a field is to develop what is known as a surrogate endpoint um for a clinical surrogate endpoint um for a clinical surrogate endpoint um for a clinical trial. In other words, you have a study trial. In other words, you have a study trial. In other words, you have a study where you apply let's say a multivitamin where you apply let's say a multivitamin where you apply let's say a multivitamin for two years and then you see a change for two years and then you see a change for two years and then you see a change in any clock. It could be a proteomic in any clock. It could be a proteomic in any clock. It could be a proteomic clock, it could be a grim age, any other clock, it could be a grim age, any other clock, it could be a grim age, any other clock. And let's say you see a reversal. clock. And let's say you see a reversal. clock. And let's say you see a reversal. Now you would like to I want to call it Now you would like to I want to call it Now you would like to I want to call it jump to the conclusion that this jump to the conclusion that this jump to the conclusion that this actually translates into a a lower actually translates into a a lower actually translates into a a lower mortality risk. And um this um so we we mortality risk. And um this um so we we mortality risk. And um this um so we we would like to think that is the case but would like to think that is the case but would like to think that is the case but from a regulatory perspective that from a regulatory perspective that from a regulatory perspective that hasn't been proven you know and in hasn't been proven you know and in hasn't been proven you know and in general the FDA evaluates biomarkers you general the FDA evaluates biomarkers you general the FDA evaluates biomarkers you know um why they want to um give know um why they want to um give know um why they want to um give guidance to companies to biotech where guidance to companies to biotech where guidance to companies to biotech where they say if you show us that your they say if you show us that your they say if you show us that your treatment reverses that biioarker treatment reverses that biioarker treatment reverses that biioarker Therefore, we believe that it actually Therefore, we believe that it actually Therefore, we believe that it actually uh helps patients, you know, and um I uh helps patients, you know, and um I uh helps patients, you know, and um I just need to tell you and the audience, just need to tell you and the audience, just need to tell you and the audience, the biomarker field has not yet the biomarker field has not yet the biomarker field has not yet developed any biioarker that is credible developed any biioarker that is credible developed any biioarker that is credible to the FDA when it comes to this to the FDA when it comes to this to the FDA when it comes to this ambition of being an official surrogate ambition of being an official surrogate ambition of being an official surrogate endpoint of a clinical trial. Having endpoint of a clinical trial. Having endpoint of a clinical trial. Having said this, um we just can't wait for uh said this, um we just can't wait for uh said this, um we just can't wait for uh for for this regulatory approval yet. for for this regulatory approval yet. for for this regulatory approval yet. Why? They are urgent questions, right? Why? They are urgent questions, right? Why? They are urgent questions, right? People um have exciting interventions. People um have exciting interventions. People um have exciting interventions. So, we need to make assumptions, you So, we need to make assumptions, you So, we need to make assumptions, you know, and um for the longest time I've know, and um for the longest time I've know, and um for the longest time I've been very cautious when it comes to this been very cautious when it comes to this been very cautious when it comes to this claim. Do methylation clock um um meet claim. Do methylation clock um um meet claim. Do methylation clock um um meet this high standard? you know, and I'm this high standard? you know, and I'm this high standard? you know, and I'm I'm coming around, you know, um just I'm coming around, you know, um just I'm coming around, you know, um just because I I see increasing evidence, you because I I see increasing evidence, you because I I see increasing evidence, you know, that um these uh uh changes um um know, that um these uh uh changes um um know, that um these uh uh changes um um track what I call validated track what I call validated track what I call validated interventions, you know, where we know interventions, you know, where we know interventions, you know, where we know the intervention has a benefit for human the intervention has a benefit for human the intervention has a benefit for human mortality risk. And then I see that it mortality risk. And then I see that it mortality risk. And then I see that it also touches also touches also touches methylation clock in the expected methylation clock in the expected methylation clock in the expected direction. It it gives me confidence, direction. It it gives me confidence, direction. It it gives me confidence, you know, that the clock does what it's you know, that the clock does what it's you know, that the clock does what it's supposed to do, you know. So, that's supposed to do, you know. So, that's supposed to do, you know. So, that's that's where I'm at, you know. that's where I'm at, you know. that's where I'm at, you know. >> What >> What >> What have you what's the most robust have you what's the most robust have you what's the most robust intervention or it doesn't have to you intervention or it doesn't have to you intervention or it doesn't have to you don't have to tell me what the don't have to tell me what the don't have to tell me what the intervention is or you could, but what's intervention is or you could, but what's intervention is or you could, but what's the most robust data that you've seen in the most robust data that you've seen in the most robust data that you've seen in terms of, you know, reversing terms of, you know, reversing terms of, you know, reversing biologic age by some of these clocks, biologic age by some of these clocks, biologic age by some of these clocks, grim age, pheno age? grim age, pheno age? grim age, pheno age? What's like Yeah, I will start with um What's like Yeah, I will start with um What's like Yeah, I will start with um interventions that are in certain ways interventions that are in certain ways interventions that are in certain ways boring to you and me. Why boring to you? boring to you and me. Why boring to you? boring to you and me. Why boring to you? You and I, we are hopefully healthy You and I, we are hopefully healthy You and I, we are hopefully healthy people and we want to optimize our people and we want to optimize our people and we want to optimize our health. But I want to start with people health. But I want to start with people health. But I want to start with people who have a condition, you know, who have a condition, you know, who have a condition, you know, >> um to answer your question, um HIV >> um to answer your question, um HIV >> um to answer your question, um HIV positive people exhibit, um epigenetic positive people exhibit, um epigenetic positive people exhibit, um epigenetic age acceleration. It's actually a age acceleration. It's actually a age acceleration. It's actually a pronounced pro-aging effect. maybe five pronounced pro-aging effect. maybe five pronounced pro-aging effect. maybe five to seven years in blood and sure enough to seven years in blood and sure enough to seven years in blood and sure enough if they stick to their anti-retroviral if they stick to their anti-retroviral if they stick to their anti-retroviral therapy that will reverse their therapy that will reverse their therapy that will reverse their epigenetic age and that uh and and I epigenetic age and that uh and and I epigenetic age and that uh and and I mention it because that mention it because that mention it because that >> how much >> how much >> how much >> uh several years you know several years >> uh several years you know several years >> uh several years you know several years to give you a number four or five years to give you a number four or five years to give you a number four or five years >> four or five years does it happen pretty >> four or five years does it happen pretty >> four or five years does it happen pretty immediately after taking the drug? Yes. immediately after taking the drug? Yes. immediately after taking the drug? Yes. >> Um probably several weeks a month, you >> Um probably several weeks a month, you >> Um probably several weeks a month, you know, but um know, but um know, but um >> there have been many studies all over >> there have been many studies all over >> there have been many studies all over the world that have shown it, you know, the world that have shown it, you know, the world that have shown it, you know, so it's it's very well established and so it's it's very well established and so it's it's very well established and um yeah, so that's one application. I um yeah, so that's one application. I um yeah, so that's one application. I mention it it's um I trust it 100% but I mention it it's um I trust it 100% but I mention it it's um I trust it 100% but I um many people are not HIV positive, you um many people are not HIV positive, you um many people are not HIV positive, you know. So therefore I say do not take know. So therefore I say do not take know. So therefore I say do not take anti-retroviral therapy, you know, it's anti-retroviral therapy, you know, it's anti-retroviral therapy, you know, it's just not. So the other intervention that just not. So the other intervention that just not. So the other intervention that has very strong evidence is anti-TNF has very strong evidence is anti-TNF has very strong evidence is anti-TNF alpha therapy really anti-inflammatory alpha therapy really anti-inflammatory alpha therapy really anti-inflammatory um drugs for people who have an um drugs for people who have an um drugs for people who have an autoimmune disease autoimmune disease autoimmune disease again that just makes sense you know but again that just makes sense you know but again that just makes sense you know but um yes and um metformin is an um yes and um metformin is an um yes and um metformin is an interesting intervention to many of us interesting intervention to many of us interesting intervention to many of us um the problem is and and um I'm coming um the problem is and and um I'm coming um the problem is and and um I'm coming around to believing that metformin around to believing that metformin around to believing that metformin affects epigenetic age. There have been affects epigenetic age. There have been affects epigenetic age. There have been a couple of studies that suggested but I a couple of studies that suggested but I a couple of studies that suggested but I need to emphasize the effect is way need to emphasize the effect is way need to emphasize the effect is way weaker than than the above. So these are weaker than than the above. So these are weaker than than the above. So these are um really um medical interventions and um really um medical interventions and um really um medical interventions and in general as you can expect a medical in general as you can expect a medical in general as you can expect a medical intervention has a much stronger effect intervention has a much stronger effect intervention has a much stronger effect than a supplement you know. Yeah. When than a supplement you know. Yeah. When than a supplement you know. Yeah. When it comes to supplements we do have some it comes to supplements we do have some it comes to supplements we do have some answer. Um, omega-3 has an beneficial answer. Um, omega-3 has an beneficial answer. Um, omega-3 has an beneficial effect. Um, apparently vitamin u multiv effect. Um, apparently vitamin u multiv effect. Um, apparently vitamin u multiv vitamins have an effect. The problem is vitamins have an effect. The problem is vitamins have an effect. The problem is that these supplements have much weaker that these supplements have much weaker that these supplements have much weaker effects. Suddenly we talk about a couple effects. Suddenly we talk about a couple effects. Suddenly we talk about a couple of months of rejuvenation, you know. of months of rejuvenation, you know. of months of rejuvenation, you know. >> So, yeah. >> So, yeah. >> So, yeah. >> And we're going to talk about those more >> And we're going to talk about those more >> And we're going to talk about those more in depth and what that means. But yes, in depth and what that means. But yes, in depth and what that means. But yes, >> I want to I want to kind of this gets me >> I want to I want to kind of this gets me >> I want to I want to kind of this gets me into the controversies and hype because into the controversies and hype because into the controversies and hype because you're talking about like these really you're talking about like these really you're talking about like these really robust effects if someone has HIV robust effects if someone has HIV robust effects if someone has HIV >> which is obviously devastating for your >> which is obviously devastating for your >> which is obviously devastating for your for your body and then they take the for your body and then they take the for your body and then they take the antivirals and that's really kind of it antivirals and that's really kind of it antivirals and that's really kind of it does have a pretty robust effect on does have a pretty robust effect on does have a pretty robust effect on obviously their life expectancy you know obviously their life expectancy you know obviously their life expectancy you know many different features of health as many different features of health as many different features of health as well as epigenetic aging. So that makes well as epigenetic aging. So that makes well as epigenetic aging. So that makes sense. But I've heard people sense. But I've heard people sense. But I've heard people >> out there talk about reversing their >> out there talk about reversing their >> out there talk about reversing their biologic age biological age by 7 years biologic age biological age by 7 years biologic age biological age by 7 years in sorry they reverse their their in sorry they reverse their their in sorry they reverse their their biological age by 5 years in 7 months by biological age by 5 years in 7 months by biological age by 5 years in 7 months by doing lifestyle interventions. doing lifestyle interventions. doing lifestyle interventions. Is that something that you think could Is that something that you think could Is that something that you think could be a real biologic effect? Do you think be a real biologic effect? Do you think be a real biologic effect? Do you think that could be noise? Do you think it that could be noise? Do you think it that could be noise? Do you think it could be cherry-picking the best clock could be cherry-picking the best clock could be cherry-picking the best clock to get whatever outcome that they're to get whatever outcome that they're to get whatever outcome that they're wanting or I mean how do you feel about wanting or I mean how do you feel about wanting or I mean how do you feel about that statement? that statement? that statement? >> Yes. So >> Yes. So >> Yes. So um it's a very good question. I think I um it's a very good question. I think I um it's a very good question. I think I the first thing I would ask um what was the first thing I would ask um what was the first thing I would ask um what was their BMI before they started and um their BMI before they started and um their BMI before they started and um many other clinical readouts. So if you many other clinical readouts. So if you many other clinical readouts. So if you start with a person who was obese, had start with a person who was obese, had start with a person who was obese, had inflammation, diabetes, inflammation, diabetes, inflammation, diabetes, many of these stressors in their lives many of these stressors in their lives many of these stressors in their lives and they really changed everything and and they really changed everything and and they really changed everything and they they take their GLP-1 receptor they they take their GLP-1 receptor they they take their GLP-1 receptor agonist, they they they suddenly go to agonist, they they they suddenly go to agonist, they they they suddenly go to the gym and they do everything right, the gym and they do everything right, the gym and they do everything right, then it would perhaps be possible and um then it would perhaps be possible and um then it would perhaps be possible and um but there are many pitfalls and I can but there are many pitfalls and I can but there are many pitfalls and I can discuss them later, but I don't think discuss them later, but I don't think discuss them later, but I don't think it's um not not possible when you start it's um not not possible when you start it's um not not possible when you start with this baseline. with this baseline. with this baseline. >> So you're very unhealthy. >> So you're very unhealthy. >> So you're very unhealthy. >> You're very unhealthy and and and above >> You're very unhealthy and and and above >> You're very unhealthy and and and above all you actually start with an all you actually start with an all you actually start with an epigenetic age measure. Let's say grim epigenetic age measure. Let's say grim epigenetic age measure. Let's say grim age that shows you are 8 years older age that shows you are 8 years older age that shows you are 8 years older than you should be. Do you see you're in than you should be. Do you see you're in than you should be. Do you see you're in this in this highest percentile of risk? this in this highest percentile of risk? this in this highest percentile of risk? So then maybe you can go back to the So then maybe you can go back to the So then maybe you can go back to the average, you know. However, now let's average, you know. However, now let's average, you know. However, now let's talk about um the opposite case. A talk about um the opposite case. A talk about um the opposite case. A biohacker biohacker biohacker um obsessed about healthy lifestyle and um obsessed about healthy lifestyle and um obsessed about healthy lifestyle and now they say I changed my um diet and now they say I changed my um diet and now they say I changed my um diet and now I reversed my age by 5 years. I I now I reversed my age by 5 years. I I now I reversed my age by 5 years. I I would have the hardest time believing would have the hardest time believing would have the hardest time believing it, you know. And by the way, um this is it, you know. And by the way, um this is it, you know. And by the way, um this is something we see over and over again something we see over and over again something we see over and over again with various uh rejuvenating with various uh rejuvenating with various uh rejuvenating interventions. They seem to work in interventions. They seem to work in interventions. They seem to work in people whose epigenetic age is already people whose epigenetic age is already people whose epigenetic age is already accelerated, you know, but not in the accelerated, you know, but not in the accelerated, you know, but not in the people who are very healthy, you know. people who are very healthy, you know. people who are very healthy, you know. So, but yeah, so um anyways, I would be So, but yeah, so um anyways, I would be So, but yeah, so um anyways, I would be very skeptical, but I'm open-minded. I'm very skeptical, but I'm open-minded. I'm very skeptical, but I'm open-minded. I'm strictly datadriven, you know. So, I strictly datadriven, you know. So, I strictly datadriven, you know. So, I would have a long conversation with that would have a long conversation with that would have a long conversation with that person, you know. person, you know. person, you know. >> Yeah. Well, you make a really good point >> Yeah. Well, you make a really good point >> Yeah. Well, you make a really good point and that is, you know, people that are and that is, you know, people that are and that is, you know, people that are already accelerating, already accelerating, already accelerating, they're aging at a faster rate. So, they they're aging at a faster rate. So, they they're aging at a faster rate. So, they have this a age acceleration, right? have this a age acceleration, right? have this a age acceleration, right? Their grim age is already, you know, Their grim age is already, you know, Their grim age is already, you know, they're going to is higher than it's they're going to is higher than it's they're going to is higher than it's supposed to. Is that correct? Is it? supposed to. Is that correct? Is it? supposed to. Is that correct? Is it? >> Yes. Higher >> Yes. Higher >> Yes. Higher >> higher than it's supposed to be. You >> higher than it's supposed to be. You >> higher than it's supposed to be. You know, their their biological age, their know, their their biological age, their know, their their biological age, their feno age is higher, their pace of aging feno age is higher, their pace of aging feno age is higher, their pace of aging is higher. So, they're they're already is higher. So, they're they're already is higher. So, they're they're already age acceleration for whatever reason. age acceleration for whatever reason. age acceleration for whatever reason. they're sedentary, they're obese, they're sedentary, they're obese, they're sedentary, they're obese, they're sedentary and obese and they they're sedentary and obese and they they're sedentary and obese and they smoke smoke smoke >> or perhaps they have vitamin >> or perhaps they have vitamin >> or perhaps they have vitamin deficiencies. That's another one I've deficiencies. That's another one I've deficiencies. That's another one I've seen like vitamin D deficiency um has seen like vitamin D deficiency um has seen like vitamin D deficiency um has been shown to be, you know, associated been shown to be, you know, associated been shown to be, you know, associated with age acceleration. And if you with age acceleration. And if you with age acceleration. And if you correct those problems by losing weight, correct those problems by losing weight, correct those problems by losing weight, by getting physically active, by by getting physically active, by by getting physically active, by quitting smoking, you know, by eating quitting smoking, you know, by eating quitting smoking, you know, by eating healthy, by healthy, by healthy, by >> getting your micronutrients and filling >> getting your micronutrients and filling >> getting your micronutrients and filling the gap so you're not deficient, then the gap so you're not deficient, then the gap so you're not deficient, then you see a more robust effect. And that you see a more robust effect. And that you see a more robust effect. And that is also a recurring theme that I've seen is also a recurring theme that I've seen is also a recurring theme that I've seen from reading the scientific literature from reading the scientific literature from reading the scientific literature where it's like okay if you already have where it's like okay if you already have where it's like okay if you already have enough vitamin D and we'll talk about enough vitamin D and we'll talk about enough vitamin D and we'll talk about this like you know if you're if you're this like you know if you're if you're this like you know if you're if you're if you're already sufficient taking a if you're already sufficient taking a if you're already sufficient taking a vitamin D supplement's not going to slow vitamin D supplement's not going to slow vitamin D supplement's not going to slow your aging the thing the thing you're your aging the thing the thing you're your aging the thing the thing you're doing you're already doing it you're doing you're already doing it you're doing you're already doing it you're avoiding deficiency and that's the key avoiding deficiency and that's the key avoiding deficiency and that's the key right you you're you're trying to stop right you you're you're trying to stop right you you're you're trying to stop that acceler things that cause the that acceler things that cause the that acceler things that cause the acceleration of aging acceleration of aging acceleration of aging >> um seem to be easy more responsive at >> um seem to be easy more responsive at >> um seem to be easy more responsive at least least least >> exactly yeah >> exactly yeah >> exactly yeah >> the other question I wanted to ask It >> the other question I wanted to ask It >> the other question I wanted to ask It goes back to something that you goes back to something that you goes back to something that you mentioned earlier when you were talking mentioned earlier when you were talking mentioned earlier when you were talking about, you know, these insurance about, you know, these insurance about, you know, these insurance companies being able to predict your companies being able to predict your companies being able to predict your mortality risk pretty accurately. Um, mortality risk pretty accurately. Um, mortality risk pretty accurately. Um, using the DNA grimage. I've also heard using the DNA grimage. I've also heard using the DNA grimage. I've also heard people say that you can take this DNA people say that you can take this DNA people say that you can take this DNA grimage test and predict the day you're grimage test and predict the day you're grimage test and predict the day you're going to die like within a month. going to die like within a month. going to die like within a month. >> No, no, that's not true. >> No, no, that's not true. >> No, no, that's not true. >> Okay. Now, why is that not true? >> Okay. Now, why is that not true? >> Okay. Now, why is that not true? >> Yeah. So, I want to start out by >> Yeah. So, I want to start out by >> Yeah. So, I want to start out by commenting on insurance companies. um commenting on insurance companies. um commenting on insurance companies. um they are in the business of predicting they are in the business of predicting they are in the business of predicting how long you live. If they make an how long you live. If they make an how long you live. If they make an error, it will cost them a fortune. And error, it will cost them a fortune. And error, it will cost them a fortune. And um they are superb at that. And u just um they are superb at that. And u just um they are superb at that. And u just to emphasize, they look at so much. So to emphasize, they look at so much. So to emphasize, they look at so much. So they will above all look at very they will above all look at very they will above all look at very traditional uh readouts such as what's traditional uh readouts such as what's traditional uh readouts such as what's your blood pressure, what's your medical your blood pressure, what's your medical your blood pressure, what's your medical history, prior history of cancer, you history, prior history of cancer, you history, prior history of cancer, you know, uh substance abuse. So they will know, uh substance abuse. So they will know, uh substance abuse. So they will look at all of the above because all of look at all of the above because all of look at all of the above because all of these variables I mentioned are very these variables I mentioned are very these variables I mentioned are very strong predictors of mortality risk and strong predictors of mortality risk and strong predictors of mortality risk and the question is um does grim age add the question is um does grim age add the question is um does grim age add something or grim age or another something or grim age or another something or grim age or another methylation that's really the question methylation that's really the question methylation that's really the question for these companies and scientifically for these companies and scientifically for these companies and scientifically speaking I can say yes it adds something speaking I can say yes it adds something speaking I can say yes it adds something but not that much you know clearly the but not that much you know clearly the but not that much you know clearly the life insurance companies have done very life insurance companies have done very life insurance companies have done very well without having the methylation well without having the methylation well without having the methylation readout. But um but the exciting thing readout. But um but the exciting thing readout. But um but the exciting thing is methylation adds something. But then is methylation adds something. But then is methylation adds something. But then these companies have to weigh the costs, these companies have to weigh the costs, these companies have to weigh the costs, you know, because these tests are not you know, because these tests are not you know, because these tests are not cheap. They cost several hundred. So is cheap. They cost several hundred. So is cheap. They cost several hundred. So is it worth it to measure? And by the way, it worth it to measure? And by the way, it worth it to measure? And by the way, that's the same question for any that's the same question for any that's the same question for any consumer. Is it really worth it? Uh consumer. Is it really worth it? Uh consumer. Is it really worth it? Uh worth it to you to measure it, you know. worth it to you to measure it, you know. worth it to you to measure it, you know. Um um sorry, the other part of the uh Um um sorry, the other part of the uh Um um sorry, the other part of the uh you had a second part of the question. you had a second part of the question. you had a second part of the question. Yeah. The question is, I guess I I can Yeah. The question is, I guess I I can Yeah. The question is, I guess I I can word it a different way. If if I were to word it a different way. If if I were to word it a different way. If if I were to go out and get a DNA grimage test. go out and get a DNA grimage test. go out and get a DNA grimage test. >> Yes. >> Yes. >> Yes. >> And it said that I was going to die when >> And it said that I was going to die when >> And it said that I was going to die when I was age 80. I was age 80. I was age 80. >> Yes. >> Yes. >> Yes. >> Am I actually going to die at age 80? >> Am I actually going to die at age 80? >> Am I actually going to die at age 80? What how reliable is that number? How What how reliable is that number? How What how reliable is that number? How accurate is that number? Or am I going accurate is that number? Or am I going accurate is that number? Or am I going to die at perhaps age 85? to die at perhaps age 85? to die at perhaps age 85? >> Yes. I want to um um tell you that grim >> Yes. I want to um um tell you that grim >> Yes. I want to um um tell you that grim age could lead to a prediction of when age could lead to a prediction of when age could lead to a prediction of when you die. Let's say age 85. It could. you die. Let's say age 85. It could. you die. Let's say age 85. It could. And we know though that this estimate is And we know though that this estimate is And we know though that this estimate is accompanied by a large arrow bar plus - accompanied by a large arrow bar plus - accompanied by a large arrow bar plus - 6 years. I'm just making it up. So let's 6 years. I'm just making it up. So let's 6 years. I'm just making it up. So let's say you're a 50 year old. you measure say you're a 50 year old. you measure say you're a 50 year old. you measure your grim age and um we apply the math your grim age and um we apply the math your grim age and um we apply the math the mathematical algorithm which by the the mathematical algorithm which by the the mathematical algorithm which by the way is very complicated you know for way is very complicated you know for way is very complicated you know for estimating your um uh age at death. Um estimating your um uh age at death. Um estimating your um uh age at death. Um but the error error rate is substantial but the error error rate is substantial but the error error rate is substantial and um this makes sense because human and um this makes sense because human and um this makes sense because human beings are so complex you know think how beings are so complex you know think how beings are so complex you know think how many things can happen um even in the many things can happen um even in the many things can happen um even in the next year you can go through a divorce next year you can go through a divorce next year you can go through a divorce you get hit by a car you get depressed you get hit by a car you get depressed you get hit by a car you get depressed you start smoking you stop smoking you you start smoking you stop smoking you you start smoking you stop smoking you know so these um it it would be know so these um it it would be know so these um it it would be unethical to report literally the age of unethical to report literally the age of unethical to report literally the age of death to a person therefore for we have death to a person therefore for we have death to a person therefore for we have decided to only ever give people an age decided to only ever give people an age decided to only ever give people an age estimate. Right? We will say you're a estimate. Right? We will say you're a estimate. Right? We will say you're a grim age is 50. And um what I want to grim age is 50. And um what I want to grim age is 50. And um what I want to really explain to anyone who listens is really explain to anyone who listens is really explain to anyone who listens is that please do not translate that age that please do not translate that age that please do not translate that age estimate in your mind into an estimate estimate in your mind into an estimate estimate in your mind into an estimate when you will die. In other words, if when you will die. In other words, if when you will die. In other words, if your grim age is 10 years younger than your grim age is 10 years younger than your grim age is 10 years younger than your calendar age, it does not mean you your calendar age, it does not mean you your calendar age, it does not mean you will now live 10 years longer than the will now live 10 years longer than the will now live 10 years longer than the average person. Do you see? You cannot average person. Do you see? You cannot average person. Do you see? You cannot uh uh um compare this differential into uh uh um compare this differential into uh uh um compare this differential into a lifespan differential. a lifespan differential. a lifespan differential. >> Then what does it mean? >> Then what does it mean? >> Then what does it mean? >> Yes. So um what does grimage really >> Yes. So um what does grimage really >> Yes. So um what does grimage really measure in a mathematical sense? What measure in a mathematical sense? What measure in a mathematical sense? What does it measure? It really measures does it measure? It really measures does it measure? It really measures the instantaneous hazard that you drop the instantaneous hazard that you drop the instantaneous hazard that you drop dead. I always say to people, it's your dead. I always say to people, it's your dead. I always say to people, it's your risk that you will die in the next year. risk that you will die in the next year. risk that you will die in the next year. That's how you need to think of it, you That's how you need to think of it, you That's how you need to think of it, you know, compared to a person of the same know, compared to a person of the same know, compared to a person of the same age and the same sex, you know. So, we age and the same sex, you know. So, we age and the same sex, you know. So, we let's start with a 50 year old let's start with a 50 year old let's start with a 50 year old um and um let's say their grim age is um and um let's say their grim age is um and um let's say their grim age is 58, 8 years older than expected. 58, 8 years older than expected. 58, 8 years older than expected. then their risk of dropping debt in the then their risk of dropping debt in the then their risk of dropping debt in the next year is more than twice that of the next year is more than twice that of the next year is more than twice that of the average 50year-old of the same sex. Does average 50year-old of the same sex. Does average 50year-old of the same sex. Does that make sense? So it's really that make sense? So it's really that make sense? So it's really mathematically speaking it's a hazard mathematically speaking it's a hazard mathematically speaking it's a hazard ratio and the hazard ratio measures ratio and the hazard ratio measures ratio and the hazard ratio measures instantaneous mortality risk. Now you instantaneous mortality risk. Now you instantaneous mortality risk. Now you can can can translate that then into um an estimate translate that then into um an estimate translate that then into um an estimate of your lifespan. It's easy to do but of your lifespan. It's easy to do but of your lifespan. It's easy to do but it's a very complicated formula it's a very complicated formula it's a very complicated formula certainly highly nonlinear and as I certainly highly nonlinear and as I certainly highly nonlinear and as I mentioned associated with a strong arrow mentioned associated with a strong arrow mentioned associated with a strong arrow bar you know bar you know bar you know >> are there companies that are have >> are there companies that are have >> are there companies that are have consumer available tests doing that consumer available tests doing that consumer available tests doing that where they're measuring the grim age and where they're measuring the grim age and where they're measuring the grim age and then doing that translation to when you then doing that translation to when you then doing that translation to when you will die. Is that something you've seen? will die. Is that something you've seen? will die. Is that something you've seen? >> No, I have not seen that. Yeah. And I'm >> No, I have not seen that. Yeah. And I'm >> No, I have not seen that. Yeah. And I'm glad because I would have a problem with glad because I would have a problem with glad because I would have a problem with that on two grounds. I find it um on that on two grounds. I find it um on that on two grounds. I find it um on some level perhaps unethical. Um but um some level perhaps unethical. Um but um some level perhaps unethical. Um but um I believe in freedom. So if people want I believe in freedom. So if people want I believe in freedom. So if people want to do something, I'm okay with it. My uh to do something, I'm okay with it. My uh to do something, I'm okay with it. My uh concern is it's scientifically unsound. concern is it's scientifically unsound. concern is it's scientifically unsound. It really is, you know, for the reasons It really is, you know, for the reasons It really is, you know, for the reasons I mentioned there's a strong arrow bar, I mentioned there's a strong arrow bar, I mentioned there's a strong arrow bar, you know. So you know. So you know. So >> right, if you're talking five or six >> right, if you're talking five or six >> right, if you're talking five or six years, years, years, >> either way, that's that's a pretty big >> either way, that's that's a pretty big >> either way, that's that's a pretty big error bar for when you're going to die. error bar for when you're going to die. error bar for when you're going to die. But it seems like people are using it But it seems like people are using it But it seems like people are using it more to to to estimate their biological more to to to estimate their biological more to to to estimate their biological age, right? In a way, right? And that's age, right? In a way, right? And that's age, right? In a way, right? And that's that's typically what people are that's typically what people are that's typically what people are >> Yes. Usually >> Yes. Usually >> Yes. Usually >> we use Grimage um of course to >> we use Grimage um of course to >> we use Grimage um of course to understand the effect of various understand the effect of various understand the effect of various stressors. Um and stressors. Um and stressors. Um and um I'm a longevity researcher. I'm very um I'm a longevity researcher. I'm very um I'm a longevity researcher. I'm very excited about finding interventions that excited about finding interventions that excited about finding interventions that reverse it in humans and of course in reverse it in humans and of course in reverse it in humans and of course in animal models. So, um, that's how I use animal models. So, um, that's how I use animal models. So, um, that's how I use it, you know, it, you know, it, you know, >> for these for these clocks. Um, when >> for these for these clocks. Um, when >> for these for these clocks. Um, when when we're looking at the like aging when we're looking at the like aging when we're looking at the like aging process as a whole, process as a whole, process as a whole, >> you know, we're talk we were talking >> you know, we're talk we were talking >> you know, we're talk we were talking about damage, you know, there's the about damage, you know, there's the about damage, you know, there's the insult that is the initial insult and insult that is the initial insult and insult that is the initial insult and then you have perhaps the the damage then you have perhaps the the damage then you have perhaps the the damage response, maybe the amplification of response, maybe the amplification of response, maybe the amplification of that damage with inflammation. Then you that damage with inflammation. Then you that damage with inflammation. Then you start to have tissue breakdown, right? start to have tissue breakdown, right? start to have tissue breakdown, right? stem cell exa exhaustion like things stem cell exa exhaustion like things stem cell exa exhaustion like things that are more downstream of the damage that are more downstream of the damage that are more downstream of the damage and ampl amplification of that damage. and ampl amplification of that damage. and ampl amplification of that damage. Do do these aging clocks where do they Do do these aging clocks where do they Do do these aging clocks where do they sit on that? Yes, we um have um gained a sit on that? Yes, we um have um gained a sit on that? Yes, we um have um gained a lot of insights into aging in general by lot of insights into aging in general by lot of insights into aging in general by the way um and also um which um aging the way um and also um which um aging the way um and also um which um aging hallmarks really affect epigenetic hallmarks really affect epigenetic hallmarks really affect epigenetic clocks you know so 10 years ago we clocks you know so 10 years ago we clocks you know so 10 years ago we barely knew anything about mechanism barely knew anything about mechanism barely knew anything about mechanism um epigenetic clocks were rightly um epigenetic clocks were rightly um epigenetic clocks were rightly criticized as blackbox readouts but criticized as blackbox readouts but criticized as blackbox readouts but after really 10 12 years of research by after really 10 12 years of research by after really 10 12 years of research by the very best labs in the world. You the very best labs in the world. You the very best labs in the world. You know, we we really um have characterized know, we we really um have characterized know, we we really um have characterized these changes. Um maybe for the these changes. Um maybe for the these changes. Um maybe for the biologists um there are these hallmarks biologists um there are these hallmarks biologists um there are these hallmarks of aging. Um and we know that clocks of aging. Um and we know that clocks of aging. Um and we know that clocks relate to mitochondrial dysfunction, the relate to mitochondrial dysfunction, the relate to mitochondrial dysfunction, the energetics. They relate um also to stem energetics. They relate um also to stem energetics. They relate um also to stem cell changes very much so, stem cell cell changes very much so, stem cell cell changes very much so, stem cell biology. biology. biology. um they um relate to um metabolic um they um relate to um metabolic um they um relate to um metabolic changes, nutrient sensing um um to some changes, nutrient sensing um um to some changes, nutrient sensing um um to some extent as well and um and also aspects extent as well and um and also aspects extent as well and um and also aspects of DNA repair you know so um that is of DNA repair you know so um that is of DNA repair you know so um that is part of the biology. They clearly relate part of the biology. They clearly relate part of the biology. They clearly relate also to changes in what is known as cell also to changes in what is known as cell also to changes in what is known as cell composition. So um in in blood we have composition. So um in in blood we have composition. So um in in blood we have many different blood cells and some many different blood cells and some many different blood cells and some cells uh are aged so-called um stressed cells uh are aged so-called um stressed cells uh are aged so-called um stressed memory memory memory uh tea cells um cytotoxic tea cells um uh tea cells um cytotoxic tea cells um uh tea cells um cytotoxic tea cells um um that um are exhausted this is um that um are exhausted this is um that um are exhausted this is actually a technical term exhausted tea actually a technical term exhausted tea actually a technical term exhausted tea cells from aging and conversely there cells from aging and conversely there cells from aging and conversely there are these naive tea cells you know so we are these naive tea cells you know so we are these naive tea cells you know so we understand that epigenetic clocks also understand that epigenetic clocks also understand that epigenetic clocks also relate to inflammation and um and that relate to inflammation and um and that relate to inflammation and um and that biology. So um epigenetic clocks should biology. So um epigenetic clocks should biology. So um epigenetic clocks should be conceptualized really as integrators be conceptualized really as integrators be conceptualized really as integrators of many uh different stressors but not of many uh different stressors but not of many uh different stressors but not all. Um they don't capture everything. all. Um they don't capture everything. all. Um they don't capture everything. And the most striking blind spot I want And the most striking blind spot I want And the most striking blind spot I want to highlight which is frustrating to me to highlight which is frustrating to me to highlight which is frustrating to me but I want to emphasize it. Um people in but I want to emphasize it. Um people in but I want to emphasize it. Um people in the aging field have heard of the aging field have heard of the aging field have heard of scinesscent cells senolytics very scinesscent cells senolytics very scinesscent cells senolytics very exciting uh intervention. I I'm very uh exciting uh intervention. I I'm very uh exciting uh intervention. I I'm very uh much following that literature. However, much following that literature. However, much following that literature. However, epigenetic clocks really don't capture epigenetic clocks really don't capture epigenetic clocks really don't capture that well you know. So um let me give that well you know. So um let me give that well you know. So um let me give you the prime example. You have cells you the prime example. You have cells you the prime example. You have cells growing in a dish. You radiate them high growing in a dish. You radiate them high growing in a dish. You radiate them high any radiation. You induce scessence. any radiation. You induce scessence. any radiation. You induce scessence. they the cells can no longer they the cells can no longer they the cells can no longer proliferate. Um, and by the way, proliferate. Um, and by the way, proliferate. Um, and by the way, radiation leads to double strand breaks. radiation leads to double strand breaks. radiation leads to double strand breaks. It really It really It really very much stresses the cells. And very much stresses the cells. And very much stresses the cells. And wouldn't it be nice if methylation wouldn't it be nice if methylation wouldn't it be nice if methylation clocks pick that up, but they don't, you clocks pick that up, but they don't, you clocks pick that up, but they don't, you know, so so radiation damage at least know, so so radiation damage at least know, so so radiation damage at least for for for >> they don't pick up double stranded >> they don't pick up double stranded >> they don't pick up double stranded brakes even. brakes even. brakes even. >> Yes. At least when you induce it by >> Yes. At least when you induce it by >> Yes. At least when you induce it by radiation, you know. So we know radiation, you know. So we know radiation, you know. So we know radiation is very bad for you but radiation is very bad for you but radiation is very bad for you but methylation changes do not result methylation changes do not result methylation changes do not result directly you know and um so and and I directly you know and um so and and I directly you know and um so and and I give you the converse of that when it give you the converse of that when it give you the converse of that when it comes to scinessence many of uh many comes to scinessence many of uh many comes to scinessence many of uh many people have heard of tieumirs um in people have heard of tieumirs um in people have heard of tieumirs um in theory you want reasonably long tieumirs theory you want reasonably long tieumirs theory you want reasonably long tieumirs at the ends of your DNA and for many at the ends of your DNA and for many at the ends of your DNA and for many years people have thought aging is about years people have thought aging is about years people have thought aging is about tieumir attrition. Now we know better tieumir attrition. Now we know better tieumir attrition. Now we know better it's not but anyways it's a famous it's not but anyways it's a famous it's not but anyways it's a famous hallmark of aging tumir shortening hallmark of aging tumir shortening hallmark of aging tumir shortening however many of the clocks have only a however many of the clocks have only a however many of the clocks have only a weak correlation with tumir biology it's weak correlation with tumir biology it's weak correlation with tumir biology it's a frustrating aspect um and um 20 years a frustrating aspect um and um 20 years a frustrating aspect um and um 20 years ago people had an exciting idea um ago people had an exciting idea um ago people had an exciting idea um overexpress a part of tomease the turd overexpress a part of tomease the turd overexpress a part of tomease the turd um overexpress turd Um and there were um overexpress turd Um and there were um overexpress turd Um and there were companies that pursued that as a companies that pursued that as a companies that pursued that as a rejuvenating intervention and um in at rejuvenating intervention and um in at rejuvenating intervention and um in at least in our hands um we did not see a least in our hands um we did not see a least in our hands um we did not see a beneficial effect at least in vitro you beneficial effect at least in vitro you beneficial effect at least in vitro you know so um although I liked uh know so um although I liked uh know so um although I liked uh epigenetic clocks for many studies but epigenetic clocks for many studies but epigenetic clocks for many studies but they don't capture the totality of aging they don't capture the totality of aging they don't capture the totality of aging you know so you really um want to you know so you really um want to you know so you really um want to complement epigenetic clocks with other complement epigenetic clocks with other complement epigenetic clocks with other readouts readouts readouts That's interesting that they're not That's interesting that they're not That's interesting that they're not because you mentioned that they do track because you mentioned that they do track because you mentioned that they do track with the DNA repair process but not with the DNA repair process but not with the DNA repair process but not >> to some extent. I I know I'm giving >> to some extent. I I know I'm giving >> to some extent. I I know I'm giving conflicting messages um but that's the conflicting messages um but that's the conflicting messages um but that's the biology. biology. biology. >> So um >> So um >> So um >> there's certain experiment that show >> there's certain experiment that show >> there's certain experiment that show that um um some aspects of DNA repair that um um some aspects of DNA repair that um um some aspects of DNA repair relate to epigenetic aging but others relate to epigenetic aging but others relate to epigenetic aging but others don't. It's it's just not a tight story, don't. It's it's just not a tight story, don't. It's it's just not a tight story, you know. So, I think um the field you know. So, I think um the field you know. So, I think um the field really needs to nail that down. really needs to nail that down. really needs to nail that down. >> Yeah. I mean, well, there's a lot of >> Yeah. I mean, well, there's a lot of >> Yeah. I mean, well, there's a lot of things that lead to aging, you know. things that lead to aging, you know. things that lead to aging, you know. It's it's a very complicated, It's it's a very complicated, It's it's a very complicated, >> you know, multiffactorial >> you know, multiffactorial >> you know, multiffactorial >> uh process when when >> uh process when when >> uh process when when >> you actually are able to per perhaps >> you actually are able to per perhaps >> you actually are able to per perhaps reverse, you know, biological aging or reverse, you know, biological aging or reverse, you know, biological aging or I guess there's two ways of thinking I guess there's two ways of thinking I guess there's two ways of thinking about it. you're slowing age about it. you're slowing age about it. you're slowing age acceleration, right? If you're taking acceleration, right? If you're taking acceleration, right? If you're taking away something that's negatively away something that's negatively away something that's negatively accelerating aging or negatively accelerating aging or negatively accelerating aging or negatively affecting your health, affecting your health, affecting your health, >> but then also, let's say you're if you >> but then also, let's say you're if you >> but then also, let's say you're if you can actually somehow slow the aging can actually somehow slow the aging can actually somehow slow the aging process, at least on the readout, the process, at least on the readout, the process, at least on the readout, the clock is showing that you're younger clock is showing that you're younger clock is showing that you're younger after doing something. Where do you after doing something. Where do you after doing something. Where do you think do you think that's like think do you think that's like think do you think that's like inflammation like these processes that inflammation like these processes that inflammation like these processes that are that are that you describe that are are that are that you describe that are are that are that you describe that are sort of tracking with these clocks are sort of tracking with these clocks are sort of tracking with these clocks are being affected? So the you know being affected? So the you know being affected? So the you know mitochondrial function, inflammation, mitochondrial function, inflammation, mitochondrial function, inflammation, those processes are improving and the those processes are improving and the those processes are improving and the clocks are sort of picking that up. Um clocks are sort of picking that up. Um clocks are sort of picking that up. Um yes and no. I mean um so epigenetic yes and no. I mean um so epigenetic yes and no. I mean um so epigenetic clocks such as grimage and do need and clocks such as grimage and do need and clocks such as grimage and do need and pace and feno age they do track pace and feno age they do track pace and feno age they do track inflammation to some extent. No inflammation to some extent. No inflammation to some extent. No question. So yes, if you reverse that um question. So yes, if you reverse that um question. So yes, if you reverse that um these clocks will pick it up. But it these clocks will pick it up. But it these clocks will pick it up. But it would be a grave error to assume that would be a grave error to assume that would be a grave error to assume that the clocks only measure that biology. the clocks only measure that biology. the clocks only measure that biology. It's really not true, you know. Um the It's really not true, you know. Um the It's really not true, you know. Um the clocks um very much relate also to stem clocks um very much relate also to stem clocks um very much relate also to stem cell functioning, you know, and um and cell functioning, you know, and um and cell functioning, you know, and um and other aspects, you know. So again they other aspects, you know. So again they other aspects, you know. So again they are integrators and um so there there are integrators and um so there there are integrators and um so there there will be interventions that actually will be interventions that actually will be interventions that actually don't even touch the in inflammosome in don't even touch the in inflammosome in don't even touch the in inflammosome in one way or another but they could have a one way or another but they could have a one way or another but they could have a very strong effect on reversing your very strong effect on reversing your very strong effect on reversing your epigenetic age and the prime example epigenetic age and the prime example epigenetic age and the prime example would be would be would be um therapies that for example completely um therapies that for example completely um therapies that for example completely rejuvenate your hematopoetic stem cells. rejuvenate your hematopoetic stem cells. rejuvenate your hematopoetic stem cells. Just assume you have an intervention Just assume you have an intervention Just assume you have an intervention where you really replace your your bone where you really replace your your bone where you really replace your your bone marrow, you know, the or hematopetic marrow, you know, the or hematopetic marrow, you know, the or hematopetic stem cells that produce all of these stem cells that produce all of these stem cells that produce all of these blood cells and you just um get um blood cells and you just um get um blood cells and you just um get um hematopoetic stem cells with an hematopoetic stem cells with an hematopoetic stem cells with an epigenetic age of zero. Um epigenetic age of zero. Um epigenetic age of zero. Um um that would very much rejuvenate your um that would very much rejuvenate your um that would very much rejuvenate your blood drastically. you know um we know blood drastically. you know um we know blood drastically. you know um we know that from mouse studies but also human that from mouse studies but also human that from mouse studies but also human studies you know the the epigenetic age studies you know the the epigenetic age studies you know the the epigenetic age in a bone marrow transplant recipient in a bone marrow transplant recipient in a bone marrow transplant recipient often um reflects the age of the donor often um reflects the age of the donor often um reflects the age of the donor you know so um so do you see there are you know so um so do you see there are you know so um so do you see there are various interventions that could have a various interventions that could have a various interventions that could have a very strong effect um but they just very strong effect um but they just very strong effect um but they just don't touch on that biology you don't touch on that biology you don't touch on that biology you mentioned mentioned mentioned >> if it's rejuvenating the blood is it >> if it's rejuvenating the blood is it >> if it's rejuvenating the blood is it also perhaps rejuvenating other organs also perhaps rejuvenating other organs also perhaps rejuvenating other organs >> that's a great hope you know So um my >> that's a great hope you know So um my >> that's a great hope you know So um my response is assume not because it would response is assume not because it would response is assume not because it would wouldn't it be nice if wouldn't it be nice if wouldn't it be nice if >> what animal studies shown have they >> what animal studies shown have they >> what animal studies shown have they looked at that? looked at that? looked at that? >> Yes, there have been animal studies I >> Yes, there have been animal studies I >> Yes, there have been animal studies I want to say in the lab from Vadim want to say in the lab from Vadim want to say in the lab from Vadim Gladishev at Harvard and um the studies Gladishev at Harvard and um the studies Gladishev at Harvard and um the studies um my reading of the studies is that um my reading of the studies is that um my reading of the studies is that they have been disappointing they didn't they have been disappointing they didn't they have been disappointing they didn't rejuvenate other organs. If anything, rejuvenate other organs. If anything, rejuvenate other organs. If anything, there was um a disappointing result that there was um a disappointing result that there was um a disappointing result that um after x number of months actually the um after x number of months actually the um after x number of months actually the stem cells had aged. So the body has the stem cells had aged. So the body has the stem cells had aged. So the body has the memory of the old mouse and that then memory of the old mouse and that then memory of the old mouse and that then aged the the the blood. Really? Does it? aged the the the blood. Really? Does it? aged the the the blood. Really? Does it? >> So did these mice get a hematopoetic >> So did these mice get a hematopoetic >> So did these mice get a hematopoetic stem cell um graft or they did? Okay. stem cell um graft or they did? Okay. stem cell um graft or they did? Okay. >> Um um Vadim um carried out really an >> Um um Vadim um carried out really an >> Um um Vadim um carried out really an elegant set of experiments various uh elegant set of experiments various uh elegant set of experiments various uh transplantation experiments and the transplantation experiments and the transplantation experiments and the scientific question is the following scientific question is the following scientific question is the following okay if I uh replace let's say the blood okay if I uh replace let's say the blood okay if I uh replace let's say the blood by that of a very young mouse or take by that of a very young mouse or take by that of a very young mouse or take other organs by the way should we other organs by the way should we other organs by the way should we replace the kidney should you know so replace the kidney should you know so replace the kidney should you know so anyway the or or the heart or any other anyway the or or the heart or any other anyway the or or the heart or any other organ um would the rejuvenation of one organ um would the rejuvenation of one organ um would the rejuvenation of one organ translate to for bodywide organ translate to for bodywide organ translate to for bodywide rejuvenation and my current reading of rejuvenation and my current reading of rejuvenation and my current reading of the literature is that we haven't found the literature is that we haven't found the literature is that we haven't found any such uh organ as a target. You know, any such uh organ as a target. You know, any such uh organ as a target. You know, >> I thought there was some evidence that >> I thought there was some evidence that >> I thought there was some evidence that if you did some of these transplants if you did some of these transplants if you did some of these transplants where you take young blood and put it where you take young blood and put it where you take young blood and put it into older mice that rejuvenated the into older mice that rejuvenated the into older mice that rejuvenated the brain, for example, brain, for example, brain, for example, >> or am I I mean that that's I don't know >> or am I I mean that that's I don't know >> or am I I mean that that's I don't know if they were measuring doing using if they were measuring doing using if they were measuring doing using clocks, but they were doing cognitive clocks, but they were doing cognitive clocks, but they were doing cognitive function and a battery of tests and the function and a battery of tests and the function and a battery of tests and the cognitive function improved and things cognitive function improved and things cognitive function improved and things like that. But no, for sure you know. So like that. But no, for sure you know. So like that. But no, for sure you know. So maybe um to remind the audience this maybe um to remind the audience this maybe um to remind the audience this this idea of heterocchronic parabiosis this idea of heterocchronic parabiosis this idea of heterocchronic parabiosis for example where you really uh connect for example where you really uh connect for example where you really uh connect the circulation of an old mouse with a the circulation of an old mouse with a the circulation of an old mouse with a young mouse. And this is a really a young mouse. And this is a really a young mouse. And this is a really a phenomenal paradigm of rejuvenation. phenomenal paradigm of rejuvenation. phenomenal paradigm of rejuvenation. Arguably one of the best ones we have Arguably one of the best ones we have Arguably one of the best ones we have along with caloric restriction. along with caloric restriction. along with caloric restriction. And um um so yes um we know that um when And um um so yes um we know that um when And um um so yes um we know that um when an old mouse is exposed to the an old mouse is exposed to the an old mouse is exposed to the circulation of a young mouse it has circulation of a young mouse it has circulation of a young mouse it has multiple benefits cognitive benefits multiple benefits cognitive benefits multiple benefits cognitive benefits also muscle benefits. So um and also also muscle benefits. So um and also also muscle benefits. So um and also importantly epigenetic clocks get importantly epigenetic clocks get importantly epigenetic clocks get rejuvenated many organs. Um so we know rejuvenated many organs. Um so we know rejuvenated many organs. Um so we know that again from several studies that again from several studies that again from several studies including from Vadim Bladesf's lab but including from Vadim Bladesf's lab but including from Vadim Bladesf's lab but others have found that too. So yes, um others have found that too. So yes, um others have found that too. So yes, um young circulation rejuvenates the liver, young circulation rejuvenates the liver, young circulation rejuvenates the liver, the kidney, all of that, you know, um on the kidney, all of that, you know, um on the kidney, all of that, you know, um on the methylation level, but there's a the methylation level, but there's a the methylation level, but there's a problem. You disconnect these mice, so problem. You disconnect these mice, so problem. You disconnect these mice, so they are no longer connected. They're no they are no longer connected. They're no they are no longer connected. They're no longer exposed to the young circulation. longer exposed to the young circulation. longer exposed to the young circulation. Then the things bounce back, the Then the things bounce back, the Then the things bounce back, the epigenetic age bounces back to that of epigenetic age bounces back to that of epigenetic age bounces back to that of the recipient mouse. It's very the recipient mouse. It's very the recipient mouse. It's very frustrating to all of us who work in the frustrating to all of us who work in the frustrating to all of us who work in the longevity field because that is a very longevity field because that is a very longevity field because that is a very common story. You have a powerful common story. You have a powerful common story. You have a powerful intervention. It actually rejuvenates intervention. It actually rejuvenates intervention. It actually rejuvenates the organ. The problem is it's the organ. The problem is it's the organ. The problem is it's transient, you know. But yes, transient, you know. But yes, transient, you know. But yes, >> it's it's kind of like the probiotics >> it's it's kind of like the probiotics >> it's it's kind of like the probiotics flow through. You have to keep taking flow through. You have to keep taking flow through. You have to keep taking them to have a benefit in the gut as them to have a benefit in the gut as them to have a benefit in the gut as soon as you stop taking them because soon as you stop taking them because soon as you stop taking them because they don't stick there, right? They're they don't stick there, right? They're they don't stick there, right? They're not taking residence there. Yes. Yes. not taking residence there. Yes. Yes. not taking residence there. Yes. Yes. Well, let's talk about caloric Well, let's talk about caloric Well, let's talk about caloric restriction since you just mentioned restriction since you just mentioned restriction since you just mentioned that as a rejuvenating that as a rejuvenating that as a rejuvenating therapy. I mean, at least many animal therapy. I mean, at least many animal therapy. I mean, at least many animal studies have shown that and I don't know studies have shown that and I don't know studies have shown that and I don't know that anyone wants to be calorie that anyone wants to be calorie that anyone wants to be calorie restricted for the rest of their life. restricted for the rest of their life. restricted for the rest of their life. Although GLP-1 receptor agonists are Although GLP-1 receptor agonists are Although GLP-1 receptor agonists are kind of doing that in a way. Um there kind of doing that in a way. Um there kind of doing that in a way. Um there was a very recent trial, the calorie was a very recent trial, the calorie was a very recent trial, the calorie trial, and I'd love for you to talk trial, and I'd love for you to talk trial, and I'd love for you to talk about this was a two-year randomized about this was a two-year randomized about this was a two-year randomized control trial where individuals were control trial where individuals were control trial where individuals were basically eating 25% fewer calories than basically eating 25% fewer calories than basically eating 25% fewer calories than they otherwise would or they were eating they otherwise would or they were eating they otherwise would or they were eating their normal, you know, daily food their normal, you know, daily food their normal, you know, daily food intake as as usual. And I wanted to ask intake as as usual. And I wanted to ask intake as as usual. And I wanted to ask you you you was this were the participants was this were the participants was this were the participants overweight in this trial or were they overweight in this trial or were they overweight in this trial or were they normal weight? Do you know? normal weight? Do you know? normal weight? Do you know? >> I don't remember. I know it's a US >> I don't remember. I know it's a US >> I don't remember. I know it's a US population so assume that they are on population so assume that they are on population so assume that they are on the chubby side for sure, you know. the chubby side for sure, you know. the chubby side for sure, you know. >> Okay. >> Okay. >> Okay. >> Yeah. >> Yeah. >> Yeah. >> Yeah. So in this in this trial, it was a >> Yeah. So in this in this trial, it was a >> Yeah. So in this in this trial, it was a two years rand two-year randomized two years rand two-year randomized two years rand two-year randomized control trial and it seemed there was control trial and it seemed there was control trial and it seemed there was many clocks that were measured many clocks that were measured many clocks that were measured >> and it seemed like they had different >> and it seemed like they had different >> and it seemed like they had different readouts. Do you want to talk a little readouts. Do you want to talk a little readouts. Do you want to talk a little bit about the the the findings? I mean I bit about the the the findings? I mean I bit about the the the findings? I mean I guess guess guess >> yes um yeah I have a lot to say about >> yes um yeah I have a lot to say about >> yes um yeah I have a lot to say about weight loss we should discuss it you weight loss we should discuss it you weight loss we should discuss it you know so but uh the calorie study is a know so but uh the calorie study is a know so but uh the calorie study is a very famous study um US population very very famous study um US population very very famous study um US population very rigorous study many many readouts um but rigorous study many many readouts um but rigorous study many many readouts um but I want to acknowledge something um and I want to acknowledge something um and I want to acknowledge something um and um the experts know it the adherence was um the experts know it the adherence was um the experts know it the adherence was not good you know so um there was an not good you know so um there was an not good you know so um there was an ambition that these people would lose ambition that these people would lose ambition that these people would lose more weight than they did, but as more weight than they did, but as more weight than they did, but as everyone knows, it's so hard to adhere everyone knows, it's so hard to adhere everyone knows, it's so hard to adhere to a diet. So the um the age reduction to a diet. So the um the age reduction to a diet. So the um the age reduction was on some level very weak. I would say was on some level very weak. I would say was on some level very weak. I would say I I I I apologize. I don't know the I I I I apologize. I don't know the I I I I apologize. I don't know the number, but I remember it was weak. I number, but I remember it was weak. I number, but I remember it was weak. I mention it because later we should talk mention it because later we should talk mention it because later we should talk about GLP-1 receptor agonist where the about GLP-1 receptor agonist where the about GLP-1 receptor agonist where the weight loss can be pronounced and the weight loss can be pronounced and the weight loss can be pronounced and the there discrepant findings actually, there discrepant findings actually, there discrepant findings actually, right? right? right? >> But anyways, back to the calorie study. >> But anyways, back to the calorie study. >> But anyways, back to the calorie study. Um um um again there were multiple blood Um um um again there were multiple blood Um um um again there were multiple blood draws from these people and so one could draws from these people and so one could draws from these people and so one could evaluate um which methylation clocks evaluate um which methylation clocks evaluate um which methylation clocks pick up a beneficial effect. And um I pick up a beneficial effect. And um I pick up a beneficial effect. And um I was disappointed that um grim age and was disappointed that um grim age and was disappointed that um grim age and feno age did not pick up my effect. But feno age did not pick up my effect. But feno age did not pick up my effect. But this new clock a new clock at the time this new clock a new clock at the time this new clock a new clock at the time Dunid and Pace really picked up my Dunid and Pace really picked up my Dunid and Pace really picked up my effect. Um and which was reassuring you effect. Um and which was reassuring you effect. Um and which was reassuring you know that um reassuring because know that um reassuring because know that um reassuring because everything I know about the biology of everything I know about the biology of everything I know about the biology of methylation clocks tells me that they methylation clocks tells me that they methylation clocks tells me that they should pick up a reduction in weight if should pick up a reduction in weight if should pick up a reduction in weight if it's strong enough. You know it's strong enough. You know it's strong enough. You know >> how much weight did they lose? Do you >> how much weight did they lose? Do you >> how much weight did they lose? Do you remember? It was remember? It was remember? It was >> pretty like not very much. >> pretty like not very much. >> pretty like not very much. >> Yeah, it was not impressive to me at >> Yeah, it was not impressive to me at >> Yeah, it was not impressive to me at least. least. least. >> So, so the clock that did pick up the >> So, so the clock that did pick up the >> So, so the clock that did pick up the >> It was Dun need and pace. And in in >> It was Dun need and pace. And in in >> It was Dun need and pace. And in in hindsight, um let's discuss why it hindsight, um let's discuss why it hindsight, um let's discuss why it picked up the picked up the picked up the >> like a 2 to 3% slowing of the rate of >> like a 2 to 3% slowing of the rate of >> like a 2 to 3% slowing of the rate of aging aging aging >> over the two years. >> over the two years. >> over the two years. >> That's true. Yeah. So it picked it up >> That's true. Yeah. So it picked it up >> That's true. Yeah. So it picked it up and it makes mathematical sense to me and it makes mathematical sense to me and it makes mathematical sense to me because Dunid and Pace again was uh um because Dunid and Pace again was uh um because Dunid and Pace again was uh um trained that's the lingo of machine trained that's the lingo of machine trained that's the lingo of machine learning but it was developed to track learning but it was developed to track learning but it was developed to track changes in BMI. So yes it picked it up. changes in BMI. So yes it picked it up. changes in BMI. So yes it picked it up. By contrast Grimage was never trained to By contrast Grimage was never trained to By contrast Grimage was never trained to look at weight loss. It was trained on look at weight loss. It was trained on look at weight loss. It was trained on mortality. So, so yes, Dunan pace worked mortality. So, so yes, Dunan pace worked mortality. So, so yes, Dunan pace worked and my reading of Dunan pace is um that and my reading of Dunan pace is um that and my reading of Dunan pace is um that it is good at that biology. People it is good at that biology. People it is good at that biology. People losing weight, it will pick it up. Um losing weight, it will pick it up. Um losing weight, it will pick it up. Um and um now the question is why didn't and um now the question is why didn't and um now the question is why didn't the other clocks pick it up? And there the other clocks pick it up? And there the other clocks pick it up? And there could be several explanations, you know, could be several explanations, you know, could be several explanations, you know, but my view is if there had been a but my view is if there had been a but my view is if there had been a larger sample size, if the people had larger sample size, if the people had larger sample size, if the people had adhered to the protocol, I'm I'm as sure adhered to the protocol, I'm I'm as sure adhered to the protocol, I'm I'm as sure as you can be that the other clocks as you can be that the other clocks as you can be that the other clocks would have picked it up. It's a sample would have picked it up. It's a sample would have picked it up. It's a sample size issue or conversely small effect size issue or conversely small effect size issue or conversely small effect size. size. size. What I can tell you is there was sorry What I can tell you is there was sorry What I can tell you is there was sorry there was a very exciting study um um there was a very exciting study um um there was a very exciting study um um that involved actually obese people BMI that involved actually obese people BMI that involved actually obese people BMI 30 and higher who had been put on a 30 and higher who had been put on a 30 and higher who had been put on a GLP-1 receptor agonist treatment GLP-1 receptor agonist treatment GLP-1 receptor agonist treatment semiglutide. semiglutide. semiglutide. And these people really lost a lot of And these people really lost a lot of And these people really lost a lot of weight over 33 weeks. And um by the way weight over 33 weeks. And um by the way weight over 33 weeks. And um by the way this um study um was published in MET this um study um was published in MET this um study um was published in MET archive. It's a pre-print so um take it archive. It's a pre-print so um take it archive. It's a pre-print so um take it with caution. It was Michael Kley's with caution. It was Michael Kley's with caution. It was Michael Kley's group in San Diego but very beautiful group in San Diego but very beautiful group in San Diego but very beautiful study very rigorous again and um a large study very rigorous again and um a large study very rigorous again and um a large sample size so credible and they looked sample size so credible and they looked sample size so credible and they looked at all methylation clocks and suddenly at all methylation clocks and suddenly at all methylation clocks and suddenly all methylation clocks picked it up all methylation clocks picked it up all methylation clocks picked it up really all you know and um so that's my really all you know and um so that's my really all you know and um so that's my thinking you know if you have a strong thinking you know if you have a strong thinking you know if you have a strong weight loss intervention you have really weight loss intervention you have really weight loss intervention you have really a strong reduction in fat lipolysis is a strong reduction in fat lipolysis is a strong reduction in fat lipolysis is you know this inflammatory signal is you know this inflammatory signal is you know this inflammatory signal is reduced um I think all methylation reduced um I think all methylation reduced um I think all methylation clocks will pick it up and clocks will pick it up and clocks will pick it up and >> right and I think it goes back to this >> right and I think it goes back to this >> right and I think it goes back to this concept that we were discussing earlier concept that we were discussing earlier concept that we were discussing earlier where if your baseline is unhealthy if where if your baseline is unhealthy if where if your baseline is unhealthy if you are obese you are accelerating your you are obese you are accelerating your you are obese you are accelerating your aging right you are you're in age aging right you are you're in age aging right you are you're in age acceleration mode right so you need to acceleration mode right so you need to acceleration mode right so you need to slow it down slow it down slow it down >> and with any clinical trial it's always >> and with any clinical trial it's always >> and with any clinical trial it's always you always get a better signal you always get a better signal you always get a better signal when you're starting with something when you're starting with something when you're starting with something that's at a population that's either that's at a population that's either that's at a population that's either deficient or unhealthy and then you're deficient or unhealthy and then you're deficient or unhealthy and then you're giving something to improve that giving something to improve that giving something to improve that deficiency or negate it or to you know deficiency or negate it or to you know deficiency or negate it or to you know improve their health and you get a more improve their health and you get a more improve their health and you get a more dramatic effect. So we know obesity dramatic effect. So we know obesity dramatic effect. So we know obesity accelerates aging we know you know that accelerates aging we know you know that accelerates aging we know you know that it's associated with you know decrease it's associated with you know decrease it's associated with you know decrease in life expectancy you know increase in in life expectancy you know increase in in life expectancy you know increase in cardiovascular disease, type two cardiovascular disease, type two cardiovascular disease, type two diabetes, cancer, right? All these all diabetes, cancer, right? All these all diabetes, cancer, right? All these all these diseases of aging. So, it's not these diseases of aging. So, it's not these diseases of aging. So, it's not surprising that you would give someone a surprising that you would give someone a surprising that you would give someone a drug that does cause rapid weight loss drug that does cause rapid weight loss drug that does cause rapid weight loss in a short amount of time. So, you're in a short amount of time. So, you're in a short amount of time. So, you're going to get a much more robust signal, going to get a much more robust signal, going to get a much more robust signal, right? right? right? >> Um, and you're obviously picking that up >> Um, and you're obviously picking that up >> Um, and you're obviously picking that up with with the agent clocks with with the agent clocks with with the agent clocks >> with the calorie trial. Um, you know, >> with the calorie trial. Um, you know, >> with the calorie trial. Um, you know, again, I don't know what the adherence again, I don't know what the adherence again, I don't know what the adherence was, but also as you mentioned, these was, but also as you mentioned, these was, but also as you mentioned, these these clocks are trained with different these clocks are trained with different these clocks are trained with different there's there's different specialties of there's there's different specialties of there's there's different specialties of them, so to speak, right? and BMI being them, so to speak, right? and BMI being them, so to speak, right? and BMI being trained on BMI. Wow. That's going to trained on BMI. Wow. That's going to trained on BMI. Wow. That's going to make you sensitive to weight loss for make you sensitive to weight loss for make you sensitive to weight loss for sure. Um and so the you know the douadan sure. Um and so the you know the douadan sure. Um and so the you know the douadan pace clock which is measuring the pace pace clock which is measuring the pace pace clock which is measuring the pace of aging um you would imagine would be of aging um you would imagine would be of aging um you would imagine would be more sensitive than than something that more sensitive than than something that more sensitive than than something that would would would >> but you know my my question as a >> but you know my my question as a >> but you know my my question as a longevity researcher is which clock longevity researcher is which clock longevity researcher is which clock should a clinician use? You know um if should a clinician use? You know um if should a clinician use? You know um if we could briefly talk about we could briefly talk about we could briefly talk about multivitamins um um this study multivitamins um um this study multivitamins um um this study interestingly here grim age f found an interestingly here grim age f found an interestingly here grim age f found an effect pheno age found an effect based effect pheno age found an effect based effect pheno age found an effect based on multivitamin use but dunit and pace on multivitamin use but dunit and pace on multivitamin use but dunit and pace failed it was not significant you know failed it was not significant you know failed it was not significant you know so and you can ask this question now for so and you can ask this question now for so and you can ask this question now for many interventions what should be the many interventions what should be the many interventions what should be the go-to clock and you know I I even I want go-to clock and you know I I even I want go-to clock and you know I I even I want to stay clear of this debate because we to stay clear of this debate because we to stay clear of this debate because we will never agree agree, you know, will never agree agree, you know, will never agree agree, you know, therefore I I just love it that the therefore I I just love it that the therefore I I just love it that the field by now simply reports at least field by now simply reports at least field by now simply reports at least five clocks, you know, so the reader can five clocks, you know, so the reader can five clocks, you know, so the reader can just look at it and um be the judge. just look at it and um be the judge. just look at it and um be the judge. >> Let's let's talk about the multivitamin. >> Let's let's talk about the multivitamin. >> Let's let's talk about the multivitamin. So this was the Cosmos trial. I've So this was the Cosmos trial. I've So this was the Cosmos trial. I've talked a lot about the Cosmos trial in talked a lot about the Cosmos trial in talked a lot about the Cosmos trial in the context of brain aging. So the the context of brain aging. So the the context of brain aging. So the larger there's you know the larger larger there's you know the larger larger there's you know the larger trials and there was three randomized trials and there was three randomized trials and there was three randomized control trials where these older adults control trials where these older adults control trials where these older adults were given a standard Centrum silver were given a standard Centrum silver were given a standard Centrum silver multivitamin a day. Oh yes, multivitamin a day. Oh yes, multivitamin a day. Oh yes, >> every day. And it was what is it about >> every day. And it was what is it about >> every day. And it was what is it about 3.6 six years for this trial and they 3.6 six years for this trial and they 3.6 six years for this trial and they were looking at I mean there's a lot of were looking at I mean there's a lot of were looking at I mean there's a lot of end points of this trial but one of them end points of this trial but one of them end points of this trial but one of them was cognitive function and brain aging was cognitive function and brain aging was cognitive function and brain aging and at the end of the trial the the and at the end of the trial the the and at the end of the trial the the people that were given the multivitamin people that were given the multivitamin people that were given the multivitamin had slowed their brain aging by 2.1 had slowed their brain aging by 2.1 had slowed their brain aging by 2.1 years and there was a battery of tests years and there was a battery of tests years and there was a battery of tests that were done there and I'm not sure if that were done there and I'm not sure if that were done there and I'm not sure if in fact some clocks were used as well in fact some clocks were used as well in fact some clocks were used as well but I know that the global brain aging but I know that the global brain aging but I know that the global brain aging was slowed by 2.1 years and their was slowed by 2.1 years and their was slowed by 2.1 years and their episodic brain aging So, episodic episodic brain aging So, episodic episodic brain aging So, episodic memories, a kind of memory where you're memories, a kind of memory where you're memories, a kind of memory where you're remembering experiences, people, right? remembering experiences, people, right? remembering experiences, people, right? Like those sorts of things. Um, that was Like those sorts of things. Um, that was Like those sorts of things. Um, that was slowed by almost 5 years compared to the slowed by almost 5 years compared to the slowed by almost 5 years compared to the placebo group, which is quite placebo group, which is quite placebo group, which is quite significant. And they did better on a significant. And they did better on a significant. And they did better on a battery of cognition tests. And so, that battery of cognition tests. And so, that battery of cognition tests. And so, that was very that's very encouraging, you was very that's very encouraging, you was very that's very encouraging, you know, and it's something that I do talk know, and it's something that I do talk know, and it's something that I do talk about a lot because I feel like it's a about a lot because I feel like it's a about a lot because I feel like it's a very easy, safe intervention that people very easy, safe intervention that people very easy, safe intervention that people can take a standard multivitamin. These can take a standard multivitamin. These can take a standard multivitamin. These have a variety of vitamins and minerals, have a variety of vitamins and minerals, have a variety of vitamins and minerals, trace elements that people are not trace elements that people are not trace elements that people are not getting from their diets. And so they're getting from their diets. And so they're getting from their diets. And so they're kind of filling that nutritional gap. kind of filling that nutritional gap. kind of filling that nutritional gap. And and so, you know, who doesn't want And and so, you know, who doesn't want And and so, you know, who doesn't want their parents and grandparents to have their parents and grandparents to have their parents and grandparents to have better brain aging? So, I'm my parents better brain aging? So, I'm my parents better brain aging? So, I'm my parents are on a multivitamin, right? are on a multivitamin, right? are on a multivitamin, right? >> Um, when it comes to looking at these >> Um, when it comes to looking at these >> Um, when it comes to looking at these epigenetic aging clocks, the phenoaging epigenetic aging clocks, the phenoaging epigenetic aging clocks, the phenoaging grimage clocks were the ones that stood grimage clocks were the ones that stood grimage clocks were the ones that stood out to me. As you mentioned, there was a out to me. As you mentioned, there was a out to me. As you mentioned, there was a battery of clocks that were that were battery of clocks that were that were battery of clocks that were that were looked at, but it seemed as though they looked at, but it seemed as though they looked at, but it seemed as though they were slowing or at least were slowing or at least were slowing or at least I'm not exactly sure all the I'm not exactly sure all the I'm not exactly sure all the calculations that go into this, but 2.7 calculations that go into this, but 2.7 calculations that go into this, but 2.7 months to 5 months, right? Like they months to 5 months, right? Like they months to 5 months, right? Like they were basically were basically were basically >> they're they're slowing the aging by >> they're they're slowing the aging by >> they're they're slowing the aging by roughly that amount. roughly that amount. roughly that amount. >> Yes. >> Yes. >> Yes. >> Um, which to me is, if you think about >> Um, which to me is, if you think about >> Um, which to me is, if you think about >> now this this trial that was done with >> now this this trial that was done with >> now this this trial that was done with the agent clocks, I think it was like a the agent clocks, I think it was like a the agent clocks, I think it was like a subset of it of the larger trial. Was it subset of it of the larger trial. Was it subset of it of the larger trial. Was it two years or did they do the 3.6 years two years or did they do the 3.6 years two years or did they do the 3.6 years for that? Do you for that? Do you for that? Do you >> It was Yeah, I think it was two years. >> It was Yeah, I think it was two years. >> It was Yeah, I think it was two years. >> Two years. Yeah. And and so um to me the >> Two years. Yeah. And and so um to me the >> Two years. Yeah. And and so um to me the question is now this wasn't that you question is now this wasn't that you question is now this wasn't that you said the Dodinan pace didn't change. said the Dodinan pace didn't change. said the Dodinan pace didn't change. >> No, it it it changed in the right >> No, it it it changed in the right >> No, it it it changed in the right direction. It just wasn't statistically direction. It just wasn't statistically direction. It just wasn't statistically significant. significant. significant. >> Oh, I see. No. Um >> Oh, I see. No. Um >> Oh, I see. No. Um >> in the right direction. You know, maybe >> in the right direction. You know, maybe >> in the right direction. You know, maybe a larger sample size would have um led a larger sample size would have um led a larger sample size would have um led to a significant finding. It was to a significant finding. It was to a significant finding. It was definitely in the right direction. Well, definitely in the right direction. Well, definitely in the right direction. Well, the question I have for you is if you're the question I have for you is if you're the question I have for you is if you're changing it by, you know, 3 to 5 months changing it by, you know, 3 to 5 months changing it by, you know, 3 to 5 months within that 2-year range within that 2-year range within that 2-year range >> according to the the grimage and feno >> according to the the grimage and feno >> according to the the grimage and feno age clocks age clocks age clocks >> and you're to keep doing that, you know, >> and you're to keep doing that, you know, >> and you're to keep doing that, you know, you know, for years. So, now we're you know, for years. So, now we're you know, for years. So, now we're talking not just 2 years, we're talking talking not just 2 years, we're talking talking not just 2 years, we're talking 20, we're talking 30, 40 years. 20, we're talking 30, 40 years. 20, we're talking 30, 40 years. >> Yes. >> Yes. >> Yes. >> How do you think that? Do you think that >> How do you think that? Do you think that >> How do you think that? Do you think that you get this accumulative effect? you get this accumulative effect? you get this accumulative effect? >> Yes, I think so. I um I think so. I um >> Yes, I think so. I um I think so. I um >> Yes, I think so. I um I think so. I um maybe to step back. If you tell an maybe to step back. If you tell an maybe to step back. If you tell an 80year-old that um a multivitamin will 80year-old that um a multivitamin will 80year-old that um a multivitamin will reduce his or her age by 3 months, they reduce his or her age by 3 months, they reduce his or her age by 3 months, they will roll their eyes. They will say, will roll their eyes. They will say, will roll their eyes. They will say, "Okay, give me something that reverses "Okay, give me something that reverses "Okay, give me something that reverses my age by 30 years, you know. Um um so my age by 30 years, you know. Um um so my age by 30 years, you know. Um um so fair enough. The effect we just need to fair enough. The effect we just need to fair enough. The effect we just need to acknowledge the effect is very minor, acknowledge the effect is very minor, acknowledge the effect is very minor, you know. However, I like the way you you know. However, I like the way you you know. However, I like the way you conceptualize it. If you um really use conceptualize it. If you um really use conceptualize it. If you um really use it for 30 years, right, and you're 50 it for 30 years, right, and you're 50 it for 30 years, right, and you're 50 year old and you use it until you're age year old and you use it until you're age year old and you use it until you're age 80, my expectation is that suddenly 80, my expectation is that suddenly 80, my expectation is that suddenly these uh 3 months benefit they these uh 3 months benefit they these uh 3 months benefit they accumulate and suddenly you have a accumulate and suddenly you have a accumulate and suddenly you have a benefit of maybe two and a half years. benefit of maybe two and a half years. benefit of maybe two and a half years. You know, it's still not uh You know, it's still not uh You know, it's still not uh great, you know, but um there is a great, you know, but um there is a great, you know, but um there is a benefit, you know. So, um, benefit, you know. So, um, benefit, you know. So, um, >> but think of the effort you have to put >> but think of the effort you have to put >> but think of the effort you have to put into just taking a multivitamin, right? into just taking a multivitamin, right? into just taking a multivitamin, right? I I think it's pretty great for that I I think it's pretty great for that I I think it's pretty great for that amount of effort. You know, if you're if amount of effort. You know, if you're if amount of effort. You know, if you're if you're just having to take one vitamin you're just having to take one vitamin you're just having to take one vitamin supplement and it's going to delay your supplement and it's going to delay your supplement and it's going to delay your your brain aging, your brain aging, your brain aging, >> you know, by 2.1 years just after, >> you know, by 2.1 years just after, >> you know, by 2.1 years just after, >> you know, in that trial, it was 3.6 year >> you know, in that trial, it was 3.6 year >> you know, in that trial, it was 3.6 year trial, but, you know, that's pretty trial, but, you know, that's pretty trial, but, you know, that's pretty robust. Five years delaying brain robust. Five years delaying brain robust. Five years delaying brain episodic brain aging. episodic brain aging. episodic brain aging. >> Yes. And and now we're talking about >> Yes. And and now we're talking about >> Yes. And and now we're talking about like globally like biological aging. If like globally like biological aging. If like globally like biological aging. If it's if it's slowing it by let's say on it's if it's slowing it by let's say on it's if it's slowing it by let's say on the high end five months after two the high end five months after two the high end five months after two years. years. years. >> Yes. >> Yes. >> Yes. >> I don't know. That seems like a pretty >> I don't know. That seems like a pretty >> I don't know. That seems like a pretty >> great effect if you're just taking a >> great effect if you're just taking a >> great effect if you're just taking a vitamin supplement for two years it's vitamin supplement for two years it's vitamin supplement for two years it's doing that. Well, let's continue on and doing that. Well, let's continue on and doing that. Well, let's continue on and and then combine other things and we'll and then combine other things and we'll and then combine other things and we'll get into some of the other trials that get into some of the other trials that get into some of the other trials that do show synergy. But do show synergy. But do show synergy. But >> yes, >> yes, >> yes, >> um I think it's interesting. The other >> um I think it's interesting. The other >> um I think it's interesting. The other question is that and this is where um question is that and this is where um question is that and this is where um you know the Cosmos trials people you know the Cosmos trials people you know the Cosmos trials people they're looking at everything right they're looking at everything right they're looking at everything right cancer mortality cardiovascular cancer mortality cardiovascular cancer mortality cardiovascular mortality all cause mortality and those mortality all cause mortality and those mortality all cause mortality and those didn't really seem to change yes didn't really seem to change yes didn't really seem to change yes >> at least within the time frame >> at least within the time frame >> at least within the time frame >> yes >> yes >> yes >> that was looked at and so you know we >> that was looked at and so you know we >> that was looked at and so you know we see these epigenetic clocks giving us a see these epigenetic clocks giving us a see these epigenetic clocks giving us a signal we see the brain aging effects signal we see the brain aging effects signal we see the brain aging effects and the question is why why are those and the question is why why are those and the question is why why are those showing up before showing up before showing up before >> yeah I I tell you my reading of it and >> yeah I I tell you my reading of it and >> yeah I I tell you my reading of it and um To me, this whole study was one um To me, this whole study was one um To me, this whole study was one triumph for epigenetic clocks. And I triumph for epigenetic clocks. And I triumph for epigenetic clocks. And I explained to you why. explained to you why. explained to you why. Assume you knew nothing um about Assume you knew nothing um about Assume you knew nothing um about multivitamins. Um you would think that multivitamins. Um you would think that multivitamins. Um you would think that there is a benefit, you know. Um clearly there is a benefit, you know. Um clearly there is a benefit, you know. Um clearly vitamins are important. It's a trivial vitamins are important. It's a trivial vitamins are important. It's a trivial tology. tology. tology. >> Avoiding deficiencies are important >> Avoiding deficiencies are important >> Avoiding deficiencies are important >> especially, you know. So you would say, >> especially, you know. So you would say, >> especially, you know. So you would say, okay, I administer that to the US okay, I administer that to the US okay, I administer that to the US population. I would hope to see an population. I would hope to see an population. I would hope to see an effect and that of course is the reason effect and that of course is the reason effect and that of course is the reason why these largecale studies were even why these largecale studies were even why these largecale studies were even initiated. Think about how difficult it initiated. Think about how difficult it initiated. Think about how difficult it is to raise the funding for such a large is to raise the funding for such a large is to raise the funding for such a large scale study. Clearly there must be very scale study. Clearly there must be very scale study. Clearly there must be very compelling reasons. Okay, but there is a compelling reasons. Okay, but there is a compelling reasons. Okay, but there is a problem now and um these hard end points problem now and um these hard end points problem now and um these hard end points mortality cardiovascular disease they mortality cardiovascular disease they mortality cardiovascular disease they didn't detect an effect. deeply didn't detect an effect. deeply didn't detect an effect. deeply frustrating. Um, frustrating. Um, frustrating. Um, >> was there a trend? It wasn't >> was there a trend? It wasn't >> was there a trend? It wasn't statistically significant. statistically significant. statistically significant. >> Yeah, I let you summarize it, but to me, >> Yeah, I let you summarize it, but to me, >> Yeah, I let you summarize it, but to me, you know, it um I I I I just looked at you know, it um I I I I just looked at you know, it um I I I I just looked at it from the point of view as a consumer it from the point of view as a consumer it from the point of view as a consumer 5 years ago, you know, I wouldn't take a 5 years ago, you know, I wouldn't take a 5 years ago, you know, I wouldn't take a multivitamin. I looked at the multivitamin. I looked at the multivitamin. I looked at the literature, no benefit, I won't take it, literature, no benefit, I won't take it, literature, no benefit, I won't take it, you know. Now, um, so, um, a person can you know. Now, um, so, um, a person can you know. Now, um, so, um, a person can now make their own judgment, you know. now make their own judgment, you know. now make their own judgment, you know. So what does it mean to me? I take it as So what does it mean to me? I take it as So what does it mean to me? I take it as a wonderful triumph of epigenetic clocks a wonderful triumph of epigenetic clocks a wonderful triumph of epigenetic clocks that they did pick up um the the signal that they did pick up um the the signal that they did pick up um the the signal and I um call this testing the test. you and I um call this testing the test. you and I um call this testing the test. you have an intervention where um you really have an intervention where um you really have an intervention where um you really think it's got to move the needle, you think it's got to move the needle, you think it's got to move the needle, you know, and then if a readout doesn't show know, and then if a readout doesn't show know, and then if a readout doesn't show it, one interpretation is well maybe the it, one interpretation is well maybe the it, one interpretation is well maybe the readout is too crude. Maybe um all cause readout is too crude. Maybe um all cause readout is too crude. Maybe um all cause mortality is a real I mean we I like it mortality is a real I mean we I like it mortality is a real I mean we I like it as a readout. I used it for Grimage. as a readout. I used it for Grimage. as a readout. I used it for Grimage. Don't get me wrong, I I like that it's Don't get me wrong, I I like that it's Don't get me wrong, I I like that it's hard and definitive. You can't argue hard and definitive. You can't argue hard and definitive. You can't argue with it. However, people die for a with it. However, people die for a with it. However, people die for a hundred different reasons, you know, hundred different reasons, you know, hundred different reasons, you know, that may really not relate to the uh that may really not relate to the uh that may really not relate to the uh biology of aging, you know, and um so biology of aging, you know, and um so biology of aging, you know, and um so now that we have actually biomarkers now that we have actually biomarkers now that we have actually biomarkers that did pick up that signal even though that did pick up that signal even though that did pick up that signal even though it's very weak is to me um really it's very weak is to me um really it's very weak is to me um really reassuring, you know. reassuring, you know. reassuring, you know. >> Yeah. And I think it's reassuring in >> Yeah. And I think it's reassuring in >> Yeah. And I think it's reassuring in combination with the the the brain aging combination with the the the brain aging combination with the the the brain aging signal that it picked up and just signal that it picked up and just signal that it picked up and just knowing that you know so many so many knowing that you know so many so many knowing that you know so many so many globally people are not getting enough globally people are not getting enough globally people are not getting enough of these important vitamins and minerals of these important vitamins and minerals of these important vitamins and minerals and trace elements and essential fatty and trace elements and essential fatty and trace elements and essential fatty acids from their diet. Then it's kind of acids from their diet. Then it's kind of acids from their diet. Then it's kind of like an insurance like okay I'm going to like an insurance like okay I'm going to like an insurance like okay I'm going to fill some of these nutritional gaps. fill some of these nutritional gaps. fill some of these nutritional gaps. They won't all get filled because you They won't all get filled because you They won't all get filled because you can't stuff everything in one pill. I can't stuff everything in one pill. I can't stuff everything in one pill. I mean, you know, you can only get a mean, you know, you can only get a mean, you know, you can only get a little bit of some things in there, little bit of some things in there, little bit of some things in there, right? right? right? >> Yes. >> Yes. >> Yes. >> But I do think that it's it's again, I >> But I do think that it's it's again, I >> But I do think that it's it's again, I agree with you. I think it is a triumph agree with you. I think it is a triumph agree with you. I think it is a triumph and it's something that I do think that and it's something that I do think that and it's something that I do think that is safe. I mean, it's really been shown is safe. I mean, it's really been shown is safe. I mean, it's really been shown to be safe and so so maybe maybe you pee to be safe and so so maybe maybe you pee to be safe and so so maybe maybe you pee a little bit more of out. So, what it's a little bit more of out. So, what it's a little bit more of out. So, what it's it seems to be doing something it seems to be doing something it seems to be doing something beneficial for the brain and at least beneficial for the brain and at least beneficial for the brain and at least for, you know, looking at these aging for, you know, looking at these aging for, you know, looking at these aging clocks, it seems like for the way you're clocks, it seems like for the way you're clocks, it seems like for the way you're aging as well. aging as well. aging as well. >> Yes. Yeah. So, what have you got to >> Yes. Yeah. So, what have you got to >> Yes. Yeah. So, what have you got to lose, you know? lose, you know? lose, you know? >> Yeah. Um, let's let's let's go back to >> Yeah. Um, let's let's let's go back to >> Yeah. Um, let's let's let's go back to um maybe some of these other vitamins. um maybe some of these other vitamins. um maybe some of these other vitamins. There's other I guess lifestyle There's other I guess lifestyle There's other I guess lifestyle interventions as well that I wanted to interventions as well that I wanted to interventions as well that I wanted to cover, but since we're on the vitamin cover, but since we're on the vitamin cover, but since we're on the vitamin train, um the big one is omega-3, right? train, um the big one is omega-3, right? train, um the big one is omega-3, right? I mean, that I've seen at least in the I mean, that I've seen at least in the I mean, that I've seen at least in the literature. And this is something that literature. And this is something that literature. And this is something that isn't surprising to me because isn't surprising to me because isn't surprising to me because going back to this theme that we've been going back to this theme that we've been going back to this theme that we've been talking about, if you're starting out talking about, if you're starting out talking about, if you're starting out with a deficiency, if you're starting with a deficiency, if you're starting with a deficiency, if you're starting out at an unhealthy point and you out at an unhealthy point and you out at an unhealthy point and you improve there, improve that, you fill improve there, improve that, you fill improve there, improve that, you fill that nutrition deficiency gap or you, that nutrition deficiency gap or you, that nutrition deficiency gap or you, you know, improve your health, lose you know, improve your health, lose you know, improve your health, lose weight, whatever, then you're going to weight, whatever, then you're going to weight, whatever, then you're going to have a stronger signal, right? have a stronger signal, right? have a stronger signal, right? >> Yes. >> Yes. >> Yes. >> Um 90% of Americans don't get enough >> Um 90% of Americans don't get enough >> Um 90% of Americans don't get enough omega-3 fatty acids. Nobody's eating omega-3 fatty acids. Nobody's eating omega-3 fatty acids. Nobody's eating seafood in the US. It's just, you know, seafood in the US. It's just, you know, seafood in the US. It's just, you know, so you're you're starting with a so you're you're starting with a so you're you're starting with a population that's already, you know, I population that's already, you know, I population that's already, you know, I don't want to say deficient, but they're don't want to say deficient, but they're don't want to say deficient, but they're not getting a sufficient amount of not getting a sufficient amount of not getting a sufficient amount of omega-3 fatty acids. omega-3 fatty acids. omega-3 fatty acids. >> And so I think it's probably why it's >> And so I think it's probably why it's >> And so I think it's probably why it's easy to keep getting this stronger easy to keep getting this stronger easy to keep getting this stronger signal because you're if you start out signal because you're if you start out signal because you're if you start out with someone who's already getting with someone who's already getting with someone who's already getting enough omega-3, maybe you go to Japan enough omega-3, maybe you go to Japan enough omega-3, maybe you go to Japan and do the study. I don't know. It would and do the study. I don't know. It would and do the study. I don't know. It would be interesting to see. be interesting to see. be interesting to see. >> Yes. Um perhaps perhaps there it just >> Yes. Um perhaps perhaps there it just >> Yes. Um perhaps perhaps there it just keeps improving inflammation and then keeps improving inflammation and then keeps improving inflammation and then you know you'll keep seeing an effect. you know you'll keep seeing an effect. you know you'll keep seeing an effect. But um it seems like many many studies But um it seems like many many studies But um it seems like many many studies have shown that omega-3 fatty acid have shown that omega-3 fatty acid have shown that omega-3 fatty acid whether it's from food supplementation a whether it's from food supplementation a whether it's from food supplementation a combination of both seem to slow combination of both seem to slow combination of both seem to slow epigenetic aging by different clocks. epigenetic aging by different clocks. epigenetic aging by different clocks. >> Yes, there has been quite some >> Yes, there has been quite some >> Yes, there has been quite some literature. It started with um literature. It started with um literature. It started with um observational studies that you cannot observational studies that you cannot observational studies that you cannot trust but um last year um we published a trust but um last year um we published a trust but um last year um we published a study um which was very rigorous. This study um which was very rigorous. This study um which was very rigorous. This was a study conducted by a Swiss was a study conducted by a Swiss was a study conducted by a Swiss professor Hiker Bishop Ferrari who professor Hiker Bishop Ferrari who professor Hiker Bishop Ferrari who looked at 780 people and um followed looked at 780 people and um followed looked at 780 people and um followed again the most rigorous um design again the most rigorous um design again the most rigorous um design randomized controlled trial, placebo randomized controlled trial, placebo randomized controlled trial, placebo control trial in a population that I was control trial in a population that I was control trial in a population that I was very interested in people 71 years or very interested in people 71 years or very interested in people 71 years or older really older people reasonably older really older people reasonably older really older people reasonably healthy um average age I want to say 75. healthy um average age I want to say 75. healthy um average age I want to say 75. five I think or 73. So older people and five I think or 73. So older people and five I think or 73. So older people and she um um evaluated she um um evaluated she um um evaluated um famous interventions. Number one, um famous interventions. Number one, um famous interventions. Number one, omega-3 1 gram um vitamin D. And we omega-3 1 gram um vitamin D. And we omega-3 1 gram um vitamin D. And we should talk about the intervention about should talk about the intervention about should talk about the intervention about vitamin D was tricky. It was high vitamin D was tricky. It was high vitamin D was tricky. It was high vitamin D versus low vitamin D. It vitamin D versus low vitamin D. It vitamin D versus low vitamin D. It wasn't vitamin D versus no vitamin D. wasn't vitamin D versus no vitamin D. wasn't vitamin D versus no vitamin D. That that's a key distinction. That that's a key distinction. That that's a key distinction. >> What was the what was the low? Oh, I >> What was the what was the low? Oh, I >> What was the what was the low? Oh, I know the high vitamin D was 2,000 IUs. know the high vitamin D was 2,000 IUs. know the high vitamin D was 2,000 IUs. >> Yes. And the low was 800 IUs. >> Yes. And the low was 800 IUs. >> Yes. And the low was 800 IUs. >> Yes. >> Yes. >> Yes. >> So, it's only double kind of. >> So, it's only double kind of. >> So, it's only double kind of. >> Yeah. Exactly. And that's a limitation >> Yeah. Exactly. And that's a limitation >> Yeah. Exactly. And that's a limitation because the results for vitamin D were because the results for vitamin D were because the results for vitamin D were disappointing. No effect on epigenetic disappointing. No effect on epigenetic disappointing. No effect on epigenetic clocks. But that's why I hasten to add clocks. But that's why I hasten to add clocks. But that's why I hasten to add >> it. Yeah. But we have other randomized >> it. Yeah. But we have other randomized >> it. Yeah. But we have other randomized control trials showing the opposite. If control trials showing the opposite. If control trials showing the opposite. If you start with the deficiency and add you start with the deficiency and add you start with the deficiency and add it, and we can talk about that. Okay. it, and we can talk about that. Okay. it, and we can talk about that. Okay. So, vitamin D. So, vitamin D. So, vitamin D. >> That's true. But um >> That's true. But um >> That's true. But um >> but there was also another disappointing >> but there was also another disappointing >> but there was also another disappointing if you look at the exercise. Yeah, we if you look at the exercise. Yeah, we if you look at the exercise. Yeah, we need to talk about exercise. So, yeah. need to talk about exercise. So, yeah. need to talk about exercise. So, yeah. So, this was called a home exercise So, this was called a home exercise So, this was called a home exercise intervention. Now, to remind you, these intervention. Now, to remind you, these intervention. Now, to remind you, these are people in their 70s and think in are people in their 70s and think in are people in their 70s and think in terms of ethics approval. You cannot terms of ethics approval. You cannot terms of ethics approval. You cannot stress these people too much. So, the stress these people too much. So, the stress these people too much. So, the this home exercise intervention was very this home exercise intervention was very this home exercise intervention was very modest. Okay. And modest. Okay. And modest. Okay. And >> it was resistance training, right? Three >> it was resistance training, right? Three >> it was resistance training, right? Three three times a week. three times a week. three times a week. >> Yes. Yeah. But it was um I'm telling you >> Yes. Yeah. But it was um I'm telling you >> Yes. Yeah. But it was um I'm telling you it was a mild mild mild resistance it was a mild mild mild resistance it was a mild mild mild resistance training you know because because um no training you know because because um no training you know because because um no effect I was very disappointed. effect I was very disappointed. effect I was very disappointed. >> Did you read that the the the starting >> Did you read that the the the starting >> Did you read that the the the starting population 88 like around 88% of them population 88 like around 88% of them population 88 like around 88% of them already identified as being physically already identified as being physically already identified as being physically active. active. active. >> Exactly. >> Exactly. >> Exactly. >> I mean which is if you were to get a US >> I mean which is if you were to get a US >> I mean which is if you were to get a US population not a chance like that population not a chance like that population not a chance like that there's no way you would have had that there's no way you would have had that there's no way you would have had that many people physically active. But many people physically active. But many people physically active. But anyway so that's anyway so that's anyway so that's >> these are people in Switzerland. >> these are people in Switzerland. >> these are people in Switzerland. Hopefully they hike in the mountain Hopefully they hike in the mountain Hopefully they hike in the mountain >> walking everywhere. Exactly. No, but >> walking everywhere. Exactly. No, but >> walking everywhere. Exactly. No, but that was interesting to me because I'm that was interesting to me because I'm that was interesting to me because I'm I'm very interested in in that I'm very interested in in that I'm very interested in in that population, people who already do a lot population, people who already do a lot population, people who already do a lot of good things. of good things. of good things. >> What can they do to improve, you know, >> What can they do to improve, you know, >> What can they do to improve, you know, their outcomes, you know, their outcomes, you know, their outcomes, you know, >> great framing of it. >> great framing of it. >> great framing of it. >> Yeah. And um yeah, so um I think we >> Yeah. And um yeah, so um I think we >> Yeah. And um yeah, so um I think we already discussed the result. The most already discussed the result. The most already discussed the result. The most credible result was omega-3 on credible result was omega-3 on credible result was omega-3 on epigenetic clocks. A couple of epigenetic clocks. A couple of epigenetic clocks. A couple of epigenetic clocks picked it up. Grimage epigenetic clocks picked it up. Grimage epigenetic clocks picked it up. Grimage version two, phenino age, donan pace version two, phenino age, donan pace version two, phenino age, donan pace also worked very well in that context. also worked very well in that context. also worked very well in that context. Um so um nice result for omega-3. the Um so um nice result for omega-3. the Um so um nice result for omega-3. the other interventions disappointed and other interventions disappointed and other interventions disappointed and >> by themselves by themselves >> by themselves by themselves >> by themselves by themselves >> by themselves but yes there was this one >> by themselves but yes there was this one >> by themselves but yes there was this one treatment arm where people actually did treatment arm where people actually did treatment arm where people actually did uh used all three beneficial uh used all three beneficial uh used all three beneficial interventions high dosage vitamin D um interventions high dosage vitamin D um interventions high dosage vitamin D um omega3 plus exercise and according to omega3 plus exercise and according to omega3 plus exercise and according to phenoge that treatment arm did the best phenoge that treatment arm did the best phenoge that treatment arm did the best you know so um that's the finding that you know so um that's the finding that you know so um that's the finding that we would have liked to you know, for all we would have liked to you know, for all we would have liked to you know, for all clocks, but it's just the pheno age clocks, but it's just the pheno age clocks, but it's just the pheno age picked it. picked it. picked it. >> Well, I think there was even a dose >> Well, I think there was even a dose >> Well, I think there was even a dose dependent where there was the group that dependent where there was the group that dependent where there was the group that just got the omega-3 and vitamin D, and just got the omega-3 and vitamin D, and just got the omega-3 and vitamin D, and that also improved more than the omega-3 that also improved more than the omega-3 that also improved more than the omega-3 alone. alone. alone. >> Yes. >> Yes. >> Yes. >> And then all three improved the most. >> And then all three improved the most. >> And then all three improved the most. So, you see this nice dose dependent So, you see this nice dose dependent So, you see this nice dose dependent effect with adding in these healthy effect with adding in these healthy effect with adding in these healthy lifestyle interventions even in an lifestyle interventions even in an lifestyle interventions even in an already presumably healthy population. already presumably healthy population. already presumably healthy population. Yes. Which is exciting. Yes. Yes. Which is exciting. Yes. Yes. Which is exciting. Yes. >> And I have the the numbers here. I think >> And I have the the numbers here. I think >> And I have the the numbers here. I think it was 3.8 eight months the pheno age it was 3.8 eight months the pheno age it was 3.8 eight months the pheno age delayed the biological aging was delayed delayed the biological aging was delayed delayed the biological aging was delayed by 3.8 months by 3.8 months by 3.8 months >> yeah over three years >> yeah over three years >> yeah over three years of that yeah of that yeah of that yeah >> and that doesn't sound like a lot again >> and that doesn't sound like a lot again >> and that doesn't sound like a lot again but they also correlated with some other but they also correlated with some other but they also correlated with some other outcomes right so I think there was in outcomes right so I think there was in outcomes right so I think there was in the in all three interventions yes it the in all three interventions yes it the in all three interventions yes it was 3.8 eight months it delayed the was 3.8 eight months it delayed the was 3.8 eight months it delayed the biological aging but also that was biological aging but also that was biological aging but also that was associated with outcomes that were associated with outcomes that were associated with outcomes that were important 61% reduced chance of getting important 61% reduced chance of getting important 61% reduced chance of getting metastatic cancer it was like a 20% metastatic cancer it was like a 20% metastatic cancer it was like a 20% reduction in pre-frailty which is also reduction in pre-frailty which is also reduction in pre-frailty which is also nice to see these outcomes correlated nice to see these outcomes correlated nice to see these outcomes correlated with this as well right with this as well right with this as well right >> I agree with that and um I can tell you >> I agree with that and um I can tell you >> I agree with that and um I can tell you the same study looked at a new concept the same study looked at a new concept the same study looked at a new concept in the field called intrinsic capacity in the field called intrinsic capacity in the field called intrinsic capacity um which um looks at various do domains um which um looks at various do domains um which um looks at various do domains of functioning, frailty, cognition, of functioning, frailty, cognition, of functioning, frailty, cognition, psychology. Um anyways, um also psychology. Um anyways, um also psychology. Um anyways, um also intrinsic capacity was improved in that intrinsic capacity was improved in that intrinsic capacity was improved in that population. Okay. So it's not just the population. Okay. So it's not just the population. Okay. So it's not just the molecular readout. Yes. molecular readout. Yes. molecular readout. Yes. >> Um I think >> Um I think >> Um I think >> for me the take-home again is something >> for me the take-home again is something >> for me the take-home again is something that you mentioned when you have this that you mentioned when you have this that you mentioned when you have this already, you know, healthy, they have to already, you know, healthy, they have to already, you know, healthy, they have to be a healthy population of 88% with them be a healthy population of 88% with them be a healthy population of 88% with them physically active, right? So and and you physically active, right? So and and you physically active, right? So and and you take that healthy population, you can take that healthy population, you can take that healthy population, you can still improve, right? You still can still improve, right? You still can still improve, right? You still can improve things. Um, do you, again, this improve things. Um, do you, again, this improve things. Um, do you, again, this comes down to the compounding factor, comes down to the compounding factor, comes down to the compounding factor, right? So, this was three years and then right? So, this was three years and then right? So, this was three years and then let's say, okay, well, they're going to let's say, okay, well, they're going to let's say, okay, well, they're going to start doing this for the rest of their start doing this for the rest of their start doing this for the rest of their lives, you know, decades. We're talking, lives, you know, decades. We're talking, lives, you know, decades. We're talking, well, in this case, they're a little bit well, in this case, they're a little bit well, in this case, they're a little bit older, but people listening to this older, but people listening to this older, but people listening to this podcast maybe in their 30s, maybe in podcast maybe in their 30s, maybe in podcast maybe in their 30s, maybe in their 20s, and their 40s. It's like, their 20s, and their 40s. It's like, their 20s, and their 40s. It's like, okay, well, I'm going to start training okay, well, I'm going to start training okay, well, I'm going to start training getting making sure I'm not vitamin D getting making sure I'm not vitamin D getting making sure I'm not vitamin D deficient, getting my omega-3, and then deficient, getting my omega-3, and then deficient, getting my omega-3, and then you have like how how is that going to you have like how how is that going to you have like how how is that going to compound over over time, and I know it's compound over over time, and I know it's compound over over time, and I know it's speculation, but it makes sense. That's speculation, but it makes sense. That's speculation, but it makes sense. That's the way I think about it. the way I think about it. the way I think about it. >> I think of it the same way. I wish I >> I think of it the same way. I wish I >> I think of it the same way. I wish I could go back in time and tell myself to could go back in time and tell myself to could go back in time and tell myself to stop eating chocolates, which really stop eating chocolates, which really stop eating chocolates, which really messed me up. So yeah, good health messed me up. So yeah, good health messed me up. So yeah, good health behaviors, you know, and supplements in behaviors, you know, and supplements in behaviors, you know, and supplements in included I think will have benefit, included I think will have benefit, included I think will have benefit, major benefits. major benefits. major benefits. >> When it comes to vitamin D, that's the >> When it comes to vitamin D, that's the >> When it comes to vitamin D, that's the one that I I mean, this one study was a one that I I mean, this one study was a one that I I mean, this one study was a bit disappointing, but as you mentioned, bit disappointing, but as you mentioned, bit disappointing, but as you mentioned, I mean, comparing 800 IUs to 2,000 IUs, I mean, comparing 800 IUs to 2,000 IUs, I mean, comparing 800 IUs to 2,000 IUs, I wouldn't imagine to see a big I wouldn't imagine to see a big I wouldn't imagine to see a big difference there because you're already difference there because you're already difference there because you're already feeling the gap. feeling the gap. feeling the gap. >> Exactly. And most of the participants >> Exactly. And most of the participants >> Exactly. And most of the participants had no um insufficiency in vitamin D. had no um insufficiency in vitamin D. had no um insufficiency in vitamin D. they really started at normal levels they really started at normal levels they really started at normal levels >> and that and we know >> and that and we know >> and that and we know >> yes >> yes >> yes >> there have been there have been in my in >> there have been there have been in my in >> there have been there have been in my in my opinion so many studies that I've my opinion so many studies that I've my opinion so many studies that I've I've come across and read over the years I've come across and read over the years I've come across and read over the years showing that vitamin D deficiency causes showing that vitamin D deficiency causes showing that vitamin D deficiency causes age acceleration in some cases severe age acceleration in some cases severe age acceleration in some cases severe like 3 years like 3 years like 3 years >> and if you correct that deficiency it'll >> and if you correct that deficiency it'll >> and if you correct that deficiency it'll slow age acceleration where then you say slow age acceleration where then you say slow age acceleration where then you say you know reversed aging by you know not you know reversed aging by you know not you know reversed aging by you know not four years or whatever I mean so Um, I four years or whatever I mean so Um, I four years or whatever I mean so Um, I think my takehome and I know the the one think my takehome and I know the the one think my takehome and I know the the one that I like the the the most recent one that I like the the the most recent one that I like the the the most recent one was the the base two the Berlin study. was the the base two the Berlin study. was the the base two the Berlin study. >> Yes. >> Yes. >> Yes. >> Where they took which was the thing that >> Where they took which was the thing that >> Where they took which was the thing that was nice about that was they had a was nice about that was they had a was nice about that was they had a deficient population and then a deficient population and then a deficient population and then a sufficient population and gave them sufficient population and gave them sufficient population and gave them vitamin D. vitamin D. vitamin D. >> Yes. And um this was a study in Berlin >> Yes. And um this was a study in Berlin >> Yes. And um this was a study in Berlin and they followed people for seven years and they followed people for seven years and they followed people for seven years which was also impressive was a large which was also impressive was a large which was also impressive was a large population and you can imagine um Berlin population and you can imagine um Berlin population and you can imagine um Berlin is of course not blessed by sunshine so is of course not blessed by sunshine so is of course not blessed by sunshine so they start out deficient you know so um they start out deficient you know so um they start out deficient you know so um it all made sense you know it all made sense you know it all made sense you know >> yeah you re reverse aging if you're if >> yeah you re reverse aging if you're if >> yeah you re reverse aging if you're if you're deficient and fill that you're deficient and fill that you're deficient and fill that sufficiency but the people that were not sufficiency but the people that were not sufficiency but the people that were not deficient actually there was no effect deficient actually there was no effect deficient actually there was no effect which is which is which is >> again what you effect. It's not about >> again what you effect. It's not about >> again what you effect. It's not about this is a magic supplement that's this is a magic supplement that's this is a magic supplement that's slowing aging. It's not doing that. It's slowing aging. It's not doing that. It's slowing aging. It's not doing that. It's helping people that are deficient helping people that are deficient helping people that are deficient correct their deficiency. And that's why correct their deficiency. And that's why correct their deficiency. And that's why there's so much in the even in the there's so much in the even in the there's so much in the even in the scientific literature with vitamin D, scientific literature with vitamin D, scientific literature with vitamin D, for example, if you're looking at for example, if you're looking at for example, if you're looking at outcomes, it's the same thing. outcomes, it's the same thing. outcomes, it's the same thing. >> Yes. >> Yes. >> Yes. >> You know, and it drives me nuts when >> You know, and it drives me nuts when >> You know, and it drives me nuts when studies don't measure their baseline studies don't measure their baseline studies don't measure their baseline levels or if they only measure 10% of levels or if they only measure 10% of levels or if they only measure 10% of the population and then use that to the population and then use that to the population and then use that to extrapolate like everyone else. They're extrapolate like everyone else. They're extrapolate like everyone else. They're like, you can't do that. Yes, like, you can't do that. Yes, like, you can't do that. Yes, >> there's so many, you know, and there's >> there's so many, you know, and there's >> there's so many, you know, and there's gene snips that are affecting vitamin D. gene snips that are affecting vitamin D. gene snips that are affecting vitamin D. There's other micronutrients. Magnesium There's other micronutrients. Magnesium There's other micronutrients. Magnesium really affects vitamin D. You need really affects vitamin D. You need really affects vitamin D. You need magnesium to convert vitamin D3 into, magnesium to convert vitamin D3 into, magnesium to convert vitamin D3 into, you know, the steroid hormone. So, you know, the steroid hormone. So, you know, the steroid hormone. So, there's so many different things that there's so many different things that there's so many different things that are affecting your vitamin D. If you are affecting your vitamin D. If you are affecting your vitamin D. If you don't measure it before and after, it's don't measure it before and after, it's don't measure it before and after, it's hard to really make a statement that it hard to really make a statement that it hard to really make a statement that it did what it did or didn't do what it was did what it did or didn't do what it was did what it did or didn't do what it was supposed to. supposed to. supposed to. >> Yes. >> Yes. >> Yes. >> Okay. So, I want to um >> Okay. So, I want to um >> Okay. So, I want to um >> we should talk about exercise. >> we should talk about exercise. >> we should talk about exercise. >> We can go into exercise. >> We can go into exercise. >> We can go into exercise. No, no, but I follow your script. Sorry. No, no, but I follow your script. Sorry. No, no, but I follow your script. Sorry. >> Oh, no, no. We we we were I was we were >> Oh, no, no. We we we were I was we were >> Oh, no, no. We we we were I was we were talking about calorie restriction and I talking about calorie restriction and I talking about calorie restriction and I just wanted to mention dietary just wanted to mention dietary just wanted to mention dietary >> patterns in general, >> patterns in general, >> patterns in general, >> you know, because you mentioned weight >> you know, because you mentioned weight >> you know, because you mentioned weight loss and we've talked a little bit about loss and we've talked a little bit about loss and we've talked a little bit about it with the GLP1. Obviously, if you lose it with the GLP1. Obviously, if you lose it with the GLP1. Obviously, if you lose weight, weight, weight, >> Yes. >> Yes. >> Yes. >> It's probably a big confounder with all >> It's probably a big confounder with all >> It's probably a big confounder with all some of these dietary pattern trials, some of these dietary pattern trials, some of these dietary pattern trials, right? Like if you're getting someone right? Like if you're getting someone right? Like if you're getting someone who's overweight and these participants who's overweight and these participants who's overweight and these participants are overweight and you're putting them are overweight and you're putting them are overweight and you're putting them on a healthy diet or a Mediterranean on a healthy diet or a Mediterranean on a healthy diet or a Mediterranean diet or something like this and they diet or something like this and they diet or something like this and they lose weight on all the diets, then how lose weight on all the diets, then how lose weight on all the diets, then how much of what you're seeing is due to much of what you're seeing is due to much of what you're seeing is due to that weight loss, right? that weight loss, right? that weight loss, right? >> Exactly. >> Exactly. >> Exactly. >> So, do you want to talk about that? Um, >> So, do you want to talk about that? Um, >> So, do you want to talk about that? Um, it was like the direct trial. Is that it was like the direct trial. Is that it was like the direct trial. Is that what it was called? what it was called? what it was called? >> Yeah. I need to tell you I don't know >> Yeah. I need to tell you I don't know >> Yeah. I need to tell you I don't know too much about it but I I I want to um too much about it but I I I want to um too much about it but I I I want to um um explain some properties of grim age um explain some properties of grim age um explain some properties of grim age um that I'm aware of. So grim age very um that I'm aware of. So grim age very um that I'm aware of. So grim age very much correlates with what is known as much correlates with what is known as much correlates with what is known as carotenoid levels in the blood. So what carotenoid levels in the blood. So what carotenoid levels in the blood. So what are those? So you you know um let's are those? So you you know um let's are those? So you you know um let's maybe back off and think of nutritional maybe back off and think of nutritional maybe back off and think of nutritional studies. Many people have so-called food studies. Many people have so-called food studies. Many people have so-called food questionnaires where they evaluate the questionnaires where they evaluate the questionnaires where they evaluate the diet of participants. And from all I diet of participants. And from all I diet of participants. And from all I know from analyzing data is that these know from analyzing data is that these know from analyzing data is that these food questionnaires often don't reflect food questionnaires often don't reflect food questionnaires often don't reflect reality. reality. reality. >> I don't remember what I ate for >> I don't remember what I ate for >> I don't remember what I ate for breakfast. Well, I didn't eat breakfast breakfast. Well, I didn't eat breakfast breakfast. Well, I didn't eat breakfast today. But today. But today. But >> yeah, I mean and and people always know >> yeah, I mean and and people always know >> yeah, I mean and and people always know what they should answer, you know, but what they should answer, you know, but what they should answer, you know, but so that may bias their memory. They will so that may bias their memory. They will so that may bias their memory. They will say, "Oh, yeah, I ate um x servings of say, "Oh, yeah, I ate um x servings of say, "Oh, yeah, I ate um x servings of broccoli." But it just doesn't reflect broccoli." But it just doesn't reflect broccoli." But it just doesn't reflect reality. But fortunately, there are reality. But fortunately, there are reality. But fortunately, there are blood tests. You can measure the blood tests. You can measure the blood tests. You can measure the so-called carotenoid levels in the blood so-called carotenoid levels in the blood so-called carotenoid levels in the blood and and have an objective readout of and and have an objective readout of and and have an objective readout of fruit vegetable consumption. And the fruit vegetable consumption. And the fruit vegetable consumption. And the striking finding in post-menopausal striking finding in post-menopausal striking finding in post-menopausal women from the women's health initiative women from the women's health initiative women from the women's health initiative was that this um measure of vegetable was that this um measure of vegetable was that this um measure of vegetable intake has a strong correlation with intake has a strong correlation with intake has a strong correlation with grim age and other epigenetic clocks grim age and other epigenetic clocks grim age and other epigenetic clocks strong meaning maybe minus.3 so it's a strong meaning maybe minus.3 so it's a strong meaning maybe minus.3 so it's a to me a very strong effect which really to me a very strong effect which really to me a very strong effect which really changed my behavior by now I really eat changed my behavior by now I really eat changed my behavior by now I really eat a lot of vegetables um a lot of vegetables um a lot of vegetables um >> can you translate that to like months >> can you translate that to like months >> can you translate that to like months like what would minus.3 three. like what would minus.3 three. like what would minus.3 three. >> Yeah, sorry. I'm >> Yeah, sorry. I'm >> Yeah, sorry. I'm I could translate it, but uh an estimate I could translate it, but uh an estimate I could translate it, but uh an estimate like like like >> Yeah. No, let me put it this way. >> Yeah. No, let me put it this way. >> Yeah. No, let me put it this way. Smoking has a correlation of 0.4. So, if Smoking has a correlation of 0.4. So, if Smoking has a correlation of 0.4. So, if you smoke a lot, it increases your age. you smoke a lot, it increases your age. you smoke a lot, it increases your age. Um vegetable consumption minus.3. So, Um vegetable consumption minus.3. So, Um vegetable consumption minus.3. So, it's actually it's actually it's actually >> Wow. >> Wow. >> Wow. >> Yeah, I was very surprised how in this >> Yeah, I was very surprised how in this >> Yeah, I was very surprised how in this and I sorry, I add one more statistic. and I sorry, I add one more statistic. and I sorry, I add one more statistic. Exercise the correlation would be 0.1. Exercise the correlation would be 0.1. Exercise the correlation would be 0.1. So, do you see? So vegetable intake has So, do you see? So vegetable intake has So, do you see? So vegetable intake has a much stronger effect. I mean orders of a much stronger effect. I mean orders of a much stronger effect. I mean orders of magnitude stronger effect on grim age magnitude stronger effect on grim age magnitude stronger effect on grim age and these methylation clocks than for and these methylation clocks than for and these methylation clocks than for example exercise you know example exercise you know example exercise you know >> and you and and you think it might come >> and you and and you think it might come >> and you and and you think it might come down to even the carotenoids perhaps or down to even the carotenoids perhaps or down to even the carotenoids perhaps or just the vitamins and minerals and just the vitamins and minerals and just the vitamins and minerals and everything in the vegetables kind of everything in the vegetables kind of everything in the vegetables kind of compounding. compounding. compounding. >> Yeah. You know I never looked into that >> Yeah. You know I never looked into that >> Yeah. You know I never looked into that but I feel that would be such a but I feel that would be such a but I feel that would be such a worthwhile research study. What I can worthwhile research study. What I can worthwhile research study. What I can tell you is this vegetable association tell you is this vegetable association tell you is this vegetable association is 100% accurate but now teasing it is 100% accurate but now teasing it is 100% accurate but now teasing it apart what is it you know um to be apart what is it you know um to be apart what is it you know um to be >> seen probably so many things I mean >> seen probably so many things I mean >> seen probably so many things I mean >> you've got the fiber matrix you're >> you've got the fiber matrix you're >> you've got the fiber matrix you're getting micron like vegetables getting micron like vegetables getting micron like vegetables especially greens and if you're talking especially greens and if you're talking especially greens and if you're talking about carotenoids you know lutein about carotenoids you know lutein about carotenoids you know lutein zeazanthin these are these are zeazanthin these are these are zeazanthin these are these are carotenoids that are in greens and carotenoids that are in greens and carotenoids that are in greens and interesting there's been a lot of interesting there's been a lot of interesting there's been a lot of studies coming out looking at blood studies coming out looking at blood studies coming out looking at blood levels of lutein and zeazanthin People levels of lutein and zeazanthin People levels of lutein and zeazanthin People usually associate that them with eye usually associate that them with eye usually associate that them with eye health. They accumulate in the eye. health. They accumulate in the eye. health. They accumulate in the eye. There have been randomized control There have been randomized control There have been randomized control trials showing they can help prevent age trials showing they can help prevent age trials showing they can help prevent age related macular degeneration. They also related macular degeneration. They also related macular degeneration. They also accumulate in the brain and they're accumulate in the brain and they're accumulate in the brain and they're associated with improved cognitive associated with improved cognitive associated with improved cognitive function, crystallized intelligence, function, crystallized intelligence, function, crystallized intelligence, improved brain aging in general. improved brain aging in general. improved brain aging in general. >> All right. >> All right. >> All right. >> And there's other carotenoids. >> And there's other carotenoids. >> And there's other carotenoids. Betaarotene is probably what most people Betaarotene is probably what most people Betaarotene is probably what most people are familiar with. Lycopine in tomatoes. are familiar with. Lycopine in tomatoes. are familiar with. Lycopine in tomatoes. So there's a v variety of these So there's a v variety of these So there's a v variety of these carotenoids which are very powerful at carotenoids which are very powerful at carotenoids which are very powerful at basically basically basically um I would say buffering oxidative um I would say buffering oxidative um I would say buffering oxidative stress and singlet oxygen for example if stress and singlet oxygen for example if stress and singlet oxygen for example if you're talking about in the eye. you're talking about in the eye. you're talking about in the eye. >> Yes. >> Yes. >> Yes. >> But um it's interesting that vegetable >> But um it's interesting that vegetable >> But um it's interesting that vegetable intake can have such a profound intake can have such a profound intake can have such a profound >> effect. There was a vegan trial too. I >> effect. There was a vegan trial too. I >> effect. There was a vegan trial too. I think also think also think also >> there was a trial looking at people that >> there was a trial looking at people that >> there was a trial looking at people that are eating a lot of vegetables versus are eating a lot of vegetables versus are eating a lot of vegetables versus like an healthy omnivore trial. on the I like an healthy omnivore trial. on the I like an healthy omnivore trial. on the I think the vegan trrowley also had slow think the vegan trrowley also had slow think the vegan trrowley also had slow their epigenetic aging more but there's their epigenetic aging more but there's their epigenetic aging more but there's always weight loss as a confounding always weight loss as a confounding always weight loss as a confounding factor because they were eating fewer factor because they were eating fewer factor because they were eating fewer calories but that's really interesting calories but that's really interesting calories but that's really interesting that there's a minus.3 that is pretty that there's a minus.3 that is pretty that there's a minus.3 that is pretty strong you gave me that reference point strong you gave me that reference point strong you gave me that reference point of smoking being you said it was wait of smoking being you said it was wait of smoking being you said it was wait smoking was 04 smoking was 04 smoking was 04 >> okay smoking point4 maybe 045 so it's >> okay smoking point4 maybe 045 so it's >> okay smoking point4 maybe 045 so it's increased correlation increased correlation increased correlation >> um exercise 0.1 >> um exercise 0.1 >> um exercise 0.1 >> okay >> okay >> okay >> so and we we We can talk later about >> so and we we We can talk later about >> so and we we We can talk later about exercise but very weak effect. In order exercise but very weak effect. In order exercise but very weak effect. In order to see an effect of exercise, you really to see an effect of exercise, you really to see an effect of exercise, you really need to study many thousands of people need to study many thousands of people need to study many thousands of people with vegetable intake. The effect is so with vegetable intake. The effect is so with vegetable intake. The effect is so strong you probably see an effect when strong you probably see an effect when strong you probably see an effect when you analyze a couple of hundred people, you analyze a couple of hundred people, you analyze a couple of hundred people, you know. So um but um regarding the you know. So um but um regarding the you know. So um but um regarding the question vegan versus question vegan versus question vegan versus carnivores, you know, I honestly have uh carnivores, you know, I honestly have uh carnivores, you know, I honestly have uh not seen convincing data. Omnivore. not seen convincing data. Omnivore. not seen convincing data. Omnivore. Omnivore. Omnivore. Omnivore. >> Or omnivore. Yeah. So or Yeah. >> Or omnivore. Yeah. So or Yeah. >> Or omnivore. Yeah. So or Yeah. >> Carnivore would be the extreme opposite. >> Carnivore would be the extreme opposite. >> Carnivore would be the extreme opposite. >> That's true. Yeah. Let me rephrase it. >> That's true. Yeah. Let me rephrase it. >> That's true. Yeah. Let me rephrase it. So I I have not seen any evidence that So I I have not seen any evidence that So I I have not seen any evidence that people who let's say eat a lot of red people who let's say eat a lot of red people who let's say eat a lot of red meat age much faster than people who are meat age much faster than people who are meat age much faster than people who are vegans. And um we looked again in the vegans. And um we looked again in the vegans. And um we looked again in the women's health initiative. I mean, there women's health initiative. I mean, there women's health initiative. I mean, there was a hint, I want to say, when we was a hint, I want to say, when we was a hint, I want to say, when we analyzed 3,000 women and then women who analyzed 3,000 women and then women who analyzed 3,000 women and then women who ate red meat, it was barely noticeable ate red meat, it was barely noticeable ate red meat, it was barely noticeable that red meat was ever so slightly that red meat was ever so slightly that red meat was ever so slightly increasing epigenetic age, but it was increasing epigenetic age, but it was increasing epigenetic age, but it was truly negligible, you know. So, um, what truly negligible, you know. So, um, what truly negligible, you know. So, um, what I can tell you is I eat so much meat. I can tell you is I eat so much meat. I can tell you is I eat so much meat. Um, hopefully it's not bad for me. Um, hopefully it's not bad for me. Um, hopefully it's not bad for me. >> Vegetables. >> Vegetables. >> Vegetables. >> I eat meat and vegetables. I try to be >> I eat meat and vegetables. I try to be >> I eat meat and vegetables. I try to be easy on the carbs, you know. I I eat easy on the carbs, you know. I I eat easy on the carbs, you know. I I eat carbs, but I try to reduce them. Yeah. carbs, but I try to reduce them. Yeah. carbs, but I try to reduce them. Yeah. Well, I mean, veget vegetables are Well, I mean, veget vegetables are Well, I mean, veget vegetables are carbohydrates. They're just complex carbohydrates. They're just complex carbohydrates. They're just complex carbohydrates, not simple. So, you're carbohydrates, not simple. So, you're carbohydrates, not simple. So, you're you're not eating the simple you're not eating the simple you're not eating the simple carbohydrates. carbohydrates. carbohydrates. >> Yeah. Exactly. >> Yeah. Exactly. >> Yeah. Exactly. >> Yeah. Um >> Yeah. Um >> Yeah. Um that that vegetable stuff is is that that vegetable stuff is is that that vegetable stuff is is interesting, though, but there's so much interesting, though, but there's so much interesting, though, but there's so much in vegetables with the micronutrients in vegetables with the micronutrients in vegetables with the micronutrients and the phytochemicals, right? That and the phytochemicals, right? That and the phytochemicals, right? That that's another thing in them. The fiber, that's another thing in them. The fiber, that's another thing in them. The fiber, I mean, there's there's a lot of things I mean, there's there's a lot of things I mean, there's there's a lot of things going on here that's going on here that's going on here that's >> Yeah. Somebody should really tease that >> Yeah. Somebody should really tease that >> Yeah. Somebody should really tease that apart. What kind of vegetables should be apart. What kind of vegetables should be apart. What kind of vegetables should be eaten, you know, and um dosages. Yeah. eaten, you know, and um dosages. Yeah. eaten, you know, and um dosages. Yeah. lots of exciting PhD dissertations could lots of exciting PhD dissertations could lots of exciting PhD dissertations could be written on that topic. be written on that topic. be written on that topic. >> Um, exercise. >> Um, exercise. >> Um, exercise. >> Yes. >> Yes. >> Yes. >> That so let's talk about that. So you're >> That so let's talk about that. So you're >> That so let's talk about that. So you're you know what there's a trial that you you know what there's a trial that you you know what there's a trial that you sent me that was pretty convincing and sent me that was pretty convincing and sent me that was pretty convincing and it was kind it was a new one in 2025 it was kind it was a new one in 2025 it was kind it was a new one in 2025 showing that 6 months of cycling showing that 6 months of cycling showing that 6 months of cycling it seemed to slow epigenetic aging or it seemed to slow epigenetic aging or it seemed to slow epigenetic aging or grim age right grim age by 7.4 months. grim age right grim age by 7.4 months. grim age right grim age by 7.4 months. >> Yes. I maybe I I'll frame it like that. >> Yes. I maybe I I'll frame it like that. >> Yes. I maybe I I'll frame it like that. So there have been very nice studies on So there have been very nice studies on So there have been very nice studies on the effect of exercise on grimage and the effect of exercise on grimage and the effect of exercise on grimage and phenoage and other clocks and um so why phenoage and other clocks and um so why phenoage and other clocks and um so why what do I mean by nice um studies where what do I mean by nice um studies where what do I mean by nice um studies where they use one way or another a wearable they use one way or another a wearable they use one way or another a wearable to really measure your step count and to really measure your step count and to really measure your step count and activity. So it's a very rigorous activity. So it's a very rigorous activity. So it's a very rigorous readout of your physical activity. readout of your physical activity. readout of your physical activity. And the studies were also convincing And the studies were also convincing And the studies were also convincing because they were largecale studies many because they were largecale studies many because they were largecale studies many thousands of people and in different thousands of people and in different thousands of people and in different countries Japan, Germany, US and the countries Japan, Germany, US and the countries Japan, Germany, US and the finding is the following. Yes, if you finding is the following. Yes, if you finding is the following. Yes, if you move more, yes, your epigenetic clocks move more, yes, your epigenetic clocks move more, yes, your epigenetic clocks um pick up a small effect and I um pick up a small effect and I um pick up a small effect and I mentioned earlier correlation minus.1. mentioned earlier correlation minus.1. mentioned earlier correlation minus.1. what it means. You need to study 3,000 what it means. You need to study 3,000 what it means. You need to study 3,000 people, then you will see a people, then you will see a people, then you will see a statistically significant effect of step statistically significant effect of step statistically significant effect of step count as an example. count as an example. count as an example. >> But I've been deeply dissatisfied with >> But I've been deeply dissatisfied with >> But I've been deeply dissatisfied with that finding because we all know that finding because we all know that finding because we all know exercise is um what they call the poly exercise is um what they call the poly exercise is um what they call the poly pill. You know, it touches so many pill. You know, it touches so many pill. You know, it touches so many systems and you it's very beneficial. So systems and you it's very beneficial. So systems and you it's very beneficial. So I would have loved to see a strong I would have loved to see a strong I would have loved to see a strong effect on blood methylation but it the effect on blood methylation but it the effect on blood methylation but it the literature shows weak effect. And literature shows weak effect. And literature shows weak effect. And >> what about muscle methylation? >> what about muscle methylation? >> what about muscle methylation? >> Yeah. So people have built um clocks for >> Yeah. So people have built um clocks for >> Yeah. So people have built um clocks for muscle. So literally human muscle muscle. So literally human muscle muscle. So literally human muscle biopsies. biopsies. biopsies. I don't know what to tell you. It's I don't know what to tell you. It's I don't know what to tell you. It's Yeah. Um, some some people claim they Yeah. Um, some some people claim they Yeah. Um, some some people claim they see an effect, you know, but I I just am see an effect, you know, but I I just am see an effect, you know, but I I just am not yet convinced. not yet convinced. not yet convinced. >> It is disappointing. So, you're asking >> It is disappointing. So, you're asking >> It is disappointing. So, you're asking >> I would say it's disappointing. So then >> I would say it's disappointing. So then >> I would say it's disappointing. So then there's this study that was published um there's this study that was published um there's this study that was published um by first author I can remember Vanam I by first author I can remember Vanam I by first author I can remember Vanam I think differently spelled from the actor think differently spelled from the actor think differently spelled from the actor but anyways and this intervention was but anyways and this intervention was but anyways and this intervention was very different because it didn't look at very different because it didn't look at very different because it didn't look at step count or what we discussed earlier step count or what we discussed earlier step count or what we discussed earlier them home exercise intervention that was them home exercise intervention that was them home exercise intervention that was the next level intervention it was the next level intervention it was the next level intervention it was putting people on a bicycle and they now putting people on a bicycle and they now putting people on a bicycle and they now um bicycled 4 and 1/2 hours a week. Now um bicycled 4 and 1/2 hours a week. Now um bicycled 4 and 1/2 hours a week. Now for the health nuts out there that's not for the health nuts out there that's not for the health nuts out there that's not much but to me this is daunting you know much but to me this is daunting you know much but to me this is daunting you know so I if if you forced me to bicycle 4 so I if if you forced me to bicycle 4 so I if if you forced me to bicycle 4 and a half hour a week I would struggle and a half hour a week I would struggle and a half hour a week I would struggle with that um why we we are all busy with that um why we we are all busy with that um why we we are all busy people you know but anyways the people people you know but anyways the people people you know but anyways the people who adhereed to that trial they had who adhereed to that trial they had who adhereed to that trial they had strong effects on V2 max strong effects on V2 max strong effects on V2 max >> 20% >> 20% >> 20% >> 20% and many other readouts you know so >> 20% and many other readouts you know so >> 20% and many other readouts you know so they didn't fake it you know so they they didn't fake it you know so they they didn't fake it you know so they really saw physiologic benefits really saw physiologic benefits really saw physiologic benefits And then sure enough suddenly the clocks And then sure enough suddenly the clocks And then sure enough suddenly the clocks worked you know. So PC Grimage as an we worked you know. So PC Grimage as an we worked you know. So PC Grimage as an we keep talking about PC. PC means keep talking about PC. PC means keep talking about PC. PC means principal componentbased Grimage. principal componentbased Grimage. principal componentbased Grimage. That's a version of Grimage that's even That's a version of Grimage that's even That's a version of Grimage that's even more robust than the original. Robust in more robust than the original. Robust in more robust than the original. Robust in the sense of test retest variability. the sense of test retest variability. the sense of test retest variability. It's a um very uh reproducible measure. It's a um very uh reproducible measure. It's a um very uh reproducible measure. So anyways um it picked up a 7month So anyways um it picked up a 7month So anyways um it picked up a 7month reduction in grimage which again dwarfs reduction in grimage which again dwarfs reduction in grimage which again dwarfs everything we just discussed you know so everything we just discussed you know so everything we just discussed you know so and that was um um a six-month and that was um um a six-month and that was um um a six-month intervention. intervention. intervention. These people were younger though I want These people were younger though I want These people were younger though I want to say they were between 30 and 65 to say they were between 30 and 65 to say they were between 30 and 65 basically a population that you can um basically a population that you can um basically a population that you can um um um put under such a stringent um um put under such a stringent um um put under such a stringent regiment you know. Well, they're young regiment you know. Well, they're young regiment you know. Well, they're young and middle-aged, but and middle-aged, but and middle-aged, but >> yes, >> yes, >> yes, >> I would I mean, so I would argue with >> I would I mean, so I would argue with >> I would I mean, so I would argue with Steve that this is 10,000 steps. Like Steve that this is 10,000 steps. Like Steve that this is 10,000 steps. Like that stuff is like it's okay. It's that stuff is like it's okay. It's that stuff is like it's okay. It's better than nothing, better than nothing, better than nothing, >> but >> but >> but >> if you really want to move the aging, I >> if you really want to move the aging, I >> if you really want to move the aging, I mean like you got to go more than that. mean like you got to go more than that. mean like you got to go more than that. And and this is the kind of stuff I mean And and this is the kind of stuff I mean And and this is the kind of stuff I mean that that we talk about on the podcast. that that we talk about on the podcast. that that we talk about on the podcast. I mean, I've had Ben Lavine on. He is a I mean, I've had Ben Lavine on. He is a I mean, I've had Ben Lavine on. He is a rock star in the cardiovascular exercise rock star in the cardiovascular exercise rock star in the cardiovascular exercise physiology world. And he's done multiple physiology world. And he's done multiple physiology world. And he's done multiple randomized control trials, but he did randomized control trials, but he did randomized control trials, but he did one that was a two-year study in 50 year one that was a two-year study in 50 year one that was a two-year study in 50 year olds. They were about 50 year olds and olds. They were about 50 year olds and olds. They were about 50 year olds and they had never been physically active, they had never been physically active, they had never been physically active, but they didn't have any other diseases. but they didn't have any other diseases. but they didn't have any other diseases. Put them on a a two-year trial where Put them on a a two-year trial where Put them on a a two-year trial where they were working out, exercising about they were working out, exercising about they were working out, exercising about five on average 5 hours a week, doing a five on average 5 hours a week, doing a five on average 5 hours a week, doing a lot of cycling. They were doing, you lot of cycling. They were doing, you lot of cycling. They were doing, you know, some some highintensity interval know, some some highintensity interval know, some some highintensity interval training in there, a little bit of training in there, a little bit of training in there, a little bit of resistance training, but a lot of it was resistance training, but a lot of it was resistance training, but a lot of it was aerobic and they improved their V2 max aerobic and they improved their V2 max aerobic and they improved their V2 max and their their heart structure. So, he and their their heart structure. So, he and their their heart structure. So, he looks at like the structural aging of looks at like the structural aging of looks at like the structural aging of the heart. So, as we age, our heart gets the heart. So, as we age, our heart gets the heart. So, as we age, our heart gets smaller with age. It gets stiffer and um smaller with age. It gets stiffer and um smaller with age. It gets stiffer and um they improve the structure of their they improve the structure of their they improve the structure of their hearts by it was like if you basically hearts by it was like if you basically hearts by it was like if you basically it looked like they reversed aging by it looked like they reversed aging by it looked like they reversed aging by about 20 years. their hearts, you know, about 20 years. their hearts, you know, about 20 years. their hearts, you know, got bigger and they were more flexible got bigger and they were more flexible got bigger and they were more flexible and it looked more like a 30-year-old and it looked more like a 30-year-old and it looked more like a 30-year-old even though they were 52 at the end of even though they were 52 at the end of even though they were 52 at the end of the trial. the trial. the trial. >> And so I would argue that, >> And so I would argue that, >> And so I would argue that, >> you know, doing >> you know, doing >> you know, doing really taking time to exercise every day really taking time to exercise every day really taking time to exercise every day something and and more than just walking something and and more than just walking something and and more than just walking Yes. Yes. Yes. >> you know, is very powerful for for >> you know, is very powerful for for >> you know, is very powerful for for longevity and for, you know, slowing age longevity and for, you know, slowing age longevity and for, you know, slowing age acceleration. acceleration. acceleration. >> Yes. Um, and so it's it is really nice >> Yes. Um, and so it's it is really nice >> Yes. Um, and so it's it is really nice to see this new trial because I have to see this new trial because I have to see this new trial because I have also been very disappointed in, you also been very disappointed in, you also been very disappointed in, you know, some of the data, but no one's know, some of the data, but no one's know, some of the data, but no one's really doing these kinds of studies really doing these kinds of studies really doing these kinds of studies where they're saying, "Hey, again, it's where they're saying, "Hey, again, it's where they're saying, "Hey, again, it's like getting a stronger signal. Let's like getting a stronger signal. Let's like getting a stronger signal. Let's let's not just walk. Let's not just do let's not just walk. Let's not just do let's not just walk. Let's not just do 10,000 steps. Let's push them to pro 10,000 steps. Let's push them to pro 10,000 steps. Let's push them to pro improve their V2 max by 20%." Like, and improve their V2 max by 20%." Like, and improve their V2 max by 20%." Like, and see what that does to their aging see what that does to their aging see what that does to their aging clocks. Right. clocks. Right. clocks. Right. >> Yes. Now, we know, you know, I mean, the >> Yes. Now, we know, you know, I mean, the >> Yes. Now, we know, you know, I mean, the um this study didn't have a control arm. um this study didn't have a control arm. um this study didn't have a control arm. We should mention that. you know so but We should mention that. you know so but We should mention that. you know so but it um I certainly was impressed by that it um I certainly was impressed by that it um I certainly was impressed by that and um it's hard to argue against and um it's hard to argue against and um it's hard to argue against exercise you know so exercise you know so exercise you know so >> yeah I mean there's so many studies >> yeah I mean there's so many studies >> yeah I mean there's so many studies showing it improves outcomes right showing it improves outcomes right showing it improves outcomes right cancer mortality cardiovascular cancer mortality cardiovascular cancer mortality cardiovascular mortality all cause mortality it mortality all cause mortality it mortality all cause mortality it improves brain aging Alzheimer's disease improves brain aging Alzheimer's disease improves brain aging Alzheimer's disease risk is lowered everything like all risk is lowered everything like all risk is lowered everything like all these age related diseases frailty you these age related diseases frailty you these age related diseases frailty you know you're you're stronger you're more know you're you're stronger you're more know you're you're stronger you're more capable you're healthier your heart's capable you're healthier your heart's capable you're healthier your heart's working better your lungs are working working better your lungs are working working better your lungs are working better it's improving organ function. better it's improving organ function. better it's improving organ function. So, we know it's good for aging for So, we know it's good for aging for So, we know it's good for aging for sure. And so, it's nice to see that. Um, sure. And so, it's nice to see that. Um, sure. And so, it's nice to see that. Um, >> I mean, there might be a real threshold >> I mean, there might be a real threshold >> I mean, there might be a real threshold to to to pick it up with these to to to pick it up with these to to to pick it up with these epigenetic clocks where you have to kind epigenetic clocks where you have to kind epigenetic clocks where you have to kind of put in the effort. of put in the effort. of put in the effort. >> Exactly. >> Exactly. >> Exactly. >> And so, are you going to put in more >> And so, are you going to put in more >> And so, are you going to put in more effort now? I mean, effort now? I mean, effort now? I mean, >> yeah, I will try. Yeah, definitely. >> yeah, I will try. Yeah, definitely. >> yeah, I will try. Yeah, definitely. >> You know, it's >> You know, it's >> You know, it's >> I >> I >> I >> hopefully there'll be more studies now >> hopefully there'll be more studies now >> hopefully there'll be more studies now as these epigenetic clocks become more as these epigenetic clocks become more as these epigenetic clocks become more available for researchers as tools. it's available for researchers as tools. it's available for researchers as tools. it's something they can add to other things something they can add to other things something they can add to other things that they're they're looking at, you that they're they're looking at, you that they're they're looking at, you know, because know, because know, because >> I want to see a 10-minute hit hit hit, >> I want to see a 10-minute hit hit hit, >> I want to see a 10-minute hit hit hit, you know, every day. Like h how is how you know, every day. Like h how is how you know, every day. Like h how is how is intensity affecting it? How is volume is intensity affecting it? How is volume is intensity affecting it? How is volume duration? I mean, there's so many things duration? I mean, there's so many things duration? I mean, there's so many things to look at. to look at. to look at. >> Yeah. You know, we need to develop >> Yeah. You know, we need to develop >> Yeah. You know, we need to develop exercise in a pill um for people who exercise in a pill um for people who exercise in a pill um for people who have who have lost mobility. have who have lost mobility. have who have lost mobility. What what do you um tell someone who is What what do you um tell someone who is What what do you um tell someone who is in a wheelchair? What do you tell to an in a wheelchair? What do you tell to an in a wheelchair? What do you tell to an 85year-old, 85year-old, 85year-old, you know? So we we need to develop you know? So we we need to develop you know? So we we need to develop interventions that still rejuvenate them interventions that still rejuvenate them interventions that still rejuvenate them and slow aging. But and slow aging. But and slow aging. But >> I would say for people that are disabled >> I would say for people that are disabled >> I would say for people that are disabled in a wheelchair, we do have deliberate in a wheelchair, we do have deliberate in a wheelchair, we do have deliberate heat exposure heat exposure heat exposure >> that mimics moderate intensity >> that mimics moderate intensity >> that mimics moderate intensity cardiovascular exercise. I've never seen cardiovascular exercise. I've never seen cardiovascular exercise. I've never seen anyone looked at an epigenetic agent anyone looked at an epigenetic agent anyone looked at an epigenetic agent clock, but um so you can get in like a clock, but um so you can get in like a clock, but um so you can get in like a hot tub or a hot sauna, your heart rate hot tub or a hot sauna, your heart rate hot tub or a hot sauna, your heart rate starts to elevate. you know, a lot of starts to elevate. you know, a lot of starts to elevate. you know, a lot of the same physiological the same physiological the same physiological mechanisms that are happening during mechanisms that are happening during mechanisms that are happening during moderate intensity exercise. There's moderate intensity exercise. There's moderate intensity exercise. There's been head-to-head comparisons with like been head-to-head comparisons with like been head-to-head comparisons with like getting on a stationary bike and, you getting on a stationary bike and, you getting on a stationary bike and, you know, doing about 100 watts. So, you're know, doing about 100 watts. So, you're know, doing about 100 watts. So, you're for 20 minutes and then comparing that for 20 minutes and then comparing that for 20 minutes and then comparing that to like a 20-minut sauna and you get a to like a 20-minut sauna and you get a to like a 20-minut sauna and you get a lot of the similar benefits. You get lot of the similar benefits. You get lot of the similar benefits. You get improvements in blood pressure, improvements in blood pressure, improvements in blood pressure, improvements in your resting heart rate, improvements in your resting heart rate, improvements in your resting heart rate, you get, you know, again, you're you get, you know, again, you're you get, you know, again, you're sweating, your core body temperature is sweating, your core body temperature is sweating, your core body temperature is going up. So that we do have some going up. So that we do have some going up. So that we do have some interventions that may mimic it. The interventions that may mimic it. The interventions that may mimic it. The pill there's so many things that change, pill there's so many things that change, pill there's so many things that change, you know, Steve, like I don't I mean you know, Steve, like I don't I mean you know, Steve, like I don't I mean maybe we'll get that, but I it's it maybe we'll get that, but I it's it maybe we'll get that, but I it's it seems like seems like seems like >> Yeah, I'm I'm joking. >> Yeah, I'm I'm joking. >> Yeah, I'm I'm joking. >> Yeah, you need something. >> Yeah, you need something. >> Yeah, you need something. >> It seems like a moonshot. >> It seems like a moonshot. >> It seems like a moonshot. >> Yeah. Um >> Yeah. Um >> Yeah. Um >> um >> um >> um >> I want to briefly comment on body >> I want to briefly comment on body >> I want to briefly comment on body temperature. There has been a very temperature. There has been a very temperature. There has been a very elegant study in mice. So um it turns elegant study in mice. So um it turns elegant study in mice. So um it turns out if you stimulate certain neurons in out if you stimulate certain neurons in out if you stimulate certain neurons in the brain the uh pre-optic nerve I think the brain the uh pre-optic nerve I think the brain the uh pre-optic nerve I think you can actually lower the body you can actually lower the body you can actually lower the body temperature of a mouse and um there was temperature of a mouse and um there was temperature of a mouse and um there was a team in Harvard um Sinisa Veratin who a team in Harvard um Sinisa Veratin who a team in Harvard um Sinisa Veratin who did just that in the mice and he lowered did just that in the mice and he lowered did just that in the mice and he lowered the body temperature of the mice I want the body temperature of the mice I want the body temperature of the mice I want to say by 3° C or some order of to say by 3° C or some order of to say by 3° C or some order of magnitude magnitude magnitude >> and then he just looked at their >> and then he just looked at their >> and then he just looked at their methylation clocks, multiple organs, and methylation clocks, multiple organs, and methylation clocks, multiple organs, and guess what? Very strong effect. So the guess what? Very strong effect. So the guess what? Very strong effect. So the mice whose body temperature was lowered, mice whose body temperature was lowered, mice whose body temperature was lowered, they really aged substantially more they really aged substantially more they really aged substantially more slowly than a control mouse. You know, slowly than a control mouse. You know, slowly than a control mouse. You know, to me that was very interesting. to me that was very interesting. to me that was very interesting. >> Well, their metabolism is probably >> Well, their metabolism is probably >> Well, their metabolism is probably slowed inflammation because if you're slowed inflammation because if you're slowed inflammation because if you're going colder, going colder, going colder, vasoc constriction also happens, I would vasoc constriction also happens, I would vasoc constriction also happens, I would assume. assume. assume. >> Yes, >> Yes, >> Yes, >> that maybe. I mean so inflammation maybe >> that maybe. I mean so inflammation maybe >> that maybe. I mean so inflammation maybe >> it's it's interesting you know so I just >> it's it's interesting you know so I just >> it's it's interesting you know so I just want to mention so um the benefits of want to mention so um the benefits of want to mention so um the benefits of sauna and all of that are undisputed you sauna and all of that are undisputed you sauna and all of that are undisputed you know but I just want to mention that know but I just want to mention that know but I just want to mention that >> um maybe lowering your core body >> um maybe lowering your core body >> um maybe lowering your core body temperature by a degree or so could be temperature by a degree or so could be temperature by a degree or so could be beneficial who knows you know beneficial who knows you know beneficial who knows you know >> during hibernation animals that >> during hibernation animals that >> during hibernation animals that hibernate hibernate hibernate >> yeah same thing there have been a couple >> yeah same thing there have been a couple >> yeah same thing there have been a couple of studies that um suggest um that of studies that um suggest um that of studies that um suggest um that there's um a slowing of aging. Um we did there's um a slowing of aging. Um we did there's um a slowing of aging. Um we did such a study at UCLA. We looked at such a study at UCLA. We looked at such a study at UCLA. We looked at marmmets in um Colorado, I think. Um and marmmets in um Colorado, I think. Um and marmmets in um Colorado, I think. Um and um sure enough, during hibernation, the um sure enough, during hibernation, the um sure enough, during hibernation, the methylation clocks um didn't advance, methylation clocks um didn't advance, methylation clocks um didn't advance, you know. So, you know. So, you know. So, >> yeah. So interesting. >> yeah. So interesting. >> yeah. So interesting. >> It is. It's interesting. I think I think >> It is. It's interesting. I think I think >> It is. It's interesting. I think I think that things kind of just you know just I that things kind of just you know just I that things kind of just you know just I think people need to realize that just think people need to realize that just think people need to realize that just normal metabolism normal neuro you know normal metabolism normal neuro you know normal metabolism normal neuro you know your firing of you know your cognitive your firing of you know your cognitive your firing of you know your cognitive function and you know neurotransmitter function and you know neurotransmitter function and you know neurotransmitter firing away all this stuff is producing firing away all this stuff is producing firing away all this stuff is producing damage yes you know so if you're just in damage yes you know so if you're just in damage yes you know so if you're just in if you're just in this slow everything if you're just in this slow everything if you're just in this slow everything down um I say co cold I associate the down um I say co cold I associate the down um I say co cold I associate the cold with slowing it down um but at cold with slowing it down um but at cold with slowing it down um but at least in the hibernation state for sure least in the hibernation state for sure least in the hibernation state for sure everything slowed down everything slowed down everything slowed down >> and so that would kind of make sense >> and so that would kind of make sense >> and so that would kind of make sense that you're kind of just slowing the that you're kind of just slowing the that you're kind of just slowing the whole process, you know. whole process, you know. whole process, you know. >> Yeah, makes sense. >> Yeah, makes sense. >> Yeah, makes sense. >> So, um, sleep is something that you and >> So, um, sleep is something that you and >> So, um, sleep is something that you and I were discussing off camera where I were discussing off camera where I were discussing off camera where there's just not a lot of evidence. We there's just not a lot of evidence. We there's just not a lot of evidence. We all know sleep is good for us. We'd like all know sleep is good for us. We'd like all know sleep is good for us. We'd like to see more evidence. I mean, there may to see more evidence. I mean, there may to see more evidence. I mean, there may be some observational studies, but there be some observational studies, but there be some observational studies, but there are lots of confounders there. are lots of confounders there. are lots of confounders there. >> Yes. So, I worked with a team at UCLA, >> Yes. So, I worked with a team at UCLA, >> Yes. So, I worked with a team at UCLA, uh, Judith Carol, um, and she looked at uh, Judith Carol, um, and she looked at uh, Judith Carol, um, and she looked at sleep disturbances in the Women's Health sleep disturbances in the Women's Health sleep disturbances in the Women's Health Initiative, Initiative, Initiative, um, and other cohorts. And sure enough, um, and other cohorts. And sure enough, um, and other cohorts. And sure enough, um, people who report u severe sleep um, people who report u severe sleep um, people who report u severe sleep disruptions, these people exhibited disruptions, these people exhibited disruptions, these people exhibited increased epigenetic age. No surprise increased epigenetic age. No surprise increased epigenetic age. No surprise here. I mean, it was a um, observational here. I mean, it was a um, observational here. I mean, it was a um, observational study, you know. Um I know um that study, you know. Um I know um that study, you know. Um I know um that people are looking at that you know people are looking at that you know people are looking at that you know especially now we have these wonderful especially now we have these wonderful especially now we have these wonderful tools for tracking sleeping. So I hope tools for tracking sleeping. So I hope tools for tracking sleeping. So I hope somebody will do the obvious study you somebody will do the obvious study you somebody will do the obvious study you know correlate the hours of deep sleep know correlate the hours of deep sleep know correlate the hours of deep sleep the hours of REM sleep with epigenetic the hours of REM sleep with epigenetic the hours of REM sleep with epigenetic aging measures. I think it will be aging measures. I think it will be aging measures. I think it will be exciting but I'm just not aware of any exciting but I'm just not aware of any exciting but I'm just not aware of any study at the moment. Yeah. study at the moment. Yeah. study at the moment. Yeah. >> Yeah. I think I think we know that >> Yeah. I think I think we know that >> Yeah. I think I think we know that >> sleep deprivation chronic sleep >> sleep deprivation chronic sleep >> sleep deprivation chronic sleep deprivation increases inflammation deprivation increases inflammation deprivation increases inflammation changes your appetite people gain weight changes your appetite people gain weight changes your appetite people gain weight too. I mean so there's all the reasons too. I mean so there's all the reasons too. I mean so there's all the reasons why it would accelerate aging and and why it would accelerate aging and and why it would accelerate aging and and that would make sense. Um but yeah I I that would make sense. Um but yeah I I that would make sense. Um but yeah I I don't know that there's enough evidence don't know that there's enough evidence don't know that there's enough evidence looking at the specific stages of sleep looking at the specific stages of sleep looking at the specific stages of sleep and there's there's a lot to tease apart and there's there's a lot to tease apart and there's there's a lot to tease apart there and you know a lot more research there and you know a lot more research there and you know a lot more research to be done in that area. to be done in that area. to be done in that area. >> Yes. But another area that's very >> Yes. But another area that's very >> Yes. But another area that's very exciting has to do with our mental exciting has to do with our mental exciting has to do with our mental health and our our social relationships. health and our our social relationships. health and our our social relationships. >> Yes. >> Yes. >> Yes. >> Right. I mean that's >> Right. I mean that's >> Right. I mean that's >> this was the biggest surprise to me in >> this was the biggest surprise to me in >> this was the biggest surprise to me in the last 6 months perhaps. So I um need the last 6 months perhaps. So I um need the last 6 months perhaps. So I um need to tell you I'm not a social scientist. to tell you I'm not a social scientist. to tell you I'm not a social scientist. I don't study behavior. I really am not. I don't study behavior. I really am not. I don't study behavior. I really am not. you know I'm so anyways there was a um you know I'm so anyways there was a um you know I'm so anyways there was a um researcher at Harvard um researcher at Harvard um researcher at Harvard um Laura Kachinsky or I I butcher her last Laura Kachinsky or I I butcher her last Laura Kachinsky or I I butcher her last name but um she is um a very rigorous name but um she is um a very rigorous name but um she is um a very rigorous scientist and she wanted to evaluate scientist and she wanted to evaluate scientist and she wanted to evaluate whether what she calls uh I think a whether what she calls uh I think a whether what she calls uh I think a social cumulative advantage um which is social cumulative advantage um which is social cumulative advantage um which is a measure of um how connected you are in a measure of um how connected you are in a measure of um how connected you are in the community your social behavior your the community your social behavior your the community your social behavior your your friends, your community. Anyways, your friends, your community. Anyways, your friends, your community. Anyways, how does that affect biologic aging? And how does that affect biologic aging? And how does that affect biologic aging? And this is similar to the vitamin study we this is similar to the vitamin study we this is similar to the vitamin study we just said. We it's got to have an just said. We it's got to have an just said. We it's got to have an effect, right? I mean, so we all know effect, right? I mean, so we all know effect, right? I mean, so we all know loneliness is the big killer in the loneliness is the big killer in the loneliness is the big killer in the elderly at the level of smoking, right? elderly at the level of smoking, right? elderly at the level of smoking, right? You you don't want to be lonely and You you don't want to be lonely and You you don't want to be lonely and socially deprived. So anyways, um she socially deprived. So anyways, um she socially deprived. So anyways, um she did a very rigorous study, large sample did a very rigorous study, large sample did a very rigorous study, large sample size and she evaluated everything a size and she evaluated everything a size and she evaluated everything a researcher would evaluate. So what am I researcher would evaluate. So what am I researcher would evaluate. So what am I talking about? Um you want to evaluate talking about? Um you want to evaluate talking about? Um you want to evaluate cortisol levels, various um hormones cortisol levels, various um hormones cortisol levels, various um hormones that measure stress. You want to measure that measure stress. You want to measure that measure stress. You want to measure inflammatory markers, you know, IL6 and inflammatory markers, you know, IL6 and inflammatory markers, you know, IL6 and um various other readouts of um various other readouts of um various other readouts of inflammation. But fortunately she had inflammation. But fortunately she had inflammation. But fortunately she had enough research funding apparently to enough research funding apparently to enough research funding apparently to measure methylation because um I say measure methylation because um I say measure methylation because um I say that because um if I had been a that because um if I had been a that because um if I had been a researcher I would have focused on urine researcher I would have focused on urine researcher I would have focused on urine and blood for measuring hormones and and blood for measuring hormones and and blood for measuring hormones and inflammation and for methylation I would inflammation and for methylation I would inflammation and for methylation I would have I would have advised that don't have I would have advised that don't have I would have advised that don't even measure it because I just don't even measure it because I just don't even measure it because I just don't think you pick pick that up. And why do think you pick pick that up. And why do think you pick pick that up. And why do I say that? Why? Why would um your I say that? Why? Why would um your I say that? Why? Why would um your connectivity, your friends, your connectivity, your friends, your connectivity, your friends, your relationship with your spouse and your relationship with your spouse and your relationship with your spouse and your family family family um why would that translate to changes um why would that translate to changes um why would that translate to changes on the DNA me molecule in in blood, you on the DNA me molecule in in blood, you on the DNA me molecule in in blood, you know, think think about the mechanism. know, think think about the mechanism. know, think think about the mechanism. It's so far removed. It's so far removed. It's so far removed. But anyways, fortunately she did do this But anyways, fortunately she did do this But anyways, fortunately she did do this study and the great surprise to me was study and the great surprise to me was study and the great surprise to me was the methylation readout dwarfed the the methylation readout dwarfed the the methylation readout dwarfed the other readouts. If anything, the other other readouts. If anything, the other other readouts. If anything, the other readouts didn't work. So grim age again readouts didn't work. So grim age again readouts didn't work. So grim age again picked it up. People who have this uh picked it up. People who have this uh picked it up. People who have this uh who are blessed really by having who are blessed really by having who are blessed really by having wonderful family relations, community, wonderful family relations, community, wonderful family relations, community, just this social advantage, you know. just this social advantage, you know. just this social advantage, you know. Sure enough, their grim age was reduced. Sure enough, their grim age was reduced. Sure enough, their grim age was reduced. So I um it really taught me something. So I um it really taught me something. So I um it really taught me something. Yeah. Yeah. Yeah. >> Um do you do you know how much it was >> Um do you do you know how much it was >> Um do you do you know how much it was reduced? Do you remember? reduced? Do you remember? reduced? Do you remember? >> No. You know, my problem is I only ever >> No. You know, my problem is I only ever >> No. You know, my problem is I only ever look at P values. I'm a statistician. look at P values. I'm a statistician. look at P values. I'm a statistician. >> I know everyone always wants to know how >> I know everyone always wants to know how >> I know everyone always wants to know how many months, but I just go by P value. many months, but I just go by P value. many months, but I just go by P value. >> You know, there's a lot of there's a lot >> You know, there's a lot of there's a lot >> You know, there's a lot of there's a lot of things here. I had Arthur Brooks on of things here. I had Arthur Brooks on of things here. I had Arthur Brooks on and you he talks about the science of and you he talks about the science of and you he talks about the science of happiness. He's amazing, by the way. If happiness. He's amazing, by the way. If happiness. He's amazing, by the way. If you you you >> don't follow him on X, you should. He's >> don't follow him on X, you should. He's >> don't follow him on X, you should. He's got really great, you know, science out got really great, you know, science out got really great, you know, science out there. But, um, and Richard Davidson's there. But, um, and Richard Davidson's there. But, um, and Richard Davidson's coming on the podcast. He's at Harvard coming on the podcast. He's at Harvard coming on the podcast. He's at Harvard and he's been involved with the Harvard and he's been involved with the Harvard and he's been involved with the Harvard Health Study looking at how social Health Study looking at how social Health Study looking at how social relationships and happiness really do relationships and happiness really do relationships and happiness really do correlate with longevity and why. correlate with longevity and why. correlate with longevity and why. >> Yes. >> Yes. >> Yes. >> But, you know, if you think about the >> But, you know, if you think about the >> But, you know, if you think about the flip side of that, the loneliness and flip side of that, the loneliness and flip side of that, the loneliness and not having those social relationships, not having those social relationships, not having those social relationships, there's also the possibility that the there's also the possibility that the there's also the possibility that the relationships were unhealthy and so relationships were unhealthy and so relationships were unhealthy and so people separated from that. You know, people separated from that. You know, people separated from that. You know, there's so there's stress probably there's so there's stress probably there's so there's stress probably that's involved in that equation. Yeah. that's involved in that equation. Yeah. that's involved in that equation. Yeah. Too. um loneliness itself has been shown Too. um loneliness itself has been shown Too. um loneliness itself has been shown to increase stress, you know, as as was to increase stress, you know, as as was to increase stress, you know, as as was picked up on this this study and others. picked up on this this study and others. picked up on this this study and others. But um there's a lot of I think nuance But um there's a lot of I think nuance But um there's a lot of I think nuance there with respect to, you know, if there with respect to, you know, if there with respect to, you know, if you're someone that has a lot of social you're someone that has a lot of social you're someone that has a lot of social relationships relationships relationships um versus someone that doesn't. And like um versus someone that doesn't. And like um versus someone that doesn't. And like a lot of times you look at the people a lot of times you look at the people a lot of times you look at the people that don't, there's usually some trauma that don't, there's usually some trauma that don't, there's usually some trauma too, right? And that definitely would too, right? And that definitely would too, right? And that definitely would cause a a stress or that's a stressor. cause a a stress or that's a stressor. cause a a stress or that's a stressor. >> Oh, I couldn't agree more. If you're in >> Oh, I couldn't agree more. If you're in >> Oh, I couldn't agree more. If you're in a toxic relationship, get out. Of a toxic relationship, get out. Of a toxic relationship, get out. Of course, you know, don't tolerate abuse. course, you know, don't tolerate abuse. course, you know, don't tolerate abuse. I mean, just uh for sure, you know, I mean, just uh for sure, you know, I mean, just uh for sure, you know, >> but those things probably make leave >> but those things probably make leave >> but those things probably make leave their mark on the epigenome, that their mark on the epigenome, that their mark on the epigenome, that stress. stress. stress. >> Yeah. I need to tell you, I always like >> Yeah. I need to tell you, I always like >> Yeah. I need to tell you, I always like studies that actually show the opposite studies that actually show the opposite studies that actually show the opposite from what I report. I want studies that from what I report. I want studies that from what I report. I want studies that show that people who are terribly show that people who are terribly show that people who are terribly stressed and depressed and don't sleep stressed and depressed and don't sleep stressed and depressed and don't sleep well that they don't age too fast. You well that they don't age too fast. You well that they don't age too fast. You know, know, know, >> have you seen that study? >> have you seen that study? >> have you seen that study? So I'm always happy when uh a sleep So I'm always happy when uh a sleep So I'm always happy when uh a sleep study shows only a weak effect, you study shows only a weak effect, you study shows only a weak effect, you know, and so because I'm rooting for know, and so because I'm rooting for know, and so because I'm rooting for these people, you know, but um yeah um these people, you know, but um yeah um these people, you know, but um yeah um I'm I'm not sure. Um let me um say I'm I'm not sure. Um let me um say I'm I'm not sure. Um let me um say something about the elderly. Again, something about the elderly. Again, something about the elderly. Again, loneliness is the big killer in old age. loneliness is the big killer in old age. loneliness is the big killer in old age. Um and unfortunately geriatric patients Um and unfortunately geriatric patients Um and unfortunately geriatric patients are often isolated. you know, many of are often isolated. you know, many of are often isolated. you know, many of their friends have died and um what to their friends have died and um what to their friends have died and um what to do about it. Um and there have been very do about it. Um and there have been very do about it. Um and there have been very nice studies in Japan, of course, where nice studies in Japan, of course, where nice studies in Japan, of course, where they deploy various robots, you know, to they deploy various robots, you know, to they deploy various robots, you know, to entertain people. And um entertain people. And um entertain people. And um >> the robots are coming. the robots are >> the robots are coming. the robots are >> the robots are coming. the robots are coming, the companions, you know, and um coming, the companions, you know, and um coming, the companions, you know, and um maybe to a western audience this is maybe to a western audience this is maybe to a western audience this is culturally a little bit alienating, but culturally a little bit alienating, but culturally a little bit alienating, but I look at it as an opportunity because I look at it as an opportunity because I look at it as an opportunity because maybe this AI revolution, you know, um maybe this AI revolution, you know, um maybe this AI revolution, you know, um and then upcoming robotics will give us and then upcoming robotics will give us and then upcoming robotics will give us companions at least to fill this urgent companions at least to fill this urgent companions at least to fill this urgent need to engage a geriat geriatric need to engage a geriat geriatric need to engage a geriat geriatric patient. I I just think it's better if patient. I I just think it's better if patient. I I just think it's better if they interact with something as opposed they interact with something as opposed they interact with something as opposed to just sitting in a chair, you know. to just sitting in a chair, you know. to just sitting in a chair, you know. >> Yeah. Ideally, their kids would come >> Yeah. Ideally, their kids would come >> Yeah. Ideally, their kids would come visit them, but I guess, you know, visit them, but I guess, you know, visit them, but I guess, you know, that's not always the case. It's that's not always the case. It's that's not always the case. It's >> just not realistic, you know. We many of >> just not realistic, you know. We many of >> just not realistic, you know. We many of these um jobs um um that deal with these um jobs um um that deal with these um jobs um um that deal with geriatric patients are underpaid. geriatric patients are underpaid. geriatric patients are underpaid. There's a shortage, you know. So, we There's a shortage, you know. So, we There's a shortage, you know. So, we need to think of creative ways of need to think of creative ways of need to think of creative ways of addressing really this need, you know. addressing really this need, you know. addressing really this need, you know. Um Yeah. Well, let's talk about I want Um Yeah. Well, let's talk about I want Um Yeah. Well, let's talk about I want to talk about give, you know, we're to talk about give, you know, we're to talk about give, you know, we're talking a lot about these diet, talking a lot about these diet, talking a lot about these diet, lifestyle, lifestyle, lifestyle, healthy, unhealthy patterns of living healthy, unhealthy patterns of living healthy, unhealthy patterns of living that affect the way we age. And now we that affect the way we age. And now we that affect the way we age. And now we have a tool that we can use to kind of have a tool that we can use to kind of have a tool that we can use to kind of give us a concrete number to give us give us a concrete number to give us give us a concrete number to give us more data and more of an understanding more data and more of an understanding more data and more of an understanding of how we're living and how um that is of how we're living and how um that is of how we're living and how um that is affecting the way we age, right? And affecting the way we age, right? And affecting the way we age, right? And this is obviously used at the level of this is obviously used at the level of this is obviously used at the level of research quite nicely, but it's also research quite nicely, but it's also research quite nicely, but it's also that's something that's available to the that's something that's available to the that's something that's available to the consumer. And I think a lot of people consumer. And I think a lot of people consumer. And I think a lot of people that are listening to this, we do have that are listening to this, we do have that are listening to this, we do have researchers listening, but we also have researchers listening, but we also have researchers listening, but we also have just people interested in their health just people interested in their health just people interested in their health and interested in living healthy. And and interested in living healthy. And and interested in living healthy. And everyone's coming from a different everyone's coming from a different everyone's coming from a different starting point. Some people are starting point. Some people are starting point. Some people are overweight and obese and and the thing overweight and obese and and the thing overweight and obese and and the thing they have to focus on is weight loss. they have to focus on is weight loss. they have to focus on is weight loss. That's like focus on that and then That's like focus on that and then That's like focus on that and then everything else can come after, right? everything else can come after, right? everything else can come after, right? Um, some people are smokers and they Um, some people are smokers and they Um, some people are smokers and they need to focus on quitting smoking. Some need to focus on quitting smoking. Some need to focus on quitting smoking. Some people are not sleeping and they need to people are not sleeping and they need to people are not sleeping and they need to sleep. Some people are not exercising sleep. Some people are not exercising sleep. Some people are not exercising and they need to exercise, right? and they need to exercise, right? and they need to exercise, right? Vitamins, minerals, all these things Vitamins, minerals, all these things Vitamins, minerals, all these things come into the equation. Some people want come into the equation. Some people want come into the equation. Some people want to do all of it. They want to do to do all of it. They want to do to do all of it. They want to do everything they can. They really want to everything they can. They really want to everything they can. They really want to feel as good as they can, age as good as feel as good as they can, age as good as feel as good as they can, age as good as they can, and give themselves the they can, and give themselves the they can, and give themselves the potential that they have to age the best potential that they have to age the best potential that they have to age the best way they can. And I'm definitely one of way they can. And I'm definitely one of way they can. And I'm definitely one of those people. I know a lot of listeners those people. I know a lot of listeners those people. I know a lot of listeners are one are in that category. And so I are one are in that category. And so I are one are in that category. And so I think the excitement for them is they think the excitement for them is they think the excitement for them is they want to go out and perhaps try to want to go out and perhaps try to want to go out and perhaps try to experiment with some of these tools that experiment with some of these tools that experiment with some of these tools that are available to them and get a baseline are available to them and get a baseline are available to them and get a baseline test of their DNA grim age or something test of their DNA grim age or something test of their DNA grim age or something and see where what their biological age and see where what their biological age and see where what their biological age is and do they have room for improvement is and do they have room for improvement is and do they have room for improvement and can they start to improve things and and can they start to improve things and and can they start to improve things and then see that improvement. What what then see that improvement. What what then see that improvement. What what would you say to those people like in would you say to those people like in would you say to those people like in terms of like first of all finding a terms of like first of all finding a terms of like first of all finding a reliable test? Do they have to go out reliable test? Do they have to go out reliable test? Do they have to go out and and do a couple of tests to make and and do a couple of tests to make and and do a couple of tests to make sure you're getting the same age at sure you're getting the same age at sure you're getting the same age at baseline to make sure it's a reliable baseline to make sure it's a reliable baseline to make sure it's a reliable test at first? And and is something is test at first? And and is something is test at first? And and is something is it something that you think people can it something that you think people can it something that you think people can use? Let's say they find a reliable use? Let's say they find a reliable use? Let's say they find a reliable test. They establish that they got the test. They establish that they got the test. They establish that they got the same close to the same age a couple of same close to the same age a couple of same close to the same age a couple of times. Then can they perhaps start doing times. Then can they perhaps start doing times. Then can they perhaps start doing the cycling for 6 months and improving the cycling for 6 months and improving the cycling for 6 months and improving their V2 max? And then also in addition their V2 max? And then also in addition their V2 max? And then also in addition to measuring their either they measure to measuring their either they measure to measuring their either they measure their V2 max or they measure an their V2 max or they measure an their V2 max or they measure an estimation of that which is probably a estimation of that which is probably a estimation of that which is probably a lot more accessible to people. They can lot more accessible to people. They can lot more accessible to people. They can go out and do a 12minute run test on a go out and do a 12minute run test on a go out and do a 12minute run test on a flat track and do the equation get an flat track and do the equation get an flat track and do the equation get an estimation. It's kind of what your Apple estimation. It's kind of what your Apple estimation. It's kind of what your Apple Watch does and a lot of wearable devices Watch does and a lot of wearable devices Watch does and a lot of wearable devices >> but also add this DNA grimage and other >> but also add this DNA grimage and other >> but also add this DNA grimage and other perhaps you know test of these perhaps you know test of these perhaps you know test of these epigenetic aging clocks in there. epigenetic aging clocks in there. epigenetic aging clocks in there. >> Yeah. Um well um I would say several >> Yeah. Um well um I would say several >> Yeah. Um well um I would say several things. First of all, unfortunately, things. First of all, unfortunately, things. First of all, unfortunately, these tests are expensive. They cost these tests are expensive. They cost these tests are expensive. They cost several hundred dollar. And um I always several hundred dollar. And um I always several hundred dollar. And um I always say you don't need to measure anything say you don't need to measure anything say you don't need to measure anything on yourself to know that you should stop on yourself to know that you should stop on yourself to know that you should stop smoking and exercise and eat vegetables, smoking and exercise and eat vegetables, smoking and exercise and eat vegetables, you know. But interestingly you know. But interestingly you know. But interestingly um longevity doctors um always tell me um longevity doctors um always tell me um longevity doctors um always tell me that an epigenetic clock measure um that an epigenetic clock measure um that an epigenetic clock measure um leads to better adherence because I you leads to better adherence because I you leads to better adherence because I you know I go to conferences and then uh know I go to conferences and then uh know I go to conferences and then uh longevity doctors approach me and they longevity doctors approach me and they longevity doctors approach me and they thank me for developing epigenetic thank me for developing epigenetic thank me for developing epigenetic clocks and I ask them well what are they clocks and I ask them well what are they clocks and I ask them well what are they good for for in your practice you know good for for in your practice you know good for for in your practice you know and that's what they say is number one and that's what they say is number one and that's what they say is number one uh use case that people who measure it uh use case that people who measure it uh use case that people who measure it they are better motivated to stick to they are better motivated to stick to they are better motivated to stick to various regimens you know um um it's various regimens you know um um it's various regimens you know um um it's important to again highlight the costs important to again highlight the costs important to again highlight the costs because um companies are trying to because um companies are trying to because um companies are trying to develop cheaper readouts um which I very develop cheaper readouts um which I very develop cheaper readouts um which I very much applaud um I I just want a $50 test much applaud um I I just want a $50 test much applaud um I I just want a $50 test and what I can tell you is and what I can tell you is and what I can tell you is technologically this is fully possible technologically this is fully possible technologically this is fully possible it's just nobody has really put their it's just nobody has really put their it's just nobody has really put their mind to it you know to really offer that mind to it you know to really offer that mind to it you know to really offer that I think you know but I mention it I think you know but I mention it I think you know but I mention it because um companies will work on that because um companies will work on that because um companies will work on that and um what it then leads to is a and um what it then leads to is a and um what it then leads to is a different clock. So um when you go out different clock. So um when you go out different clock. So um when you go out there and you look at different there and you look at different there and you look at different providers they may offer clocks that providers they may offer clocks that providers they may offer clocks that have been less characterized um in the have been less characterized um in the have been less characterized um in the literature. I'm not saying these clocks literature. I'm not saying these clocks literature. I'm not saying these clocks are worse in any way. It's just there's are worse in any way. It's just there's are worse in any way. It's just there's not that the the same level of not that the the same level of not that the the same level of literature. We discussed earlier today literature. We discussed earlier today literature. We discussed earlier today there are these five clocks that there are these five clocks that there are these five clocks that everyone uses um why they all use a everyone uses um why they all use a everyone uses um why they all use a particular particular technology the particular particular technology the particular particular technology the so-called illuminina array so-called illuminina array so-called illuminina array and um also do need and pace everyone and um also do need and pace everyone and um also do need and pace everyone uses that technology and therefore um we uses that technology and therefore um we uses that technology and therefore um we can leverage legacy data that have been can leverage legacy data that have been can leverage legacy data that have been collected over the last 10 years you collected over the last 10 years you collected over the last 10 years you know to see well what is the effect of know to see well what is the effect of know to see well what is the effect of eating vegetables or exercise whereas if eating vegetables or exercise whereas if eating vegetables or exercise whereas if you lower the cost you don't have these you lower the cost you don't have these you lower the cost you don't have these legacy data so less characterized you legacy data so less characterized you legacy data so less characterized you know know know >> where should someone if someone wants to >> where should someone if someone wants to >> where should someone if someone wants to get one of these tests done perhaps they get one of these tests done perhaps they get one of these tests done perhaps they have the money and they can afford it have the money and they can afford it have the money and they can afford it and they want the motivation because I and they want the motivation because I and they want the motivation because I absolutely agree that data does motivate absolutely agree that data does motivate absolutely agree that data does motivate you um what what should they look for in you um what what should they look for in you um what what should they look for in terms of the they want to make sure it's terms of the they want to make sure it's terms of the they want to make sure it's one of those tests that use the one of those tests that use the one of those tests that use the aluminina array they want to make sure aluminina array they want to make sure aluminina array they want to make sure it's the reliable does it have to say it's the reliable does it have to say it's the reliable does it have to say like DNA grim age does it have to say like DNA grim age does it have to say like DNA grim age does it have to say pheno age uh the duadin and paste like pheno age uh the duadin and paste like pheno age uh the duadin and paste like how does someone navigate that world and how does someone navigate that world and how does someone navigate that world and try to find the most reliable test to try to find the most reliable test to try to find the most reliable test to use. Yeah, I want to tell you that use. Yeah, I want to tell you that use. Yeah, I want to tell you that overall my um um um reading of the overall my um um um reading of the overall my um um um reading of the community is that there are several good community is that there are several good community is that there are several good providers of tests really you know providers of tests really you know providers of tests really you know because the beauty of this illuminina because the beauty of this illuminina because the beauty of this illuminina array is that it follows a very array is that it follows a very array is that it follows a very standardized protocol you know and um uh standardized protocol you know and um uh standardized protocol you know and um uh many years of research went into how to many years of research went into how to many years of research went into how to pre-process the data how to optimize the pre-process the data how to optimize the pre-process the data how to optimize the signal versus technical noise you know signal versus technical noise you know signal versus technical noise you know that has been standardized. So I I think that has been standardized. So I I think that has been standardized. So I I think um as long as you go to a lab that has um as long as you go to a lab that has um as long as you go to a lab that has experience with generating these data, experience with generating these data, experience with generating these data, you're in really good shape, you know. you're in really good shape, you know. you're in really good shape, you know. >> Yeah. >> Yeah. >> Yeah. >> And and why would people not want to go >> And and why would people not want to go >> And and why would people not want to go out and use the Horvath epigenetic agent out and use the Horvath epigenetic agent out and use the Horvath epigenetic agent clock for their biological age? clock for their biological age? clock for their biological age? >> No. Um you know, when you use an >> No. Um you know, when you use an >> No. Um you know, when you use an illuminina array, they they give you the illuminina array, they they give you the illuminina array, they they give you the Horvath clock. They give you they give Horvath clock. They give you they give Horvath clock. They give you they give you they will give you a hundred you they will give you a hundred you they will give you a hundred readouts. If anything you may get readouts. If anything you may get readouts. If anything you may get traumatized by what they give you. traumatized by what they give you. traumatized by what they give you. Remember I started discussing various Remember I started discussing various Remember I started discussing various protein markers CRP or um famous markers protein markers CRP or um famous markers protein markers CRP or um famous markers like plasminogen activator inhibitor one like plasminogen activator inhibitor one like plasminogen activator inhibitor one or anyways various famous proteins also or anyways various famous proteins also or anyways various famous proteins also get estimated with methylation you know get estimated with methylation you know get estimated with methylation you know um and maybe if I um want to mention an um and maybe if I um want to mention an um and maybe if I um want to mention an very important innovation in the last very important innovation in the last very important innovation in the last year really people use methylation to year really people use methylation to year really people use methylation to estimate the ages of different organs estimate the ages of different organs estimate the ages of different organs you know so it's a heart measure but you know so it's a heart measure but you know so it's a heart measure but they will say your kidney is older or they will say your kidney is older or they will say your kidney is older or your lung you know so that's where the your lung you know so that's where the your lung you know so that's where the field is at developing um organ specific field is at developing um organ specific field is at developing um organ specific uh methylation markers and uh methylation markers and uh methylation markers and >> and those are consumer consumer >> and those are consumer consumer >> and those are consumer consumer available as well available as well available as well >> that's already available to the consumer >> that's already available to the consumer >> that's already available to the consumer you know so you may end up with a report you know so you may end up with a report you know so you may end up with a report 50 pages 100 pages you may be 50 pages 100 pages you may be 50 pages 100 pages you may be overwhelmed by it you know um but um you overwhelmed by it you know um but um you overwhelmed by it you know um but um you don't need to obsess too much about um don't need to obsess too much about um don't need to obsess too much about um who does the analysis because as long as who does the analysis because as long as who does the analysis because as long as you have access to the data you could you have access to the data you could you have access to the data you could then apply these latest tools that are then apply these latest tools that are then apply these latest tools that are um being developed to analyze it. You um being developed to analyze it. You um being developed to analyze it. You know know know >> how would you do that? >> how would you do that? >> how would you do that? >> You know there are web pages you upload >> You know there are web pages you upload >> You know there are web pages you upload the data to a web page and it outputs the data to a web page and it outputs the data to a web page and it outputs the results. the results. the results. >> Like what web page? >> Like what web page? >> Like what web page? >> Yeah. Um I started a um nonprofit >> Yeah. Um I started a um nonprofit >> Yeah. Um I started a um nonprofit foundation. It's called Epigenetic Clock foundation. It's called Epigenetic Clock foundation. It's called Epigenetic Clock Foundation. I know they have a Foundation. I know they have a Foundation. I know they have a calculator where people upload data and calculator where people upload data and calculator where people upload data and they get an output but um I just want to they get an output but um I just want to they get an output but um I just want to emphasize there are many other um emphasize there are many other um emphasize there are many other um outlets you know so you can do some outlets you know so you can do some outlets you know so you can do some Google searches on who offers that. Google searches on who offers that. Google searches on who offers that. Yeah. Yeah. Yeah. >> Well I've I've kind of not >> Well I've I've kind of not >> Well I've I've kind of not >> I think based on our last conversation >> I think based on our last conversation >> I think based on our last conversation and my skepticism on you know using and my skepticism on you know using and my skepticism on you know using these clocks at the on the individual these clocks at the on the individual these clocks at the on the individual level and then trusting the consu what's level and then trusting the consu what's level and then trusting the consu what's consumer available. I haven't really consumer available. I haven't really consumer available. I haven't really experimented with them since it's been experimented with them since it's been experimented with them since it's been years. And so now I we were talking a years. And so now I we were talking a years. And so now I we were talking a couple of weeks ago and I was going to couple of weeks ago and I was going to couple of weeks ago and I was going to I'm going to do some experiments, but we I'm going to do some experiments, but we I'm going to do some experiments, but we didn't have enough time two weeks to to didn't have enough time two weeks to to didn't have enough time two weeks to to do all this and come on the podcast and do all this and come on the podcast and do all this and come on the podcast and talk about it. But I'm now interested talk about it. But I'm now interested talk about it. But I'm now interested because of all the progress that's been because of all the progress that's been because of all the progress that's been done in the field and in including the done in the field and in including the done in the field and in including the consumer available tests that are out consumer available tests that are out consumer available tests that are out there um in you know seeing seeing there um in you know seeing seeing there um in you know seeing seeing seeing what I get from my my data um and seeing what I get from my my data um and seeing what I get from my my data um and see what room for improvement I have and see what room for improvement I have and see what room for improvement I have and whether or not I it does get picked up whether or not I it does get picked up whether or not I it does get picked up because again I'm already healthy and I because again I'm already healthy and I because again I'm already healthy and I do take a lot of supplements already. So do take a lot of supplements already. So do take a lot of supplements already. So >> yes, >> yes, >> yes, >> I want to briefly mention the most >> I want to briefly mention the most >> I want to briefly mention the most obvious medical use case perhaps. It's obvious medical use case perhaps. It's obvious medical use case perhaps. It's really finding people who age faster really finding people who age faster really finding people who age faster >> um and then thinking about what to do >> um and then thinking about what to do >> um and then thinking about what to do about it. And we talked about various about it. And we talked about various about it. And we talked about various interventions. The problem with you and interventions. The problem with you and interventions. The problem with you and me is we probably are already optimized, me is we probably are already optimized, me is we probably are already optimized, you know. Um let's um um I would be you know. Um let's um um I would be you know. Um let's um um I would be surprised if you learn anything new you surprised if you learn anything new you surprised if you learn anything new you know um but maybe you start a completely know um but maybe you start a completely know um but maybe you start a completely different regimen and then then it would different regimen and then then it would different regimen and then then it would be interesting how does it affect your be interesting how does it affect your be interesting how does it affect your methylation readouts you know methylation readouts you know methylation readouts you know >> right and then probably presumably don't >> right and then probably presumably don't >> right and then probably presumably don't want to measure it when you're sick or want to measure it when you're sick or want to measure it when you're sick or >> yeah maybe um let's talk a little bit >> yeah maybe um let's talk a little bit >> yeah maybe um let's talk a little bit about variability because they have also about variability because they have also about variability because they have also been major insights that surprised me um been major insights that surprised me um been major insights that surprised me um I'll start maybe with a background. So I'll start maybe with a background. So I'll start maybe with a background. So um we talked about these principal um we talked about these principal um we talked about these principal componentbased versions of clocks such componentbased versions of clocks such componentbased versions of clocks such as PC grim age that was used in the as PC grim age that was used in the as PC grim age that was used in the cosmos multivitamin study and anyway cosmos multivitamin study and anyway cosmos multivitamin study and anyway these are very uh reproducible these are very uh reproducible these are very uh reproducible and um I to give you a number let's say and um I to give you a number let's say and um I to give you a number let's say you measured that marker two days apart you measured that marker two days apart you measured that marker two days apart you you you um measure PC grimage on you you you um measure PC grimage on you you you um measure PC grimage on Monday and then another measure on Monday and then another measure on Monday and then another measure on Wednesday and nothing has happened. I Wednesday and nothing has happened. I Wednesday and nothing has happened. I would expect a technical variation of would expect a technical variation of would expect a technical variation of maybe four or five months perhaps and or maybe four or five months perhaps and or maybe four or five months perhaps and or two months. It's a few months, you know, two months. It's a few months, you know, two months. It's a few months, you know, and um so this is just technical and um so this is just technical and um so this is just technical variance, you know, but um and and um um variance, you know, but um and and um um variance, you know, but um and and um um but um um other clocks um um do need and but um um other clocks um um do need and but um um other clocks um um do need and pace is slightly less robust but also pace is slightly less robust but also pace is slightly less robust but also very high technical reproducibility, you very high technical reproducibility, you very high technical reproducibility, you know. Um however, if you use different know. Um however, if you use different know. Um however, if you use different types of clocks, you will get different types of clocks, you will get different types of clocks, you will get different measures. So if you take Grimage and measures. So if you take Grimage and measures. So if you take Grimage and then compare it to what people call then compare it to what people call then compare it to what people call Horvath pant tissue clock you may get Horvath pant tissue clock you may get Horvath pant tissue clock you may get very discrepant results because um they very discrepant results because um they very discrepant results because um they measure different aspects of biology. measure different aspects of biology. measure different aspects of biology. The Horvath pantissue clock is very good The Horvath pantissue clock is very good The Horvath pantissue clock is very good for stem cell biology um hematopoetic for stem cell biology um hematopoetic for stem cell biology um hematopoetic stem cells precursors of leukemia that stem cells precursors of leukemia that stem cells precursors of leukemia that type of biology just not good for type of biology just not good for type of biology just not good for mortality risk you know. Yeah, I think mortality risk you know. Yeah, I think mortality risk you know. Yeah, I think that raises another question in my mind, that raises another question in my mind, that raises another question in my mind, especially for people and consumers that especially for people and consumers that especially for people and consumers that are interested in maybe measuring some are interested in maybe measuring some are interested in maybe measuring some some of these clocks and seeing where some of these clocks and seeing where some of these clocks and seeing where they're where they're at. Um, and if they're where they're at. Um, and if they're where they're at. Um, and if they're going to do any interventions, they're going to do any interventions, they're going to do any interventions, where they're at after the intervention, where they're at after the intervention, where they're at after the intervention, but you know, but you know, but you know, which clock is best. So, are we talking which clock is best. So, are we talking which clock is best. So, are we talking about like if you're wanting to look at about like if you're wanting to look at about like if you're wanting to look at the douadan pace and the the pace of the douadan pace and the the pace of the douadan pace and the the pace of your aging um versus your DNA grimage, your aging um versus your DNA grimage, your aging um versus your DNA grimage, right? I mean, what is right? I mean, what is right? I mean, what is Maybe you kind of need both almost or Maybe you kind of need both almost or Maybe you kind of need both almost or >> absolutely I I would look at both you >> absolutely I I would look at both you >> absolutely I I would look at both you know I really would it's a bit like the know I really would it's a bit like the know I really would it's a bit like the example of a biochemical test in when example of a biochemical test in when example of a biochemical test in when you go to a doctor you know do you focus you go to a doctor you know do you focus you go to a doctor you know do you focus on hemoglobin A1C do you focus on cyatin on hemoglobin A1C do you focus on cyatin on hemoglobin A1C do you focus on cyatin C or um give me all you know let me look C or um give me all you know let me look C or um give me all you know let me look at it because they do give you different at it because they do give you different at it because they do give you different lenses at the changes in the methylone lenses at the changes in the methylone lenses at the changes in the methylone >> but you would you would predict and this >> but you would you would predict and this >> but you would you would predict and this isn't some This is something that again isn't some This is something that again isn't some This is something that again with some of these trials we're seeing with some of these trials we're seeing with some of these trials we're seeing the do a dindenon pace is picked up but the do a dindenon pace is picked up but the do a dindenon pace is picked up but then the grimage is not or vice versa then the grimage is not or vice versa then the grimage is not or vice versa and it's the question then becomes how and it's the question then becomes how and it's the question then becomes how these clocks were I don't know trained these clocks were I don't know trained these clocks were I don't know trained and and and >> yes >> yes >> yes >> developed and what they're more >> developed and what they're more >> developed and what they're more sensitive to and that's another thing so sensitive to and that's another thing so sensitive to and that's another thing so if you are someone that loses a lot of if you are someone that loses a lot of if you are someone that loses a lot of weight then you would you know both weight then you would you know both weight then you would you know both would pick it pick it up but presumably would pick it pick it up but presumably would pick it pick it up but presumably the one that's trained more on BMI would the one that's trained more on BMI would the one that's trained more on BMI would be more sensitive. Yes, remember the be more sensitive. Yes, remember the be more sensitive. Yes, remember the exercise study um um that we discussed exercise study um um that we discussed exercise study um um that we discussed four and a half hours of bicycling four and a half hours of bicycling four and a half hours of bicycling grimage was better than Dunid and Pace grimage was better than Dunid and Pace grimage was better than Dunid and Pace you know and so we you know and so we you know and so we >> inflammation right does grimage pick up >> inflammation right does grimage pick up >> inflammation right does grimage pick up inflammation? inflammation? inflammation? >> Yes. Yes. But you know we are really >> Yes. Yes. But you know we are really >> Yes. Yes. But you know we are really learning about these clocks you know learning about these clocks you know learning about these clocks you know because all of them were built with um because all of them were built with um because all of them were built with um AI machine learning models and um we are AI machine learning models and um we are AI machine learning models and um we are trying to understand what perturbs them trying to understand what perturbs them trying to understand what perturbs them you know what kind of interventions you know what kind of interventions you know what kind of interventions touch them and ultimately what the field touch them and ultimately what the field touch them and ultimately what the field needs to develop is what we discussed needs to develop is what we discussed needs to develop is what we discussed earlier surrogate endpoints for a earlier surrogate endpoints for a earlier surrogate endpoints for a clinical trial because when you do a clinical trial because when you do a clinical trial because when you do a clinical trial you need to tell you tell clinical trial you need to tell you tell clinical trial you need to tell you tell the regulator what is the primary the regulator what is the primary the regulator what is the primary readout you can tell them I look at 10 readout you can tell them I look at 10 readout you can tell them I look at 10 clocks you know so and and the very clocks you know so and and the very clocks you know so and and the very fortunate situation is that um um fortunate situation is that um um fortunate situation is that um um there's a biomarker consortium biomarker there's a biomarker consortium biomarker there's a biomarker consortium biomarker of aging consortium that really of aging consortium that really of aging consortium that really rigorously evaluates all of these clocks rigorously evaluates all of these clocks rigorously evaluates all of these clocks um and also substantial um research um and also substantial um research um and also substantial um research funding goes into that field there was funding goes into that field there was funding goes into that field there was an announcement by ARPA our age to study an announcement by ARPA our age to study an announcement by ARPA our age to study interventions but also to develop then interventions but also to develop then interventions but also to develop then um biomarkers for tracking longevity um biomarkers for tracking longevity um biomarkers for tracking longevity interventions you know and so I'm very interventions you know and so I'm very interventions you know and so I'm very hopeful actually that um the science hopeful actually that um the science hopeful actually that um the science will advance that next time you and I will advance that next time you and I will advance that next time you and I talk you know I can tell you this clock talk you know I can tell you this clock talk you know I can tell you this clock is the primary readout you know is the primary readout you know is the primary readout you know >> how do you think AI might change >> how do you think AI might change >> how do you think AI might change >> you know these clocks and development >> you know these clocks and development >> you know these clocks and development and the you know progress in them as and the you know progress in them as and the you know progress in them as well like are are you hopeful that using well like are are you hopeful that using well like are are you hopeful that using AI technology will help you make them AI technology will help you make them AI technology will help you make them better? better? better? >> Yes, absolutely. And maybe to give you >> Yes, absolutely. And maybe to give you >> Yes, absolutely. And maybe to give you some perspective, so Akalu in the lab some perspective, so Akalu in the lab some perspective, so Akalu in the lab published Grimage 2019, published Grimage 2019, published Grimage 2019, way before Chad GPT, before anything. way before Chad GPT, before anything. way before Chad GPT, before anything. And now it's 2026 and Grimage still And now it's 2026 and Grimage still And now it's 2026 and Grimage still seems to be the best mortality seems to be the best mortality seems to be the best mortality predictor. To me that's deeply predictor. To me that's deeply predictor. To me that's deeply frustrating because I want to see um um frustrating because I want to see um um frustrating because I want to see um um step changes in these biomarkers and I'm step changes in these biomarkers and I'm step changes in these biomarkers and I'm sure it can be achieved. Now the good sure it can be achieved. Now the good sure it can be achieved. Now the good news is people have already published um news is people have already published um news is people have already published um new clocks based on AI. You know they do new clocks based on AI. You know they do new clocks based on AI. You know they do use large language models. Um I um one use large language models. Um I um one use large language models. Um I um one person um um Lucas um um published what person um um Lucas um um published what person um um Lucas um um published what he called Grimage version three but he called Grimage version three but he called Grimage version three but there are no new clock systems age then there are no new clock systems age then there are no new clock systems age then there's OMIC MH so these clocks have all there's OMIC MH so these clocks have all there's OMIC MH so these clocks have all come out in the last few months and the come out in the last few months and the come out in the last few months and the reason why I don't talk much about them reason why I don't talk much about them reason why I don't talk much about them is because they haven't gone through is because they haven't gone through is because they haven't gone through this extensive review by the community this extensive review by the community this extensive review by the community you know but I fingers crossed you know you know but I fingers crossed you know you know but I fingers crossed you know that any of these newer clocks are way that any of these newer clocks are way that any of these newer clocks are way better than grim age. Why? Because we better than grim age. Why? Because we better than grim age. Why? Because we need even better clocks for clinical need even better clocks for clinical need even better clocks for clinical trials. trials. trials. >> Yeah. >> Yeah. >> Yeah. >> Mhm. I think >> Mhm. I think >> Mhm. I think since we're talking about new technology since we're talking about new technology since we're talking about new technology and you know it's something that I'm and you know it's something that I'm and you know it's something that I'm super interested in as you know that is super interested in as you know that is super interested in as you know that is and it's just this this concept that in and it's just this this concept that in and it's just this this concept that in in that goes back to the Yamanaka in that goes back to the Yamanaka in that goes back to the Yamanaka factors and basically the the birth of factors and basically the the birth of factors and basically the the birth of these induced potent stem cells right I these induced potent stem cells right I these induced potent stem cells right I mean Yam Chinya Yamanaka won the Nobel mean Yam Chinya Yamanaka won the Nobel mean Yam Chinya Yamanaka won the Nobel Prize in was it 2006 Prize in was it 2006 Prize in was it 2006 >> for discovering you could add four >> for discovering you could add four >> for discovering you could add four transcription factor proteins. These, transcription factor proteins. These, transcription factor proteins. These, for people listening, are a type of for people listening, are a type of for people listening, are a type of protein that can, you know, change the protein that can, you know, change the protein that can, you know, change the way several different genes are way several different genes are way several different genes are expressed, expressed, expressed, >> activated, deactivated, >> activated, deactivated, >> activated, deactivated, >> and he could add them to any cell, old >> and he could add them to any cell, old >> and he could add them to any cell, old cell, a skin cell from an 80-year-old, cell, a skin cell from an 80-year-old, cell, a skin cell from an 80-year-old, and revert that cell to a to a, you and revert that cell to a to a, you and revert that cell to a to a, you know, pur potent stem cell state, which know, pur potent stem cell state, which know, pur potent stem cell state, which is so cool. is so cool. is so cool. >> Yes. >> Yes. >> Yes. >> And fascinating. Yes. And you could just >> And fascinating. Yes. And you could just >> And fascinating. Yes. And you could just sit there and think about that for hours sit there and think about that for hours sit there and think about that for hours and all the things that it means and how and all the things that it means and how and all the things that it means and how it happens and you know I mean just on it happens and you know I mean just on it happens and you know I mean just on and on. So you know the the and we I and on. So you know the the and we I and on. So you know the the and we I think we talked a little bit about this think we talked a little bit about this think we talked a little bit about this in our last conversation which is you in our last conversation which is you in our last conversation which is you know what happens to the epiggenome know what happens to the epiggenome know what happens to the epiggenome when you reset it from like an older when you reset it from like an older when you reset it from like an older more differentiated type of cell like more differentiated type of cell like more differentiated type of cell like the skin to a stem cell. And it seems the skin to a stem cell. And it seems the skin to a stem cell. And it seems like the epiggenome like the epiggenome like the epiggenome changes right? changes right? changes right? >> For sure. you know so um back in 2013 I >> For sure. you know so um back in 2013 I >> For sure. you know so um back in 2013 I published the pan tissue clock figure published the pan tissue clock figure published the pan tissue clock figure five in that paper showed yamanaka five in that paper showed yamanaka five in that paper showed yamanaka factors reversed the age to a prenatal factors reversed the age to a prenatal factors reversed the age to a prenatal state so so you take a skin cell from a state so so you take a skin cell from a state so so you take a skin cell from a 50 year old and um the epigenetic age of 50 year old and um the epigenetic age of 50 year old and um the epigenetic age of an induced puripotent stem cells is a an induced puripotent stem cells is a an induced puripotent stem cells is a negative number meaning prenatal you negative number meaning prenatal you negative number meaning prenatal you know and of course so many people have know and of course so many people have know and of course so many people have worked on the idea then to apply these worked on the idea then to apply these worked on the idea then to apply these um Yamanaka factors briefly um Yamanaka factors briefly um Yamanaka factors briefly um and briefly interrupted um and briefly interrupted um and briefly interrupted reprogramming. There are many names in reprogramming. There are many names in reprogramming. There are many names in that field. Juan Carlos Belmont um that field. Juan Carlos Belmont um that field. Juan Carlos Belmont um Manuel Serrano but so many more who have Manuel Serrano but so many more who have Manuel Serrano but so many more who have worked on David Sinclair famously who worked on David Sinclair famously who worked on David Sinclair famously who who now um has a clinical trial for who now um has a clinical trial for who now um has a clinical trial for optic nerve regeneration based on that optic nerve regeneration based on that optic nerve regeneration based on that idea. Yeah, but um the idea being so idea. Yeah, but um the idea being so idea. Yeah, but um the idea being so apply these factors or a subset of these apply these factors or a subset of these apply these factors or a subset of these factors to rejuvenate organs and why factors to rejuvenate organs and why factors to rejuvenate organs and why inter inter inter >> rejuvenate but keep their their >> rejuvenate but keep their their >> rejuvenate but keep their their identity, right? They're not going to identity, right? They're not going to identity, right? They're not going to become a stem cell. become a stem cell. become a stem cell. >> Exactly. Because you don't ever want >> Exactly. Because you don't ever want >> Exactly. Because you don't ever want that skin cell forgets that it's a skin that skin cell forgets that it's a skin that skin cell forgets that it's a skin cell or a liver cell that it's a liver cell or a liver cell that it's a liver cell or a liver cell that it's a liver cell. And why is that dangerous to cell. And why is that dangerous to cell. And why is that dangerous to cancer? That's a um great danger. And um cancer? That's a um great danger. And um cancer? That's a um great danger. And um there have have been substantial um there have have been substantial um there have have been substantial um developments. So on the one hand I developments. So on the one hand I developments. So on the one hand I mentioned the study from David Sinclair mentioned the study from David Sinclair mentioned the study from David Sinclair where he now administers where he now administers where he now administers um adeno associated virus and AAV to the um adeno associated virus and AAV to the um adeno associated virus and AAV to the eye of people who um really need to eye of people who um really need to eye of people who um really need to regrow optic nerve or um and um the the regrow optic nerve or um and um the the regrow optic nerve or um and um the the study apparently will start this year study apparently will start this year study apparently will start this year 2026. So the the longevity field is 2026. So the the longevity field is 2026. So the the longevity field is waited waiting with a baited breath. waited waiting with a baited breath. waited waiting with a baited breath. Will that succeed? It would be a triumph Will that succeed? It would be a triumph Will that succeed? It would be a triumph for the whole field. for the whole field. for the whole field. There have been extensive There have been extensive There have been extensive characterizations in mice. So which kind characterizations in mice. So which kind characterizations in mice. So which kind of organs benefit if you target them um of organs benefit if you target them um of organs benefit if you target them um and also in vitro. So we understand and also in vitro. So we understand and also in vitro. So we understand quite a lot but um what companies quite a lot but um what companies quite a lot but um what companies struggle with is where exactly do you struggle with is where exactly do you struggle with is where exactly do you deploy it for what kind of condition deploy it for what kind of condition deploy it for what kind of condition always keeping in mind um to ensure always keeping in mind um to ensure always keeping in mind um to ensure safety. safety. safety. >> Yeah. And there's questions in my mind >> Yeah. And there's questions in my mind >> Yeah. And there's questions in my mind that are even more mechanistic you know that are even more mechanistic you know that are even more mechanistic you know just because that interests me. Yes. just because that interests me. Yes. just because that interests me. Yes. which is, you know, if you are if you're which is, you know, if you are if you're which is, you know, if you are if you're taking an old cell that has these taking an old cell that has these taking an old cell that has these hallmarks of aging, there's like 12 of hallmarks of aging, there's like 12 of hallmarks of aging, there's like 12 of them now, right? You're talking about them now, right? You're talking about them now, right? You're talking about mitochondrial dysfunction. You know, mitochondrial dysfunction. You know, mitochondrial dysfunction. You know, inflammation is now even a hallmark. It inflammation is now even a hallmark. It inflammation is now even a hallmark. It used to be just this amplifier that used to be just this amplifier that used to be just this amplifier that still is an amplifier, but you know, you still is an amplifier, but you know, you still is an amplifier, but you know, you have your proteostasis have your proteostasis have your proteostasis isn't working right. So, it's um your isn't working right. So, it's um your isn't working right. So, it's um your proteins are fold not folding properly proteins are fold not folding properly proteins are fold not folding properly and they're also being not degraded and they're also being not degraded and they're also being not degraded properly. You've got DNA damage, nuclear properly. You've got DNA damage, nuclear properly. You've got DNA damage, nuclear damage, genomic instability, all these damage, genomic instability, all these damage, genomic instability, all these things that are that happen with age in things that are that happen with age in things that are that happen with age in older cells. older cells. older cells. And if you're going to change if you're And if you're going to change if you're And if you're going to change if you're basically just going to change the way basically just going to change the way basically just going to change the way the gene expression pattern is in the the gene expression pattern is in the the gene expression pattern is in the epiggenome, so to speak. epiggenome, so to speak. epiggenome, so to speak. >> Yes. >> Yes. >> Yes. >> Like how does that get rid of all this >> Like how does that get rid of all this >> Like how does that get rid of all this damage damage damage >> and what doesn't it get rid of? >> and what doesn't it get rid of? >> and what doesn't it get rid of? >> Yeah. apparently it doesn't get rid of >> Yeah. apparently it doesn't get rid of >> Yeah. apparently it doesn't get rid of all types of damage. Um the obvious all types of damage. Um the obvious all types of damage. Um the obvious damage is of course um various somatic damage is of course um various somatic damage is of course um various somatic mutations in the DNA if um you just mutations in the DNA if um you just mutations in the DNA if um you just don't touch it. Um the impressive part don't touch it. Um the impressive part don't touch it. Um the impressive part is how many hallmarks do get reset you is how many hallmarks do get reset you is how many hallmarks do get reset you know um I seem to remember one aspect know um I seem to remember one aspect know um I seem to remember one aspect that wasn't restored was tumier length that wasn't restored was tumier length that wasn't restored was tumier length so that wasn't um so that wasn't um so that wasn't um >> and also um even when it comes to the >> and also um even when it comes to the >> and also um even when it comes to the epiggenome epiggenome epiggenome c there are vestigages that don't seem c there are vestigages that don't seem c there are vestigages that don't seem to be touched by that you know so to be touched by that you know so to be touched by that you know so certain cytoines that certain cytoines that certain cytoines that >> do not get completely reversed you know >> do not get completely reversed you know >> do not get completely reversed you know so Um, so Um, so Um, >> it's so interesting. Do Do mitochondria >> it's so interesting. Do Do mitochondria >> it's so interesting. Do Do mitochondria get healthier? get healthier? get healthier? >> Yes. Mhm. So, mitochondria >> Yes. Mhm. So, mitochondria >> Yes. Mhm. So, mitochondria >> oxidative. >> oxidative. >> oxidative. >> What about mitochondrial DNA? >> What about mitochondrial DNA? >> What about mitochondrial DNA? >> Yeah. Uh, sorry, no, I I forgot. Yeah. >> Yeah. Uh, sorry, no, I I forgot. Yeah. >> Yeah. Uh, sorry, no, I I forgot. Yeah. >> So, mitochondria get healthier. Yes. >> So, mitochondria get healthier. Yes. >> So, mitochondria get healthier. Yes. >> Um, stem cells stem cells get >> Um, stem cells stem cells get >> Um, stem cells stem cells get >> Yes. >> Yes. >> Yes. >> rejuvenated or what do you what do they >> rejuvenated or what do you what do they >> rejuvenated or what do you what do they just start working better? I mean what just start working better? I mean what just start working better? I mean what >> um I want to um draw an attention >> um I want to um draw an attention >> um I want to um draw an attention because most of our conversation was because most of our conversation was because most of our conversation was about epigenetic clocks and now we talk about epigenetic clocks and now we talk about epigenetic clocks and now we talk about other readers. about other readers. about other readers. >> Yes. >> Yes. >> Yes. >> Um it's important to distinguish because >> Um it's important to distinguish because >> Um it's important to distinguish because >> um methylation clocks do detect a >> um methylation clocks do detect a >> um methylation clocks do detect a benefit of interrupted reprogramming in benefit of interrupted reprogramming in benefit of interrupted reprogramming in certain organs but not all. I just want certain organs but not all. I just want certain organs but not all. I just want to alert to alert to alert >> which organs do they not or which do >> which organs do they not or which do >> which organs do they not or which do they do do detect? You know, I remember they do do detect? You know, I remember they do do detect? You know, I remember um I'm trying to think of old um I'm trying to think of old um I'm trying to think of old publications, but I remember in skin publications, but I remember in skin publications, but I remember in skin there was a strong effect. I want to say there was a strong effect. I want to say there was a strong effect. I want to say um also muscle, you know, um also muscle, you know, um also muscle, you know, >> it's just not all organs. Um um and now >> it's just not all organs. Um um and now >> it's just not all organs. Um um and now I'm talking about interrupted I'm talking about interrupted I'm talking about interrupted reprogramming because as we said if you reprogramming because as we said if you reprogramming because as we said if you go all the way you will find an effect go all the way you will find an effect go all the way you will find an effect you know but I um I mention it because you know but I um I mention it because you know but I um I mention it because um um when it comes to that um um um when it comes to that um um um when it comes to that um intervention you really want to measure intervention you really want to measure intervention you really want to measure many readouts that we discussed you know many readouts that we discussed you know many readouts that we discussed you know so um above all organ function test you so um above all organ function test you so um above all organ function test you know so depending on the target organ know so depending on the target organ know so depending on the target organ you need to really establish that it you need to really establish that it you need to really establish that it works Well, as an example, if you study works Well, as an example, if you study works Well, as an example, if you study the liver, really measure the liver the liver, really measure the liver the liver, really measure the liver functioning, you know, or kidney, you functioning, you know, or kidney, you functioning, you know, or kidney, you know, that um just show functional know, that um just show functional know, that um just show functional restoration on a molecular level. Um restoration on a molecular level. Um restoration on a molecular level. Um there have been very detailed functions there have been very detailed functions there have been very detailed functions of gene transcription rever um that of gene transcription rever um that of gene transcription rever um that indicate that the gene expression indicate that the gene expression indicate that the gene expression reverses reverses reverses reverts back to a more youthful profile. reverts back to a more youthful profile. reverts back to a more youthful profile. But there's a problem with that But there's a problem with that But there's a problem with that statement that many people may not statement that many people may not statement that many people may not appreciate which is um it's actually appreciate which is um it's actually appreciate which is um it's actually very difficult to build clocks based on very difficult to build clocks based on very difficult to build clocks based on gene expression. Um so what does it mean gene expression. Um so what does it mean gene expression. Um so what does it mean that gene expression is rejuvenated and that gene expression is rejuvenated and that gene expression is rejuvenated and the field has struggled with that for the field has struggled with that for the field has struggled with that for many many years you know but um but I many many years you know but um but I many many years you know but um but I can mention so people look at so-called can mention so people look at so-called can mention so people look at so-called um mezenymal markers so um um some of um mezenymal markers so um um some of um mezenymal markers so um um some of you may have heard epithelial messenymal you may have heard epithelial messenymal you may have heard epithelial messenymal transition so transition so transition so um change their phenotype as we age in um change their phenotype as we age in um change their phenotype as we age in part due to inflammatory signals. So the part due to inflammatory signals. So the part due to inflammatory signals. So the an epithelial cell forgets that it's an an epithelial cell forgets that it's an an epithelial cell forgets that it's an epithelial cells. It thinks it's um epithelial cells. It thinks it's um epithelial cells. It thinks it's um meenyal cell. Um but anyway, so so meenyal cell. Um but anyway, so so meenyal cell. Um but anyway, so so that's a readout inflammatory markers. that's a readout inflammatory markers. that's a readout inflammatory markers. Um um um we mentioned oxidative Um um um we mentioned oxidative Um um um we mentioned oxidative phosphorilation. So various readouts phosphorilation. So various readouts phosphorilation. So various readouts that convince a researcher okay the cell that convince a researcher okay the cell that convince a researcher okay the cell seems to be younger. Mhm. seems to be younger. Mhm. seems to be younger. Mhm. >> If we talk about the extreme case of of >> If we talk about the extreme case of of >> If we talk about the extreme case of of making an induced pipotent stem cell, do making an induced pipotent stem cell, do making an induced pipotent stem cell, do the somatic mutations persist in that as the somatic mutations persist in that as the somatic mutations persist in that as well? well? well? >> Yes. >> Yes. >> Yes. >> That's disappointing >> That's disappointing >> That's disappointing >> because you cannot touch it, right? It's >> because you cannot touch it, right? It's >> because you cannot touch it, right? It's a DNA is changed. a DNA is changed. a DNA is changed. >> Yeah. I mean, it's just >> Yeah. I mean, it's just >> Yeah. I mean, it's just >> you you we got to solve that problem, >> you you we got to solve that problem, >> you you we got to solve that problem, you No, but you need to ask a different you No, but you need to ask a different you No, but you need to ask a different question perhaps that is has a hopeful question perhaps that is has a hopeful question perhaps that is has a hopeful answer perhaps answer perhaps answer perhaps >> which is do somatic mutations actually >> which is do somatic mutations actually >> which is do somatic mutations actually matter matter matter >> that's a and um now um to be clear um >> that's a and um now um to be clear um >> that's a and um now um to be clear um cancer is often due to somatic cancer is often due to somatic cancer is often due to somatic mutations. So if you say does cancer mutations. So if you say does cancer mutations. So if you say does cancer matter of course it does but what matter of course it does but what matter of course it does but what happens as we age all cells in your body happens as we age all cells in your body happens as we age all cells in your body accumulate somatic mutations. They accumulate somatic mutations. They accumulate somatic mutations. They really do really do really do >> and the question is does that actually >> and the question is does that actually >> and the question is does that actually translate to biologic aging? And translate to biologic aging? And translate to biologic aging? And >> doesn't it depend where the mutations >> doesn't it depend where the mutations >> doesn't it depend where the mutations are? Of course, and you already asked are? Of course, and you already asked are? Of course, and you already asked the right question because most of these the right question because most of these the right question because most of these zomatic mutations have zero consequence. zomatic mutations have zero consequence. zomatic mutations have zero consequence. That's and I love that actually. That's and I love that actually. That's and I love that actually. By the way, the same statement holds for By the way, the same statement holds for By the way, the same statement holds for methylation. As I mentioned, millions of methylation. As I mentioned, millions of methylation. As I mentioned, millions of changes, but fortunately, many of them changes, but fortunately, many of them changes, but fortunately, many of them don't matter. But same with somatic don't matter. But same with somatic don't matter. But same with somatic mutations you know and um when you ask mutations you know and um when you ask mutations you know and um when you ask aging researchers how important are aging researchers how important are aging researchers how important are somatic mutations for true blue aging somatic mutations for true blue aging somatic mutations for true blue aging you know you will get different answers. you know you will get different answers. you know you will get different answers. So some people will say it's hugely So some people will say it's hugely So some people will say it's hugely important and then there are other important and then there are other important and then there are other people will say it's negligible. It um people will say it's negligible. It um people will say it's negligible. It um the field is really split on that the field is really split on that the field is really split on that question. question. question. >> Yeah. I mean if you're getting somatic >> Yeah. I mean if you're getting somatic >> Yeah. I mean if you're getting somatic mutations in regular regulatory parts of mutations in regular regulatory parts of mutations in regular regulatory parts of the genes or even you know parts that the genes or even you know parts that the genes or even you know parts that are are are promoter whatever I mean you'd think promoter whatever I mean you'd think promoter whatever I mean you'd think that you start to have dysfunction and that you start to have dysfunction and that you start to have dysfunction and level of the proteins right things level of the proteins right things level of the proteins right things aren't going to work properly but again aren't going to work properly but again aren't going to work properly but again if if is the key word if you get them in if if is the key word if you get them in if if is the key word if you get them in those regions so you would think the those regions so you would think the those regions so you would think the more I mean obviously if you get more more I mean obviously if you get more more I mean obviously if you get more and more of these mutations then the and more of these mutations then the and more of these mutations then the chance of you having it in a part that chance of you having it in a part that chance of you having it in a part that matters goes up right like matters goes up right like matters goes up right like >> for Sure. I mean, we just to be clear, >> for Sure. I mean, we just to be clear, >> for Sure. I mean, we just to be clear, we don't want it. The question is uh how we don't want it. The question is uh how we don't want it. The question is uh how bad are they? Let me um turn it around bad are they? Let me um turn it around bad are they? Let me um turn it around and ask a question to you and the and ask a question to you and the and ask a question to you and the audience. audience. audience. >> Imagine you had a way to completely stop >> Imagine you had a way to completely stop >> Imagine you had a way to completely stop somatic mutation. You have the perfect somatic mutation. You have the perfect somatic mutation. You have the perfect therapy. Would you stop aging? therapy. Would you stop aging? therapy. Would you stop aging? >> I mean, can't we use crisper to sort of >> I mean, can't we use crisper to sort of >> I mean, can't we use crisper to sort of I mean, if you if there was a way you I mean, if you if there was a way you I mean, if you if there was a way you could every time you got a mutation just could every time you got a mutation just could every time you got a mutation just use crisper to change it. use crisper to change it. use crisper to change it. >> Yeah. And also coming back to DNA >> Yeah. And also coming back to DNA >> Yeah. And also coming back to DNA repair, right? So you you let's say you repair, right? So you you let's say you repair, right? So you you let's say you have ways to improve DNA repair. have ways to improve DNA repair. have ways to improve DNA repair. >> Um I'm asking the question because um um >> Um I'm asking the question because um um >> Um I'm asking the question because um um my answer is the following. I think if my answer is the following. I think if my answer is the following. I think if you stopped all sorts of um if you you stopped all sorts of um if you you stopped all sorts of um if you completely stopped somatic mutations, I completely stopped somatic mutations, I completely stopped somatic mutations, I think you would still age. Um I don't think you would still age. Um I don't think you would still age. Um I don't have uh definitive proof, but I that's have uh definitive proof, but I that's have uh definitive proof, but I that's where I'm at. You know, for me, um, a where I'm at. You know, for me, um, a where I'm at. You know, for me, um, a lot of aging. lot of aging. lot of aging. >> But would you age slower? >> But would you age slower? >> But would you age slower? >> Yeah, no question. It has a benefit. You >> Yeah, no question. It has a benefit. You >> Yeah, no question. It has a benefit. You would still age, you know, would still age, you know, would still age, you know, >> still age for sure. It's not No, >> still age for sure. It's not No, >> still age for sure. It's not No, >> but you would because, um, aging happens >> but you would because, um, aging happens >> but you would because, um, aging happens at all levels. We mentioned the at all levels. We mentioned the at all levels. We mentioned the epiggenome today a lot, epiggenome today a lot, epiggenome today a lot, >> but also the transcriptto and the >> but also the transcriptto and the >> but also the transcriptto and the proteome. Yeah. Right. proteins proteome. Yeah. Right. proteins proteome. Yeah. Right. proteins aggregate and that protein aggregation aggregate and that protein aggregation aggregate and that protein aggregation may have nothing to do with zomatic may have nothing to do with zomatic may have nothing to do with zomatic mutations or even methylation you know mutations or even methylation you know mutations or even methylation you know and so I mean damage accumulation and so I mean damage accumulation and so I mean damage accumulation happens at so many levels and the debate happens at so many levels and the debate happens at so many levels and the debate is in certain ways um which um how much is in certain ways um which um how much is in certain ways um which um how much do we gain if we clean up damage at a do we gain if we clean up damage at a do we gain if we clean up damage at a certain level you know certain level you know certain level you know >> all the all the damage >> all the all the damage >> all the all the damage >> so there's 12 hallmarks right that's why >> so there's 12 hallmarks right that's why >> so there's 12 hallmarks right that's why I mean obviously genome stability is I mean obviously genome stability is I mean obviously genome stability is just one right just one right just one right >> so if you take care of that, you're >> so if you take care of that, you're >> so if you take care of that, you're still got 11 more to take care of. still got 11 more to take care of. still got 11 more to take care of. You're still going to be aging. But so You're still going to be aging. But so You're still going to be aging. But so if you were to clean up all 12, if you were to clean up all 12, if you were to clean up all 12, >> I mean, there's no doubt you have a >> I mean, there's no doubt you have a >> I mean, there's no doubt you have a benefit. benefit. benefit. >> Then what happens? I mean, >> Then what happens? I mean, >> Then what happens? I mean, >> but you know, I liked our earlier >> but you know, I liked our earlier >> but you know, I liked our earlier discussion about um let's say organ discussion about um let's say organ discussion about um let's say organ transplantation because I'm looking for transplantation because I'm looking for transplantation because I'm looking for a miracle intervention. I'm making a miracle intervention. I'm making a miracle intervention. I'm making something up. something up. something up. >> Okay. >> Okay. >> Okay. >> Imagine somebody has a pill that really >> Imagine somebody has a pill that really >> Imagine somebody has a pill that really prevents sarcopenia. you keep your prevents sarcopenia. you keep your prevents sarcopenia. you keep your muscle strength. Could it be that this muscle strength. Could it be that this muscle strength. Could it be that this benefits so many organs and suddenly we benefits so many organs and suddenly we benefits so many organs and suddenly we increase health span by 5 years, you increase health span by 5 years, you increase health span by 5 years, you know, or we have another pill um that know, or we have another pill um that know, or we have another pill um that really um preserves your kidney really um preserves your kidney really um preserves your kidney function, you know, how much do you function, you know, how much do you function, you know, how much do you gain? So, I I like uh these silver gain? So, I I like uh these silver gain? So, I I like uh these silver bullet dreams. You have one bullet dreams. You have one bullet dreams. You have one intervention, you really improve one intervention, you really improve one intervention, you really improve one organ and it have has massive benefit. organ and it have has massive benefit. organ and it have has massive benefit. We know that. We know resistance We know that. We know resistance We know that. We know resistance training absolutely helps you not only training absolutely helps you not only training absolutely helps you not only maintain but increase your muscle mass maintain but increase your muscle mass maintain but increase your muscle mass and that's hugely important for life and that's hugely important for life and that's hugely important for life expectancy and quality of life. So I expectancy and quality of life. So I expectancy and quality of life. So I mean I would imagine if you just mean I would imagine if you just mean I would imagine if you just improved muscle function with age that improved muscle function with age that improved muscle function with age that you would have an effect on you would have an effect on you would have an effect on >> I'm I'm with you on that you know. >> I'm I'm with you on that you know. >> I'm I'm with you on that you know. >> Yeah. >> Yeah. >> Yeah. >> But let's now again talk about the 85y >> But let's now again talk about the 85y >> But let's now again talk about the 85y old. So you let's say we have such a old. So you let's say we have such a old. So you let's say we have such a pill. give them this intervention and um pill. give them this intervention and um pill. give them this intervention and um you really even restore muscle you really even restore muscle you really even restore muscle functioning, will they suddenly live 5 functioning, will they suddenly live 5 functioning, will they suddenly live 5 years years years >> longer? >> longer? >> longer? >> I hope they will, but I'm I'm just >> I hope they will, but I'm I'm just >> I hope they will, but I'm I'm just saying that these are the interventions. saying that these are the interventions. saying that these are the interventions. >> But what about their what about their >> But what about their what about their >> But what about their what about their heart their cardiovascular disease risk? heart their cardiovascular disease risk? heart their cardiovascular disease risk? >> I mean, if if if it's true that people's >> I mean, if if if it's true that people's >> I mean, if if if it's true that people's organs age at different rates and there organs age at different rates and there organs age at different rates and there is individual variation there. So you is individual variation there. So you is individual variation there. So you know maybe maybe my heart is aging know maybe maybe my heart is aging know maybe maybe my heart is aging faster than yours. Maybe you are more faster than yours. Maybe you are more faster than yours. Maybe you are more susceptible to your brain aging more. I susceptible to your brain aging more. I susceptible to your brain aging more. I don't know like if that is true. I mean don't know like if that is true. I mean don't know like if that is true. I mean >> it is true. >> it is true. >> it is true. >> It is right. I mean that's >> It is right. I mean that's >> It is right. I mean that's >> we know that even from methylation >> we know that even from methylation >> we know that even from methylation clocks. Yeah. clocks. Yeah. clocks. Yeah. >> That their or that that even even within >> That their or that that even even within >> That their or that that even even within a person and you know obviously their a person and you know obviously their a person and you know obviously their diet and their lifestyle everything's diet and their lifestyle everything's diet and their lifestyle everything's like it should be the same affecting the like it should be the same affecting the like it should be the same affecting the same organs the same but it doesn't same organs the same but it doesn't same organs the same but it doesn't right. Yes. either it doesn't or there's right. Yes. either it doesn't or there's right. Yes. either it doesn't or there's other things that are that are happening other things that are that are happening other things that are that are happening um that we don't quite understand. But um that we don't quite understand. But um that we don't quite understand. But um where was I going with this? Yeah, um where was I going with this? Yeah, um where was I going with this? Yeah, that basically if our organs are a aging that basically if our organs are a aging that basically if our organs are a aging at different rates then you know at different rates then you know at different rates then you know obviously the the muscle would only obviously the the muscle would only obviously the the muscle would only affect the people that are going to die affect the people that are going to die affect the people that are going to die from their falls or whatever. You know I from their falls or whatever. You know I from their falls or whatever. You know I I I don't know. Yes. I I don't know. Yes. I I don't know. Yes. >> Um I think I think it's the uh it's an >> Um I think I think it's the uh it's an >> Um I think I think it's the uh it's an interesting it's an interesting question interesting it's an interesting question interesting it's an interesting question in terms of like what organs are aging in terms of like what organs are aging in terms of like what organs are aging faster in you and you know there's faster in you and you know there's faster in you and you know there's biomarkers that can help you understand biomarkers that can help you understand biomarkers that can help you understand that risk but the aging clocks that is that risk but the aging clocks that is that risk but the aging clocks that is something that people can now go and something that people can now go and something that people can now go and test right test right test right >> yes that's where the field is at so um >> yes that's where the field is at so um >> yes that's where the field is at so um and now I'm talking about the biomarker and now I'm talking about the biomarker and now I'm talking about the biomarker field in general so um people have field in general so um people have field in general so um people have developed um protein markers of various developed um protein markers of various developed um protein markers of various organ orans which is the obvious thing organ orans which is the obvious thing organ orans which is the obvious thing you know organs secrete various proteins you know organs secrete various proteins you know organs secrete various proteins or measure them you know or measure them you know or measure them you know >> the exciting aspect is that um the same >> the exciting aspect is that um the same >> the exciting aspect is that um the same has happened at the level of um has happened at the level of um has happened at the level of um methylation so people have methylation methylation so people have methylation methylation so people have methylation readouts of different organs I'm not readouts of different organs I'm not readouts of different organs I'm not saying they are optimized there's room saying they are optimized there's room saying they are optimized there's room for improvement perhaps to be seen but for improvement perhaps to be seen but for improvement perhaps to be seen but um that's how I envision really um um that's how I envision really um um that's how I envision really um medicine 2.0 And O preventative medicine 2.0 And O preventative medicine 2.0 And O preventative medicine, you measure many readouts of medicine, you measure many readouts of medicine, you measure many readouts of organ function. You diagnose that organ function. You diagnose that organ function. You diagnose that something is going the wrong way and something is going the wrong way and something is going the wrong way and then you target it. You restore it. You then you target it. You restore it. You then you target it. You restore it. You know, precision medicine really. know, precision medicine really. know, precision medicine really. >> I even I even, >> I even I even, >> I even I even, >> you know, I've done my my >> you know, I've done my my >> you know, I've done my my gene array before and looked at there's gene array before and looked at there's gene array before and looked at there's like all these different companies that like all these different companies that like all these different companies that are able to go and look at your snips or are able to go and look at your snips or are able to go and look at your snips or even your whole genome. And even those even your whole genome. And even those even your whole genome. And even those tests when you when you get the raw data tests when you when you get the raw data tests when you when you get the raw data back and sort of look at them, you'll back and sort of look at them, you'll back and sort of look at them, you'll have genes that say, "Oh, you're have genes that say, "Oh, you're have genes that say, "Oh, you're predisposed to coronary heart disease or predisposed to coronary heart disease or predisposed to coronary heart disease or you know, so they're already sort of you know, so they're already sort of you know, so they're already sort of targeting organs or neurogenerative targeting organs or neurogenerative targeting organs or neurogenerative disease like Alzheimer's disease." So we disease like Alzheimer's disease." So we disease like Alzheimer's disease." So we know there are even genes that are know there are even genes that are know there are even genes that are involved in predisposing you to certain involved in predisposing you to certain involved in predisposing you to certain diseases. diseases. diseases. >> True. >> True. >> True. >> That are based on your organs. And so it >> That are based on your organs. And so it >> That are based on your organs. And so it makes sense that the methylation makes sense that the methylation makes sense that the methylation patterns would also play a role in that patterns would also play a role in that patterns would also play a role in that because they play a role in because they play a role in because they play a role in >> Yeah. You know, >> Yeah. You know, >> Yeah. You know, >> I want to briefly comment on that. Um >> I want to briefly comment on that. Um >> I want to briefly comment on that. Um because I used to be an um a human because I used to be an um a human because I used to be an um a human geneticist actually at some point I geneticist actually at some point I geneticist actually at some point I studied genetics. Um and you're entirely studied genetics. Um and you're entirely studied genetics. Um and you're entirely correct. Of course there are these snips correct. Of course there are these snips correct. Of course there are these snips and also polygenic risk scores for and also polygenic risk scores for and also polygenic risk scores for various disorders but I would like that various disorders but I would like that various disorders but I would like that people know these associations are people know these associations are people know these associations are absolutely minute more often than not. I absolutely minute more often than not. I absolutely minute more often than not. I mean they are famous association mean they are famous association mean they are famous association APOE4 for Alzheimer's. there's strong APOE4 for Alzheimer's. there's strong APOE4 for Alzheimer's. there's strong association but I just want you to know association but I just want you to know association but I just want you to know that if you have a a genetic risk for a that if you have a a genetic risk for a that if you have a a genetic risk for a certain cardiovascular disease these certain cardiovascular disease these certain cardiovascular disease these effects are absolutely minute and they effects are absolutely minute and they effects are absolutely minute and they are dwarfed by you just walking your are dwarfed by you just walking your are dwarfed by you just walking your 10,000 steps okay I mean it's like I um 10,000 steps okay I mean it's like I um 10,000 steps okay I mean it's like I um >> however interestingly methylation is a >> however interestingly methylation is a >> however interestingly methylation is a far stronger signal than um snips so far stronger signal than um snips so far stronger signal than um snips so epigenetics um order of magnitude more epigenetics um order of magnitude more epigenetics um order of magnitude more informative than genetics, you know. informative than genetics, you know. informative than genetics, you know. >> So, looking at the epigenetic organ >> So, looking at the epigenetic organ >> So, looking at the epigenetic organ specific epigenetic clocks even. specific epigenetic clocks even. specific epigenetic clocks even. >> Yes. It's it's just you can't compare >> Yes. It's it's just you can't compare >> Yes. It's it's just you can't compare it, you know. I'm a health nut. I I it, you know. I'm a health nut. I I it, you know. I'm a health nut. I I spent uh many hundreds of dollars on spent uh many hundreds of dollars on spent uh many hundreds of dollars on various tests. Many tests have no use. I various tests. Many tests have no use. I various tests. Many tests have no use. I just But I I haven't spent money on a just But I I haven't spent money on a just But I I haven't spent money on a G-W was test. Um um I mean I did for G-W was test. Um um I mean I did for G-W was test. Um um I mean I did for ancestry. I just want you to know that ancestry. I just want you to know that ancestry. I just want you to know that it doesn't inform me personally, you it doesn't inform me personally, you it doesn't inform me personally, you know. So I I just think we have better know. So I I just think we have better know. So I I just think we have better readouts and we mentioned proteomics readouts and we mentioned proteomics readouts and we mentioned proteomics clocks you know so and and above all clocks you know so and and above all clocks you know so and and above all just your regular biochemist biochemical just your regular biochemist biochemical just your regular biochemist biochemical markers you know um just go with what markers you know um just go with what markers you know um just go with what the doctor orders there's a reason why the doctor orders there's a reason why the doctor orders there's a reason why your medical doctor doesn't order a your medical doctor doesn't order a your medical doctor doesn't order a genetic test for you know it's less genetic test for you know it's less genetic test for you know it's less informative informative informative >> right yes >> right yes >> right yes >> you're you're not doomed if you have a >> you're you're not doomed if you have a >> you're you're not doomed if you have a bad prognosis based on genetics you know bad prognosis based on genetics you know bad prognosis based on genetics you know just just just >> exactly absolutely not I mean there's a >> exactly absolutely not I mean there's a >> exactly absolutely not I mean there's a lot of people that have APOE4 that do lot of people that have APOE4 that do lot of people that have APOE4 that do not have Alzheimer's disease and there's not have Alzheimer's disease and there's not have Alzheimer's disease and there's a lot of people with Alzheimer's disease a lot of people with Alzheimer's disease a lot of people with Alzheimer's disease that do not have an ApoE4 alil. So that do not have an ApoE4 alil. So that do not have an ApoE4 alil. So >> true. >> true. >> true. >> It's not it's not it's not a >> It's not it's not it's not a >> It's not it's not it's not a >> hopeful message. Yeah. >> hopeful message. Yeah. >> hopeful message. Yeah. >> Yeah. Diet and lifestyle matter and >> Yeah. Diet and lifestyle matter and >> Yeah. Diet and lifestyle matter and that's kind of the point of the that's kind of the point of the that's kind of the point of the conversation that we had. We're talking conversation that we had. We're talking conversation that we had. We're talking about these epigenetic clocks as a, you about these epigenetic clocks as a, you about these epigenetic clocks as a, you know, biioarker readout that is a little know, biioarker readout that is a little know, biioarker readout that is a little bit, bit, bit, you know, more comprehensive than just you know, more comprehensive than just you know, more comprehensive than just getting a C reactive protein or HBA1C or getting a C reactive protein or HBA1C or getting a C reactive protein or HBA1C or even, you know, looking at your your even, you know, looking at your your even, you know, looking at your your lipid levels because it can actually lipid levels because it can actually lipid levels because it can actually look at your biological age, right? And look at your biological age, right? And look at your biological age, right? And that's so cool. So, um, thank you so that's so cool. So, um, thank you so that's so cool. So, um, thank you so much for for coming on. Is there much for for coming on. Is there much for for coming on. Is there anything else that we need to discuss anything else that we need to discuss anything else that we need to discuss that we didn't that we didn't that we didn't >> get to um so much? >> get to um so much? >> get to um so much? >> No, I think we covered everything. That >> No, I think we covered everything. That >> No, I think we covered everything. That was a real pleasure. Yeah. was a real pleasure. Yeah. was a real pleasure. Yeah. >> Have you done your your have you done >> Have you done your your have you done >> Have you done your your have you done any of these biological tests on any of these biological tests on any of these biological tests on yourself? You yourself? You yourself? You >> Yes, for sure. Um >> Yes, for sure. Um >> Yes, for sure. Um >> do you like the results? >> do you like the results? >> do you like the results? >> Yeah, I do. You know, so um I remember a >> Yeah, I do. You know, so um I remember a >> Yeah, I do. You know, so um I remember a pheno age result a couple of maybe half pheno age result a couple of maybe half pheno age result a couple of maybe half a year ago was 13 years younger if I a year ago was 13 years younger if I a year ago was 13 years younger if I remember that. I like that. So, I'm remember that. I like that. So, I'm remember that. I like that. So, I'm actually doing well on various um uh actually doing well on various um uh actually doing well on various um uh biologic tests. biologic tests. biologic tests. >> How old are you? >> How old are you? >> How old are you? >> I'm 58 right now. >> I'm 58 right now. >> I'm 58 right now. >> Oh, you're 58. Wow, you look great. >> Oh, you're 58. Wow, you look great. >> Oh, you're 58. Wow, you look great. >> I don't I look horrible. >> I don't I look horrible. >> I don't I look horrible. >> Thank you. But I look horrible. >> Thank you. But I look horrible. >> Thank you. But I look horrible. >> Have you done the organ specific one? >> Have you done the organ specific one? >> Have you done the organ specific one? >> Uh not yet, you know. So, yeah. >> Uh not yet, you know. So, yeah. >> Uh not yet, you know. So, yeah. >> Okay. >> Okay. >> Okay. >> I um again, I'm trying all sorts of >> I um again, I'm trying all sorts of >> I um again, I'm trying all sorts of health behaviors. I actually don't need health behaviors. I actually don't need health behaviors. I actually don't need any readouts, you know, for motivation. any readouts, you know, for motivation. any readouts, you know, for motivation. I'm a bit of a health nut. So I don't I'm a bit of a health nut. So I don't I'm a bit of a health nut. So I don't >> So what's your what's your what's your >> So what's your what's your what's your >> So what's your what's your what's your routine? What do you eat? What like what routine? What do you eat? What like what routine? What do you eat? What like what what's your health nut routine? Your what's your health nut routine? Your what's your health nut routine? Your supplements? supplements? supplements? >> Um I I go with validated interventions. >> Um I I go with validated interventions. >> Um I I go with validated interventions. We we talk about omega-3, multivitamin, We we talk about omega-3, multivitamin, We we talk about omega-3, multivitamin, creatin I take a lot. I By the way, I creatin I take a lot. I By the way, I creatin I take a lot. I By the way, I love your podcast. I learn a lot from love your podcast. I learn a lot from love your podcast. I learn a lot from you. you. you. >> It's um Yeah, I started multivitamin >> It's um Yeah, I started multivitamin >> It's um Yeah, I started multivitamin after you started talking about it. that after you started talking about it. that after you started talking about it. that motivated me. Um, from you, I learned motivated me. Um, from you, I learned motivated me. Um, from you, I learned the importance of, uh, having a cooling the importance of, uh, having a cooling the importance of, uh, having a cooling mattress for sleeping. So, I implemented mattress for sleeping. So, I implemented mattress for sleeping. So, I implemented that advice from you. that advice from you. that advice from you. >> Are you sleeping better? Do you sleep >> Are you sleeping better? Do you sleep >> Are you sleeping better? Do you sleep better? better? better? >> I think so. Yeah. But, um, by the way, I >> I think so. Yeah. But, um, by the way, I >> I think so. Yeah. But, um, by the way, I love placebo effects. They always work. love placebo effects. They always work. love placebo effects. They always work. Nothing wrong with that, you know. Nothing wrong with that, you know. Nothing wrong with that, you know. >> I don't like no SIBO effects, but I love >> I don't like no SIBO effects, but I love >> I don't like no SIBO effects, but I love placebo effects. placebo effects. placebo effects. >> That's right. Yeah. So I um the reason >> That's right. Yeah. So I um the reason >> That's right. Yeah. So I um the reason why I mentioned it I I do I think it why I mentioned it I I do I think it why I mentioned it I I do I think it worked you know but uh I don't have hard worked you know but uh I don't have hard worked you know but uh I don't have hard data on that you know. data on that you know. data on that you know. >> Do you take vitamin D? >> Do you take vitamin D? >> Do you take vitamin D? >> Yes >> Yes >> Yes >> vitamin D. And you eat a lot of >> vitamin D. And you eat a lot of >> vitamin D. And you eat a lot of vegetables exercise where how does that vegetables exercise where how does that vegetables exercise where how does that come in? come in? come in? >> Yeah I do every day 30 minutes you know >> Yeah I do every day 30 minutes you know >> Yeah I do every day 30 minutes you know not too much you know not too much you know not too much you know >> I follow routines you know. >> I follow routines you know. >> I follow routines you know. >> Yeah. >> Yeah. >> Yeah. >> I mean exercise needs to be a routine. >> I mean exercise needs to be a routine. >> I mean exercise needs to be a routine. It needs to be part of your personal It needs to be part of your personal It needs to be part of your personal hygiene. hygiene. hygiene. >> Yes. I also take medications again >> Yes. I also take medications again >> Yes. I also take medications again against high glucose. I'm I'm actually a against high glucose. I'm I'm actually a against high glucose. I'm I'm actually a pre-diabetic because of my decades of pre-diabetic because of my decades of pre-diabetic because of my decades of eating hundreds of grams of chocolate eating hundreds of grams of chocolate eating hundreds of grams of chocolate each day. So I I each day. So I I each day. So I I um but yeah, so I take something called um but yeah, so I take something called um but yeah, so I take something called a carbos, you know, to um but um also I a carbos, you know, to um but um also I a carbos, you know, to um but um also I take take take >> Does that have any effect on aging? A >> Does that have any effect on aging? A >> Does that have any effect on aging? A carbos has carbos has carbos has >> I have no idea, you know. So yeah, >> I have no idea, you know. So yeah, >> I have no idea, you know. So yeah, >> I I just um >> I I just um >> I I just um >> Yeah. So anyways, um I take statins, I >> Yeah. So anyways, um I take statins, I >> Yeah. So anyways, um I take statins, I take isettoype, you know, so take isettoype, you know, so take isettoype, you know, so >> various interventions where there's very >> various interventions where there's very >> various interventions where there's very credible evidence, you know, that they credible evidence, you know, that they credible evidence, you know, that they move the needle. I'm always impressed by move the needle. I'm always impressed by move the needle. I'm always impressed by people who swallow 120 pills, but it's people who swallow 120 pills, but it's people who swallow 120 pills, but it's not me. You know, I take a not me. You know, I take a not me. You know, I take a >> I take a lot, but not 120. Do you take >> I take a lot, but not 120. Do you take >> I take a lot, but not 120. Do you take ubiquininal? If you're taking a statin, ubiquininal? If you're taking a statin, ubiquininal? If you're taking a statin, you might want to you might want to you might want to >> think about that because it statins >> think about that because it statins >> think about that because it statins target the melonate pathway which is HMG target the melonate pathway which is HMG target the melonate pathway which is HMG COA important for cholesterol synthesis. COA important for cholesterol synthesis. COA important for cholesterol synthesis. That's why it's most widely prescribed That's why it's most widely prescribed That's why it's most widely prescribed drug for lowering LDL cholesterol, but drug for lowering LDL cholesterol, but drug for lowering LDL cholesterol, but also um that pathway is important for also um that pathway is important for also um that pathway is important for making CoQ10 in your mitochondria. Um making CoQ10 in your mitochondria. Um making CoQ10 in your mitochondria. Um and so that's something to consider as and so that's something to consider as and so that's something to consider as well. So taking CoQ10, I say well. So taking CoQ10, I say well. So taking CoQ10, I say ubiquininal, it's the reduced form ubiquininal, it's the reduced form ubiquininal, it's the reduced form ubiquinone also does the does the trick, ubiquinone also does the does the trick, ubiquinone also does the does the trick, but uh you might want to look into that but uh you might want to look into that but uh you might want to look into that as well. as well. as well. >> Thanks. I know I would learn something >> Thanks. I know I would learn something >> Thanks. I know I would learn something from visiting you. Well do. from visiting you. Well do. from visiting you. Well do. >> Well, Steve, thank you so much for all >> Well, Steve, thank you so much for all >> Well, Steve, thank you so much for all your contributions to the aging field your contributions to the aging field your contributions to the aging field and the ones that you continue to make. and the ones that you continue to make. and the ones that you continue to make. >> Um people can look up your publications >> Um people can look up your publications >> Um people can look up your publications and many many many publications. and many many many publications. and many many many publications. Where else you you're on X? What's your Where else you you're on X? What's your Where else you you're on X? What's your what's your what's your what's your >> I have a handle prof um my Twitter account is all about um my Twitter account is all about epigenetic clocks and um and longevity epigenetic clocks and um and longevity epigenetic clocks and um and longevity interventions. Um um but yeah um I want interventions. Um um but yeah um I want interventions. Um um but yeah um I want to thank you. I think you um really do a to thank you. I think you um really do a to thank you. I think you um really do a great service to the public to educate great service to the public to educate great service to the public to educate them. All I can say is I follow you. I them. All I can say is I follow you. I them. All I can say is I follow you. I listen to you. I think it's awesome. listen to you. I think it's awesome. listen to you. I think it's awesome. >> Thank you. Thank you so much. I I really >> Thank you. Thank you so much. I I really >> Thank you. Thank you so much. I I really appreciate that. Um, is there anywhere appreciate that. Um, is there anywhere appreciate that. Um, is there anywhere else you want to direct people to else you want to direct people to else you want to direct people to besides your Twitter and your besides your Twitter and your besides your Twitter and your publications? publications? publications? >> Um, no. Um, stay young. Um, um, try not >> Um, no. Um, stay young. Um, um, try not >> Um, no. Um, stay young. Um, um, try not to be stressed too much, you know, and, to be stressed too much, you know, and, to be stressed too much, you know, and, um, yeah, enjoy life. um, yeah, enjoy life. um, yeah, enjoy life. >> Enjoy life. I think that's good. Try not >> Enjoy life. I think that's good. Try not >> Enjoy life. I think that's good. Try not to stress too much because at the end of to stress too much because at the end of to stress too much because at the end of the day, your deadline the day, your deadline the day, your deadline >> doesn't really matter, right? I need to >> doesn't really matter, right? I need to >> doesn't really matter, right? I need to tell you. So the hopeful message about tell you. So the hopeful message about tell you. So the hopeful message about stress is that short-term stress does stress is that short-term stress does stress is that short-term stress does not seem to affect epigenetic clocks, not seem to affect epigenetic clocks, not seem to affect epigenetic clocks, psychological stress. So I I always love psychological stress. So I I always love psychological stress. So I I always love that. that. that. >> Repeat it. Short term is that repeatedly >> Repeat it. Short term is that repeatedly >> Repeat it. Short term is that repeatedly or just or just or just >> like >> like >> like >> So there's some literature that really >> So there's some literature that really >> So there's some literature that really severe psychological stress, we're severe psychological stress, we're severe psychological stress, we're talking now childhood talking now childhood talking now childhood sexual abuse, perhaps even PTSD sexual abuse, perhaps even PTSD sexual abuse, perhaps even PTSD that affects your epigenetic age. But I that affects your epigenetic age. But I that affects your epigenetic age. But I always like it that um these short-term always like it that um these short-term always like it that um these short-term stresses don't seem to touch you. So stresses don't seem to touch you. So stresses don't seem to touch you. So which is a hopeful message for everyone which is a hopeful message for everyone which is a hopeful message for everyone who is terrible who is terrible who is terrible >> like being worried about a podcast. >> like being worried about a podcast. >> like being worried about a podcast. >> That's right. I I have never deadlines. >> That's right. I I have never deadlines. >> That's right. I I have never deadlines. >> Exactly. So I've never seen evidence >> Exactly. So I've never seen evidence >> Exactly. So I've never seen evidence that this has a strong effect, you know. that this has a strong effect, you know. that this has a strong effect, you know. >> Well, don't stress too hard. That's the >> Well, don't stress too hard. That's the >> Well, don't stress too hard. That's the That's the bottom line. Thank you so That's the bottom line. Thank you so That's the bottom line. Thank you so much for this conversation. It was a much for this conversation. It was a much for this conversation. It was a pleasure. Yeah.